US20080097476A1 - Precision control systems for tissue visualization and manipulation assemblies - Google Patents

Precision control systems for tissue visualization and manipulation assemblies Download PDF

Info

Publication number
US20080097476A1
US20080097476A1 US11/848,429 US84842907A US2008097476A1 US 20080097476 A1 US20080097476 A1 US 20080097476A1 US 84842907 A US84842907 A US 84842907A US 2008097476 A1 US2008097476 A1 US 2008097476A1
Authority
US
United States
Prior art keywords
catheter
imaging
tissue
hood
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/848,429
Inventor
Ruey-Feng Peh
Vahid Saadat
Edmund Tam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intuitive Surgical Operations Inc
Original Assignee
Voyage Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Voyage Medical Inc filed Critical Voyage Medical Inc
Priority to US11/848,429 priority Critical patent/US20080097476A1/en
Assigned to VOYAGE MEDICAL, INC. reassignment VOYAGE MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PEH, RUEY-FENG, SAADAT, VAHID, TAM, EDMUND A.
Publication of US20080097476A1 publication Critical patent/US20080097476A1/en
Priority to US12/464,800 priority patent/US10070772B2/en
Assigned to Intuitive Surgical Operations, Inc. reassignment Intuitive Surgical Operations, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VOYAGE MEDICAL, INC.
Priority to US16/117,993 priority patent/US11779195B2/en
Priority to US18/462,175 priority patent/US20240032776A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00064Constructional details of the endoscope body
    • A61B1/00071Insertion part of the endoscope body
    • A61B1/0008Insertion part of the endoscope body characterised by distal tip features
    • A61B1/00082Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00064Constructional details of the endoscope body
    • A61B1/00071Insertion part of the endoscope body
    • A61B1/0008Insertion part of the endoscope body characterised by distal tip features
    • A61B1/00085Baskets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00064Constructional details of the endoscope body
    • A61B1/00071Insertion part of the endoscope body
    • A61B1/0008Insertion part of the endoscope body characterised by distal tip features
    • A61B1/00089Hoods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00064Constructional details of the endoscope body
    • A61B1/00071Insertion part of the endoscope body
    • A61B1/0008Insertion part of the endoscope body characterised by distal tip features
    • A61B1/00097Sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/005Flexible endoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/012Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
    • A61B1/015Control of fluid supply or evacuation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/012Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
    • A61B1/018Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00039Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
    • A61B2017/00044Sensing electrocardiography, i.e. ECG
    • A61B2017/00048Spectral analysis
    • A61B2017/00053Mapping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00106Sensing or detecting at the treatment site ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • A61B2017/003Steerable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B17/3423Access ports, e.g. toroid shape introducers for instruments or hands
    • A61B2017/3425Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00375Ostium, e.g. ostium of pulmonary vein or artery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00898Alarms or notifications created in response to an abnormal condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2068Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis using pointers, e.g. pointers having reference marks for determining coordinates of body points
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/30Surgical robots
    • A61B2034/301Surgical robots for introducing or steering flexible instruments inserted into the body, e.g. catheters or endoscopes

Definitions

  • the present invention relates generally to medical devices used for accessing, visualizing, and/or treating regions of tissue within a body. More particularly, the present invention relates to systems for controlling and navigating devices used to directly visualize and/or manipulate tissue regions within a body lumen which are generally difficult to access and/or image.
  • ultrasound devices have been used to produce images from within a body in vivo.
  • Ultrasound has been used both with, and without contrast agents, which typically enhance ultrasound-derived images.
  • catheters or probes having position sensors deployed within the body lumen such as the interior of a cardiac chamber.
  • positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.
  • Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging.
  • Other conventional balloons utilize a cavity, or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.
  • such imaging balloons have many inherent disadvantages. For instance, such balloons generally require that the balloon be inflated to a relatively large size which may undesirably displace surrounding tissue and interfere with fine positioning of the imaging system against the tissue. Moreover, the working area created by such inflatable balloons are generally cramped and limited in size. Furthermore, inflated balloons may be susceptible to pressure changes in the surrounding fluid. For example, if the environment surrounding the inflated balloon undergoes pressure changes, e.g., during systolic and diastolic pressure cycles; in a beating heart, the constant pressure change may affect, the inflated balloon volume and its positioning to produce unsteady or undesirable conditions for optimal tissue imaging.
  • these types of imaging modalities are generally unable to provide desirable images useful for sufficient diagnosis and therapy of the endoluminal structure, due in part to factors such as dynamic forces generated by the natural movement of the heart.
  • anatomic structures within, the body can occlude or obstruct the image acquisition process.
  • the presence and movement of opaque bodily fluids such as blood generally make in vivo imaging of tissue regions within the heart difficult.
  • CT computed tomography
  • MRI magnetic resonance imaging
  • fluoroscopic imaging is widely used to identify anatomic landmarks within the heart and other regions of fire body.
  • fluoroscopy fails to provide an accurate image of the tissue quality or surface and also fails to provide for instrumentation for performing tissue manipulation or other therapeutic procedures upon the visualized tissue regions.
  • fluoroscopy provides a shadow of tire intervening tissue onto a plate or sensor when it may be desirable to view the intraluminal surface of the tissue to diagnose pathologies or to perform some form of therapy on it.
  • tissue imaging system which is able to provide real-time in vivo images of tissue regions within body lumens such as the heart through opaque media such as blood and which also provide instruments for therapeutic procedures upon the visualized tissue are desirable.
  • tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below.
  • a tissue imaging and manipulation apparatus comprises ah optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.
  • the deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or assembly may be disposed for imaging tissue.
  • the imaging hood When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field is defined by the imaging hood.
  • the open area is the area within which the tissue region of interest may be imaged.
  • the imaging hood may also define an atraumatic contact lip or edge for placement or abutment against the tissue region of interest.
  • the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control
  • the deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.
  • fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open area completely and displaces any blood from within the open area.
  • the fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, FluorinertTM, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid.
  • the fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.
  • the tissue imaging and treatment system may generally comprise a catheter body having a lumen defined therethrough, a visualization element disposed adjacent the catheter body, the visualization element having a field of view, a transparent fluid source in fluid communication with the lumen, and a barrier or membrane extendable from the catheter body to localize, between the visualization element and the field of view, displacement of blood by transparent fluid that flows from the lumen, and a piercing instrument translatable through the displaced blood for piercing into the tissue surface within the field of view.
  • the imaging hood may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools which may be deployed through the deployment catheter.
  • the imaging hood may be utilized with various catheter control assemblies to provide for precise catheter motion.
  • robotically-controlled catheter systems may be utilized with, the imaging hood and various instruments delivered through the hood.
  • magnetic navigational systems may also be utilized to control and/or locate a hood within the patient body.
  • FIG. 1A shows a side view of one variation of a tissue imaging apparatus during deployment from a sheath or delivery catheter.
  • FIG. 1B shows the deployed tissue imaging apparatus of FIG. 1A having an optionally expandable hood or sheath attached to an imaging and/or diagnostic catheter.
  • FIG. 1C shows an end view of a deployed imaging apparatus.
  • FIGS. 1D to 1 F show the apparatus of FIGS. 1A to 1 C with an additional lumen, e.g. for passage of a guidewire therethrough.
  • FIGS. 2A and 2B show one example of a deployed tissue imager positioned against or adjacent to the tissue to be imaged and a flow of fluid, such as saline, displacing blood from within the expandable hood.
  • a flow of fluid such as saline
  • FIG. 3A shows an articulatable imaging assembly which may be manipulated, via push-pull wires or by computer control.
  • FIGS. 3B and 3C show steerable instruments, respectively, where an articulatable delivery catheter may be steered within the imaging hood or a distal portion of the deployment catheter itself may be steered.
  • FIGS. 4A to 4 C show side and cross-sectional end views, respectively, of another variation having an off-axis imaging capability.
  • FIG. 5 shows an illustrative view of an example of a tissue imager advanced intravascularly within a heart for imaging tissue regions within an atrial chamber.
  • FIGS. 6A to 6 C illustrate deployment catheters having one or more optional inflatable balloons or anchors for stabilizing the device during a procedure.
  • FIGS. 7A and 7B illustrate a variation of an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface.
  • an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface.
  • FIG. 7C shows another variation for anchoring the imaging hood having one or more tubular support members integrated with the imaging hood; each support members may define a lumen therethrough for advancing a helical tissue anchor within.
  • FIG. 8A shows an illustrative example of one variation of how a tissue imager may be utilized with an imaging device.
  • FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system.
  • FIGS. 9A to 9 C illustrate an example of capturing several images of the tissue at multiple regions.
  • FIGS. 10A and 10B show charts illustrating how fluid pressure within the imaging hood may be coordinated with the surrounding blood pressure; the fluid pressure in the imaging hood may be coordinated with the blood pressure or it may be regulated based, upon pressure feedback from the blood.
  • FIG. 11A shows a side view of another variation of a tissue imager having an imaging balloon within an expandable hood.
  • FIG. 11B shows another variation of a tissue imager utilizing a translucent or transparent imaging balloon.
  • FIG. 12A shows another variation in which a flexible expandable or distensible membrane may be incorporated within the imaging hood to alter the volume of fluid dispensed.
  • FIGS. 12B and 12C show another variation in which, the imaging hood may be partially or selectively deployed from the catheter to alter the area of the tissue being visualized as well as the volume of the dispensed fluid.
  • FIGS. 13A and 13B show exemplary side and cross-sectional views, respectively, of another variation, in which the injected fluid may be drawn back into the device for minimizing fluid input into a body being treated.
  • FIGS. 14A to 14 D show various configurations and methods for configuring an imaging hood into a low-profile for delivery and/or deployment.
  • FIGS. 15A and 15B show an imaging hood having an helically expanding frame or support.
  • FIGS. 16A and 16B show another imaging hood having one or more hood support members, which, are pivotably attached at their proximal ends to deployment catheter, integrated with a hood membrane.
  • FIGS. 17A and 17B show yet another variation of the imaging hood having at least two or more longitudinally positioned support members supporting the imaging hood membrane where the support members are movable relative to one another via a torquing or pulling or pushing force.
  • FIGS. 18A and 18B show another variation where a distal portion of the deployment catheter may have several pivoting members which form a tubular shape in its low profile configuration.
  • FIGS. 19A and 19B show another variation where the distal portion, of deployment catheter may be fabricated from a flexible metallic or polymeric material to form a radially expanding hood.
  • FIGS. 20A and 20B show another variation where the imaging hood may be formed from a plurality of overlapping hood members which overlie one another in an overlapping pattern.
  • FIGS. 21A and 21B show another example of an expandable hood which is highly conformable against tissue anatomy with varying geography.
  • FIG. 22A shows yet another example of an expandable hood having a number of optional electrodes placed about the contact edge or lip of the hood for sensing tissue contact or detecting arrhythmias.
  • FIG. 22B shows another variation for conforming the imaging hood against the underlying tissue where an inflatable contact edge may be disposed around the circumference of the imaging hood.
  • FIG. 23 shows a variation of the system which may be instrumented with a transducer for detecting the presence of blood seeping back into the imaging hood.
  • FIGS. 24A and 24B show variations of the imaging hood instrumented with sensors for detecting, various physical parameters; the sensors may be instrumented around the outer surface of the imaging hood and also within the imaging hood.
  • FIGS. 25A and 25B show a variation where the imaging hood may have one or more LEDs over the hood itself for providing illumination of the tissue to be visualized.
  • FIGS. 26A and 26B show another variation in which a separate illumination tool having one or more LEDs mounted thereon may be utilized within the imaging hood.
  • FIG. 27 shows one example of how a therapeutic tool may be advanced through the tissue imager for treating a tissue region of interest.
  • FIG. 28 shows another example of a helical therapeutic tool for treating the tissue region of interest.
  • FIG. 29 shows a variation, of how a therapeutic tool may be utilized with an expandable imaging balloon.
  • FIGS. 30A and 30B show alternative configurations for therapeutic instruments which may be utilized; one variation is shown having an angled instrument arm and another variation is shown with an off-axis instrument arm.
  • FIGS. 31A to 31 C show side and end views, respectively, of an imaging system which may be utilized with an ablation probe.
  • FIGS. 32A and 32B show side and end views, respectively, of another variation of the imaging hood with an ablation probe, where the imaging hood may be enclosed, for regulating a temperature of the underlying tissue.
  • FIGS. 33A and 33B show an example in which the imaging fluid itself may be altered in temperature to facilitate various procedures upon the underlying tissue.
  • FIGS. 34A and 34B show an example of a laser ring generator which may be utilized with the imaging system and an example for applying the laser ring generator within the left, atrium of a heart for treating atrial fibrillation.
  • FIGS. 35A to 35 C show an example of an extendible cannula generally comprising an elongate tubular member which may be positioned within the deployment catheter during delivery and then projected distally through the imaging hood and optionally beyond.
  • FIGS. 36A and 36B show side and end views, respectively, of an imaging hood having one or more tubular support members integrated with the hood for passing instruments or tools therethrough for treatment upon the underlying tissue.
  • FIGS. 37A and 37B illustrate how an imaging device may be guided within a heart chamber to a region, of interest utilizing a lighted probe positioned temporarily within, e.g., a lumen of the coronary sinus.
  • FIGS. 38A and 38B show an imaging hood having a removable disk-shaped member for implantation upon the tissue surface.
  • FIGS. 39A to 39 C show one method for implanting the removable disk of FIGS. 38A and 38B .
  • FIGS. 40A and 40B illustrate an imaging hood having a deployable anchor assembly attached to the tissue contact edge and an assembly view of the anchors and the suture or wire connected to the anchors, respectively
  • FIGS. 41A to 41 D show one method for deploying the anchor assembly of FIGS. 40A and 40B for closing an opening or wound.
  • FIG. 42 shows another variation in which the imaging system may be fluidly coupled to a dialysis unit for filtering a patient's blood.
  • FIGS. 43A and 43B show a variation of the deployment catheter having a first deployable hood and a second deployable hood positioned distal to the first hood: the deployment catheter may also have a side-viewing imaging element positioned between the first and second hoods for imaging tissue between the expanded hoods.
  • FIGS. 44A and 44B show side and end views, respectively, of a deployment catheter having a side-imaging balloon in an un-inflated low-profile configuration.
  • FIGS. 45A to 45 C show side, top, and end views, respectively, of the inflated balloon, of FIGS. 44A and 44B defining a visualization field in the inflated balloon.
  • FIGS. 46A and 46B show side and cross-sectional end views, respectively, for one method of use in visualizing a lesion upon a vessel wall within the visualisation field of the inflated balloon from FIGS. 45A to 45 C.
  • FIGS. 47A and 47B show assembly views of examples of a robotically-controlled guide instrument for precisely controlling a position of a hood.
  • FIG. 47C illustrates an example of how a robotic guide instrument may be utilized with a visualization system.
  • FIGS. 48A and 48B show perspective views of a variation of a robotic control assembly showing base having four proximal drive assemblies and the imaging hood positioned at a distal end of the catheter.
  • FIG. 48C illustrates a perspective view of another variation of a robotic control assembly having an inflatable imaging balloon assembly.
  • FIG. 49 shows a partially disassembled perspective view of the precision control driver.
  • FIG. 50 shows a perspective assembly view of the guide instrument mounted upon an instrument driver.
  • FIG. 51 shows the partially disassembled perspective view of the catheter instrument driver.
  • FIGS. 52A and 52B show perspective views of another variation of the tissue visualization catheter with precision control steering.
  • FIG. 53 illustrates an example of a simplified assembly view of the mechanisms within, the control drive unit for controlling the articulation of hood.
  • FIGS. 54A and 54B show an assembled view and exploded assembly view, respectively, of a tissue visualization hood having a pivotably articulating steering assembly.
  • FIGS. 55A to 55 C show an assembled view, detailed spine, and exploded assembly view, respectively, of a tissue visualization hood utilizing steerable spine segments.
  • FIGS. 56A to 56 C show another variation in an assembled view, detailed spine, and exploded assembly view, respectively, of a tissue visualization hood also utilizing steerable spine segments.
  • FIG. 57A shows a perspective view of a hood having a ferromagnetic ring attached circumferentially around the lip of the hood.
  • FIG. 57B shows a perspective view of an example of a magnetic navigation system, which, may be used to steer the imaging hood through the patient body.
  • FIG. 58 shows a perspective view of another variation, of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood via ultrasound transducers and having a magnetic ring circumferentially positioned about the lip of the hood.
  • FIG. 59 shows a perspective view of another variation of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood via ultrasound, transducers and having electromagnetic coils wound about one or more struts.
  • FIG. 60 shows a perspective view of another variation of the tissue visualization catheter having a ferromagnetic disc positioned within the hood.
  • FIG. 61 shows a perspective view of a position sensor assembly which may be utilized to detect, an orientation and/or location of the hood within the body as well as to draw the hood against an internal tissue region.
  • FIG. 62 illustrates an example of triangulation of the transducers to determine the orientation and position of the hood within a patient body.
  • FIGS. 63A to 63 C illustrate an example for orienting and drawing a hood within a left atrial chamber against the tissue surface to “walk” the hood along the tissue wall to visually survey the underlying surface.
  • FIG. 64 illustrates another example where a catheter having several transducers may be positioned within, the coronary sinus to communicate with the hood.
  • a tissue-imaging and manipulation apparatus described below is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and instruments for performing various procedures upon the imaged tissue regions.
  • Such an apparatus may be utilized for many procedures, e.g., facilitating transseptal access to the left, atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures.
  • tissue imagine and manipulation assembly 10 may be delivered intravascularly through the patient's body in a low-profile configuration via a delivery catheter or sheath 14 .
  • tissue such as the mitral valve located at the outflow tract of the left atrium of the heart
  • it is generally desirable to enter or access the left atrium while minimizing trauma to the patient.
  • one conventional approach involves puncturing the intra-atrial septum from the right atrial chamber to the left atrial, chamber in a procedure commonly called a transseptal procedure or septostomy.
  • transseptal access to the left, atrial chamber of the heart may allow for larger devices to be introduced into the venous system than can generally be introduced percutaneously into the arterial system.
  • Imaging hood 12 may be advanced relative to catheter 14 and deployed from a distal, opening of catheter 14 , as shown by the arrow. Upon deployment, imaging hood 12 may be unconstrained to expand, or open into a deployed imaging configuration, as shown in FIG. 1B .
  • Imaging hood 12 may be fabricated from a variety of pliable or conformable biocompatible material including but not limited to, e.g., polymeric, plastic, or woven materials.
  • a woven material is Kevlar® (E. I.
  • imaging hood 12 may be fabricated from a translucent or opaque material and in a variety of different colors to optimize or attenuate any reflected lighting from surrounding fluids or structures, i.e., anatomical or mechanical structures or instruments. In either case, imaging hood 12 may be fabricated into a uniform structure or a scaffold-supported structure, in which case a scaffold made of a shape memory alloy, such as Nitinol or a spring steel, or plastic, etc., may be fabricated and covered with the polymeric, plastic, or woven, material.
  • a shape memory alloy such as Nitinol or a spring steel, or plastic, etc.
  • imaging hood 12 may comprise any of a wide variety of barriers or membrane structures, as may generally be used to localize displacement of blood or the like from a selected volume of a body lumen or heart chamber.
  • a volume within an inner surface 13 of imaging hood 12 will be significantly less than a volume of the hood 12 between inner surface 13 and outer surface 11 .
  • Imaging hood 12 may be attached at interface 24 to a deployment catheter 16 which may be translated independently of deployment catheter or sheath 14 . Attachment of interface 24 may be accomplished through any number of conventional methods.
  • Deployment catheter 16 may define a fluid delivery lumen 18 as well as an imaging lumen 20 within which, an optical imaging fiber or assembly may be disposed for imaging tissue.
  • imaging hood 12 When deployed, imaging hood 12 may expand into any number of shapes, e.g., cylindrical, corneal as shown, semi-spherical, etc., provided that an open area or field 26 is defined by imaging hood 12 . The open area 26 is the area within which the tissue region of interest may be imaged.
  • Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest.
  • the diameter of imaging hood 12 at its maximum fully deployed diameter is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16 ).
  • the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter of deployment catheter 16 .
  • FIG. 1C shows an end view of the imaging hood 12 in its deployed configuration. Also shown are the contact lip or edge 22 and fluid delivery lumen 18 and imaging lumen 20 .
  • the imaging and manipulation assembly 10 may additionally define a guidewire lumen therethrough, e.g., a concentric or eccentric lumen, as shown in the side and end views, respectively, of FIGS. 1D to 1 F.
  • the deployment catheter 16 may define guidewire lumen 19 for facilitating the passage of the system over or along a guidewire 17 , which may be advanced intravascularly within a body lumen. The deployment catheter 16 may then be advanced over the guidewire 17 , as generally known in the art.
  • the displacing fluid may be pumped at positive pressure through fluid delivery lumen 18 until the fluid fills open area 26 completely and displaces any fluid 28 from within open area 26 .
  • the displacing fluid flow may be laminarized to improve its clearing effect and to help prevent blood from re-entering the imaging hood 12 .
  • fluid flow may be started before the deployment takes place.
  • the displacing fluid, also described herein as imaging fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid.
  • any number of therapeutic drugs may be suspended within the fluid or may comprise the fluid itself which is pumped into open area 26 and which is subsequently passed into and through the heart and the patient body.
  • deployment catheter 16 may be manipulated to position deployed imaging hood 12 against or near the underlying tissue region of interest to be imaged, in this example a portion of annulus A of mitral valve MV within the left atrial chamber.
  • the translucent fluid 28 such as saline, may then be pumped through fluid delivery lumen 18 , intermittently or continuously, until the blood 30 is at least partially, and preferably completely, displaced from within open area 26 by fluid 28 , as shown in FIG. 2B .
  • contact edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of clear fluid 28 from open area 26 may be maintained to inhibit significant backflow of blood 30 back into open area 26 .
  • Contact, edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contact, edge 22 conform to an uneven or rough underlying anatomical tissue surface.
  • the fluid 28 may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow 28 may cease and blood 30 may be allowed to seep or flow back into imaging hood 12 . This process may be repeated a number of times at the same tissue region or at multiple tissue regions.
  • a number of articulation and manipulation controls may be utilized.
  • one or more push-pull wires 42 may be routed through deployment catheter 16 for steering the distal end portion of the device in various directions 46 to desirably position the imaging hood 12 adjacent to a region of tissue to be visualized.
  • deployment catheter 16 and imaging hood 12 may be articulated into any number of configurations 44 .
  • the push-pull wire or wires 42 may be articulated via their proximal ends from outside the patient body manually utilizing one or more controls.
  • deployment catheter 16 may be articulated by computer control, as further described below.
  • an articulatable delivery catheter 48 which may be articulated via one or more push-pull wires and having an imaging lumen, and one or more working lumens, may be delivered through the deployment catheter 16 and into imaging hood 12 .
  • the clear displacing fluid may be pumped through delivery catheter 48 or deployment catheter 16 to clear the field within imaging hood 12 .
  • the articulatable delivery catheter 48 may be articulated within the imaging hood to obtain a better image of tissue adjacent to the imaging hood 12 .
  • articulatable delivery catheter 48 may be articulated to direct an instrument or tool, passed through the catheter 48 , as described in detail below, to specific areas of tissue imaged through imaging hood 12 without having to reposition deployment catheter 16 and re-clear the imaging field within hood 12 .
  • a distal portion of the deployment catheter 16 itself may comprise a distal, end 49 which is articulatable within imaging hood 12 , as shown in FIG. 3C .
  • Directed imaging, instrument delivery, etc. may be accomplished directly through one of more lumens within deployment catheter 16 to specific regions of the underlying tissue imaged within imaging hood 12 .
  • Visualization within the imaging hood 12 may be accomplished through an imaging lumen 20 defined through deployment catheter 16 , as described above. In such a configuration, visualization is available in a straight-line manner, i.e., images are generated from the field distally along a longitudinal axis defined by the deployment catheter 16 .
  • an articulatable imaging assembly having a pivotable support member 50 may be connected to, mounted to, or otherwise passed through deployment catheter 16 to provide for visualization off-axis relative to the longitudinal axis defined by deployment catheter 16 , as shown in FIG. 4A .
  • Support member 50 may have an imaging element 52 , e.g., a CCD or CMOS imager or optical fiber, attached at its distal end with its proximal end connected to deployment catheter 16 via a pivoting connection 54 .
  • the optical fibers 58 may be passed through deployment catheter 16 , as shown in the cross-section of FIG. 4B , and routed through the support member 50 .
  • the use of optical fibers 58 may provide for increased diameter sizes of the one or several lumens 56 through deployment catheter 16 for the passage of diagnostic and/or therapeutic tools therethrough.
  • electronic chips such as a charge coupled device (CCD) or a CMOS imager, which are typically known, may be utilized in place of the optical fibers 58 , in which case the electronic imager may be positioned in the distal portion of the deployment catheter 16 with, electric wires being routed proximally through the deployment catheter 16 .
  • CCD charge coupled device
  • CMOS imager which are typically known
  • the electronic imagers may be wirelessly coupled to a receiver for the wireless transmission of images.
  • Additional optical fibers or light emitting diodes (LEDs) can be used to provide lighting for the image or operative theater, as described below in further detail.
  • Support member 50 may be pivoted via connection 54 such that the member 50 can be positioned in a low-profile configuration within channel or groove 60 defined in a distal portion of catheter 16 , as shown in the cross-section of FIG. 4C .
  • support member 50 can be positioned within channel or groove 60 with imaging hood 12 also in its low-profile configuration.
  • imaging hood 12 may be expanded into its deployed configuration and support member 50 may be deployed into its off-axis configuration for imaging the tissue adjacent to hood 12 , as in FIG. 4A .
  • Other configurations for support member 50 for off-axis visualization may be utilized, as desired.
  • FIG. 5 shows an illustrative cross-sectional view of a heart H having tissue regions of interest being viewed via an imaging assembly 10 .
  • delivery catheter assembly 70 may be introduced percutaneously into the patient's vasculature and advanced through the superior vena cava SVC and into the right atrium RA.
  • the delivery catheter or sheath 72 may be articulated through the atrial septum AS and into the left atrium LA for viewing or treating the tissue, e.g., the annulus A, surrounding the mitral valve MY.
  • deployment catheter 16 and imaging hood 12 may be advanced out of delivery catheter 72 and brought into contact or in proximity to the tissue region of interest.
  • delivery catheter assembly 70 may be advanced through the inferior vena cava IVC, if so desired.
  • other regions of the heart H. e.g., the right ventricle RV or left ventricle LV, may also be accessed and imaged or treated by imaging assembly 10 .
  • the delivery catheter or sheath 14 may comprise a conventional intra-vascular catheter or an endoluminal delivery device.
  • robotically-controlled delivery catheters may also be optionally utilized with the imaging assembly described herein, in which case a computer-controller 74 may be used to control the articulation and positioning of the delivery catheter 14 .
  • An example of a robotically-controlled delivery catheter which may be utilized is described in further detail in US Pat. Pub. 2002/0087169 A1 to Brock et al. entitled “Flexible Instrument”, which is incorporated herein by reference in its entirety.
  • Other robotically-controlled delivery catheters manufactured by Hansen Medical, Inc. may also be utilized with the delivery catheter 14 , as described in further detail below.
  • one or more inflatable balloons or anchors 76 may be positioned along the length of catheter 16 , as shown in FIG. 6A .
  • the inflatable balloons 76 may be inflated from a low-profile into their expanded configuration to temporarily anchor or stabilize the catheter 16 position relative to the heart H.
  • FIG. 6B shows a first balloon 78 inflated while FIG. 6G also shows a second balloon 80 inflated proximal to the first balloon 78 .
  • the septal wall AS may be: wedged or sandwiched between the balloons 78 , 80 to temporarily stabilize the catheter 16 and imaging hood 12 .
  • a single balloon 78 or both balloons 78 , 80 may be used. Other alternatives may utilize expandable mesh members, malecots, or any other temporary expandable structure.
  • the balloon assembly 76 may be deflated or re-configured into a low-profile for removal of the deployment catheter 16 .
  • various anchoring mechanisms may be optionally employed for temporarily holding the imaging hood 12 against the tissue.
  • Such anchoring mechanisms may be particularly useful for imaging tissue which is subject to movement, e.g., when imaging tissue within the chambers of a beating heart.
  • a tool delivery catheter 82 having at least one instrument lumen and an optional visualization lumen may be delivered through deployment catheter 16 and into an expanded imaging hood 12 .
  • anchoring mechanisms such as a helical tissue piercing device 84 may be passed through the tool delivery catheter 82 , as shown in FIG. 7A , and into imaging hood 12 .
  • the helical tissue engaging device 84 may be torqued from its proximal end outside the patient body to temporarily anchor itself into the underlying tissue surface T. Once embedded within the tissue T, the helical tissue engaging device 84 may be pulled proximally relative to deployment catheter 16 while the deployment catheter 16 and imaging hood 12 are pushed distally, as indicated by the arrows in FIG. 7B , to gently force the contact edge or lip 22 of imaging hood against the tissue T. The positioning of the tissue engaging device 84 may be locked temporarily relative to the deployment catheter 16 to ensure secure positioning of the imaging hood 12 during a diagnostic or therapeutic procedure within the imaging hood 12 .
  • tissue engaging device 84 may be disengaged from the tissue by torquing its proximal end in the opposite direction to remove the anchor form the tissue T and the deployment catheter 16 may be repositioned to another region of tissue where the anchoring process may be repeated or removed from the patient body.
  • the tissue engaging device 84 may also be constructed from other known tissue engaging devices such as vacuum-assisted engagement or grasper-assisted engagement tools, among others.
  • helical anchor 84 is shown, this is intended to be illustrative and other types of temporary anchors may be utilized, e.g., hooked or barbed anchors, graspers, etc.
  • the tool delivery catheter 82 may be omitted entirely and the anchoring device may be delivered directly through a lumen defined through the deployment catheter 16 .
  • FIG. 7C shows an imaging hood 12 having one or more tubular support members 86 , e.g., four support members 86 as shown, integrated with the imaging hood 12 .
  • Tire tubular support members 86 may define lumens therethrough each having helical tissue engaging devices 88 positioned within.
  • the helical tissue engaging devices 88 may be urged distally to extend front imaging hood 12 and each may be torqued from its proximal end to engage the underlying tissue T.
  • Each of the helical tissue engaging devices 88 may be advanced through the length of deployment catheter 16 or they may be positioned within tubular support members 86 during tire delivery and deployment of imaging hood 12 . Once the procedure within imaging hood 12 is finished, each of the tissue engaging devices 88 may be disengaged from the tissue and the imaging hood 12 may be repositioned to another region of tissue or removed from the patient body.
  • FIG. 8A An illustrative example is shown in FIG. 8A of a tissue imaging assembly connected to a fluid delivery system 90 and to an optional processor 98 and image recorder and/or viewer 100 .
  • the fluid, delivery system 90 may generally comprise a pump 92 and an optional valve 94 for controlling the flow rate of the fluid into the system.
  • a fluid reservoir 96 fluidly connected to pump 92 , may hold, the fluid to be pumped through imaging hood 12 .
  • An optional central processing unit or processor 98 may be in electrical communication with fluid delivery system 90 for controlling flow parameters such as the flow rate and/or velocity of the pumped fluid.
  • the processor 98 may also be in electrical communication with an image recorder and/or viewer 100 for directly viewing the images of tissue received from within imaging hood 12 .
  • Imager recorder and/or viewer 100 may also be used not only to record the image but also the location of the viewed tissue region, if so desired.
  • processor 98 may also be utilized to coordinate the fluid flow and the image capture.
  • processor 98 may be programmed to provide for fluid flow from reservoir 96 until the tissue area has been, displaced of blood to obtain a clear image. Once the image has been determined to be sufficiently clear, either visually by a practitioner or by computer, an image of the tissue may be captured automatically by recorder 100 and pump 92 may be automatically stopped or slowed by processor 98 to cease the fluid flow into the patient.
  • Other variations for fluid delivery and image capture are, of course, possible and the aforementioned configuration is intended only to be illustrative and not limiting.
  • FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system 110 .
  • system 110 may have a housing or handle assembly 112 which can be held or manipulated by the physician from outside the patient body.
  • the fluid reservoir 114 shown in this variation as a syringe, can be fluidly coupled to the handle assembly 112 and actuated via a pumping mechanism 116 , e.g., lead screw.
  • Fluid reservoir 114 may be a simple reservoir separated from the handle assembly 112 and fluidly coupled to handle assembly 112 via one or more tubes. The fluid flow rate and other mechanisms may be metered by the electronic controller 118 .
  • Deployment of imaging hood 12 may be actuated by a hood deployment switch 120 located on the handle assembly 112 while dispensation of the fluid from reservoir 114 may be actuated by a fluid deployment switch 122 , which can be electrically coupled to the controller 118 .
  • Controller 118 may also be electrically coupled to a wired or wireless antenna 124 optionally integrated with the handle assembly 112 , as shown in the figure.
  • the wireless antenna 124 can be used to wirelessly transmit images captured from, the imaging hood 12 to a receiver, e.g., via Bluetooth® wireless technology (Bluetooth SIG, Inc., Bellevue, Wash.), RF, etc., for viewing on a monitor 128 or for recording for later viewing.
  • Bluetooth® wireless technology Bluetooth SIG, Inc., Bellevue, Wash.
  • Articulation control of the deployment catheter 16 , or a delivery catheter or sheath 14 through which the deployment catheter 16 may be delivered may be accomplished by computer control, as described above, in which case an additional controller may be utilized, with handle assembly 112 .
  • handle assembly 112 may incorporate one or more articulation controls 126 for manual manipulation, of the position of deployment catheter 16 .
  • Handle assembly 112 may also define one or more instrument, ports 130 through which a number of intravascular tools may be passed for tissue manipulation and treatment within imaging hood 12 , as described further below.
  • fluid or debris may be sucked into imaging hood 12 for evacuation from the patient body by optionally fluidly coupling a suction pump 132 to handle assembly 112 or directly to deployment catheter 16 .
  • fluid may be pumped continuously into imaging hood 12 to provide for clear viewing of the underlying tissue.
  • fluid may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point: the fluid flow may cease and the blood may be allowed to seep or flow back into image hood 12 .
  • FIGS. 9A to 9 C illustrate an example of capturing several, images of the tissue at multiple regions.
  • Deployment catheter 16 may be desirably positioned and imaging hood 12 deployed and brought into position against a region of tissue to be imaged, in this example the tissue surrounding a mitral valve MV within the left atrium of a patient's heart.
  • the imaging hood 12 may be optionally anchored to the tissue, as described above, and then cleared by pumping the imaging fluid into the hood 12 . Once sufficiently clear, the tissue may be visualized and the image captured by control electronics 118 .
  • the first captured image 140 may be stored and/or transmitted wirelessly 124 to a monitor 128 for viewing by the physician, as shown in FIG. 9A .
  • the deployment catheter 16 may be then repositioned to an adjacent portion of mitral valve MV, as shown in FIG. 9B , where the process may be repeated to capture a second image 142 for viewing and/or recording.
  • the deployment catheter 16 may again be repositioned to another region of tissue, as shown in FIG. 9C , where a third image 144 may be captured for viewing and/or recording. This procedure may be repeated as many times as necessary for capturing a comprehensive image of the tissue surrounding mitral valve MV, or any other tissue region.
  • the pump may be stopped, during positioning and blood or surrounding fluid may be allowed to enter within imaging hood 12 until the tissue is to be imaged, where the imaging hood 12 may be cleared, as above.
  • the fluid when the imaging hood 12 is cleared by pumping the imaging fluid within for clearing the blood or other bodily fluid, the fluid may be pumped continuously to maintain the imaging fluid within the hood 12 at a positive pressure or it may be pumped under computer control for slowing or stopping the fluid flow into the hood 12 upon detection of various parameters or until a clear image of the underlying tissue is obtained.
  • the control electronics 118 may also be programmed to coordinate the fluid flow into the imaging hood 12 with various physical parameters to maintain a clear image within imaging hood 12 .
  • FIG. 10A shows a chart 150 illustrating how fluid pressure within the imaging hood 12 may be coordinated with the surrounding blood pressure.
  • Chart 150 shows the cyclical blood pressure 156 alternating between, diastolic pressure 152 and systolic pressure 154 over time T due to the beating motion of the patient heart.
  • the fluid pressure of the imaging fluid, indicated by plot 160 within imaging hood 12 may be automatically timed to correspond to the blood pressure changes 160 such that an increased pressure is maintained within imaging hood 12 which is consistently above the blood pressure 156 by a slight increase ⁇ P, as illustrated by the pressure difference at the peak systolic pressure 158 .
  • This pressure difference, ⁇ P may be maintained within imaging hood 12 over the pressure variance of the surrounding blood pressure to maintain a positive imaging fluid pressure within imaging hood 12 to maintain a clear view of the underlying tissue.
  • One benefit of maintaining a constant ⁇ P is a constant flow and maintenance of a clear field.
  • FIG. 10B shows a chart 162 illustrating another variation for maintaining a clear view of the underlying tissue
  • one or more sensors within the imaging hood 12 may be configured to sense, pressure changes within the imaging hood 12 and to correspondingly increase the imaging fluid pressure within imaging hood 12 .
  • This may result in a time delay, ⁇ T, as illustrated by the shifted fluid pressure 160 relative to the cycling blood pressure 156 , although the time delays ⁇ T may be negligible in maintaining the clear image of the underlying tissue.
  • Predictive software algorithms can also be used to substantially eliminate this time delay by predicting when the next pressure wave peak will arrive and by increasing the pressure ahead of the pressure wave's arrival by an amount of time equal to the aforementioned time delay to essentially cancel the time delay out.
  • imaging hood 12 The variations in fluid pressure within imaging hood 12 may be accomplished in part due to the nature of imaging hood 12 .
  • An inflatable balloon which is conventionally utilized for imaging tissue, may be affected, by the surrounding blood pressure changes.
  • an imaging hood 12 retains a constant volume therewithin and is structurally unaffected by the surrounding blood pressure changes, thus allowing for pressure increases therewithin.
  • the material that hood 12 is made from may also contribute to the manner in which the pressure is modulated within this hood 12 .
  • a stiffer hood material such as high durometer polyurethane or Nylon, may facilitate the maintaining of an open hood when deployed.
  • a relatively lower durometer or softer material such as a low durometer PVC or polyurethane, may collapse from the surrounding fluid pressure and may not adequately maintain a deployed or expanded hood.
  • FIG. 11A shows another variation comprising an additional imaging balloon 172 within an imaging hood 174 .
  • an expandable balloon 172 having a translucent skin may be positioned within imaging hood 174 .
  • Balloon 172 may be made from any distensible biocompatible material having sufficient translucent properties which allow for visualization therethrough.
  • the balloon 172 can also be tilled with contrast media to allow it to be viewed on fluoroscopy to aid in its positioning.
  • the imager, e.g., fiber optic, positioned within deployment catheter 170 may then be utilized to view the tissue region through the balloon 172 and any additional fluid which may be pumped into imaging hood 174 via one or more optional fluid ports 176 , which may be positioned proximally of balloon 172 along a portion of deployment catheter 170 .
  • balloon 172 may define one or more holes over its surface which allow for seepage or passage of the fluid contained therein to escape and displace the blood from within: imaging hood 174 .
  • FIG. 11B shows another alternative in which balloon 180 may be utilized alone.
  • Balloon 180 attached to deployment catheter 178 , may be filled with fluid, such as saline or contrast media, and is preferably allowed to come into direct contact with the tissue region to be imaged.
  • FIG. 12A shows another alternative in which deployment catheter 16 incorporates imaging hood 12 , as above, and includes an additional flexible membrane 182 within imaging hood 12 .
  • Flexible membrane 182 may be attached at a distal end of catheter 16 and optionally at contact edge 22 .
  • Imaging hood 12 may be utilized, as above, and membrane 182 may be deployed from catheter 16 in vivo or prior to placing catheter 16 within a patient to reduce the volume within imaging hood 12 . The volume may be reduced or minimized to reduce the amount of fluid dispensed for visualization or simply reduced depending upon the area of tissue to be visualized.
  • FIGS. 12B and 12C show yet another alternative in which imaging hood 186 may be withdrawn proximally within deployment catheter 184 or deployed distally from catheter 186 , as shown, to vary the volume of imaging hood 186 and thus the volume of dispensed fluid.
  • Imaging hood 186 may be seen in FIG. 12B as being partially deployed from, e.g., a circumferentially defined lumen within catheter 184 , such as annular lumen 188 .
  • the underlying tissue may be visualized with imaging hood 186 only partially deployed.
  • imaging hood 186 ′ may be fully deployed, as shown in FIG. 12C , by urging hood 186 ′ distally out from annular lumen 188 .
  • the area of tissue to be visualized may be increased as hood 186 ′ is expanded circumferentially.
  • FIGS. 13A and 13B show perspective and cross-sectional side views, respectively, of yet another variation of imaging assembly which may utilize a fluid suction system for minimizing the amount of fluid injected into the patient's heart or other body lumen during tissue visualization.
  • Deployment catheter 190 in this variation may define an inner tubular member 196 which may be integrated with deployment catheter 190 or independently translatable.
  • Fluid delivery lumen 198 defined through member 196 may be fluidly connected to imaging hood 192 , which may also define one or more open channels 194 over its contact lip region. Fluid pumped through fluid delivery lumen 198 may thus fill open area 202 to displace any blood or other fluids or objects therewithin.
  • Tubular member 196 may also define one or more additional working channels 200 for the passage of any fools or visualization devices.
  • the imaging hood may take on any number of configurations when positioned or configured for a low-profile delivery within the delivery catheter, as shown in the examples of FIGS. 14A to 14 D. These examples are intended to be illustrative and are not intended to be limiting in scope.
  • FIG. 14A shows one example in which imaging hood 212 may be compressed within catheter 210 by folding hood 212 along a plurality of pleats.
  • Hood 212 may also comprise scaffolding or frame 214 made of a super-elastic or shape memory material or alloy, e.g. Nitinol, Elgiloy, shape memory polymers, electroactive polymers, or a spring stainless steel.
  • the shape memory material may act to expand or deploy imaging hood 212 into its expanded configuration when urged in the direction of the arrow from the constraints of catheter 210 .
  • FIG. 14B shows another example in which imaging hood 216 may be expanded or deployed from catheter 210 from a folded and overlapping configuration.
  • Frame or scaffolding 214 may also be utilized in this example.
  • FIG. 14C shows yet another example in which imaging hood 218 may be rolled.
  • FIG. 14D shows a configuration in which imaging hood 220 may be fabricated from an extremely compliant material which allows for hood 220 to be simply compressed into a low-profile shape. From this low-profile compressed shape, simply releasing hood 220 may allow for it to expand into its deployed configuration, especially if a scaffold or frame of a shape memory or superelastic material, e.g., Nitinol, is utilized in its construction.
  • a scaffold or frame of a shape memory or superelastic material e.g., Nitinol
  • FIGS. 15A and 15B illustrates an helically expanding frame or support 230 .
  • helical frame 230 may be integrated with, the imaging hood 12 membrane.
  • helical frame 230 may expand, into a conical or tapered shape.
  • Helical frame 230 may alternatively be made out of heat-activated Nitinol to allow it to expand upon application of a current.
  • FIGS. 16A and 16B show yet another variation in which imaging hood 12 may comprise one or more hood support members 232 integrated with the hood membrane. These longitudinally attached support members 232 may be pivotably attached at their proximal ends to deployment catheter 16 .
  • One or more pullwires 234 may be routed through the length of deployment catheter 16 and extend, through one or more openings 238 defined in deployment, catheter 16 proximally to imaging hood 12 into attachment with a corresponding support member 232 at a pullwire attachment point 236 .
  • the support, members 232 may be fabricated from a plastic or metal, such as stainless steel.
  • the support members 232 may be made from a superelastic or shape memory alloy, such as Nitinol, which may self-expand into its deployed configuration without the use or need of pullwires.
  • Nitinol a superelastic or shape memory alloy
  • a heat-activated Nitinol may also be used which expands upon the application of thermal energy or electrical, energy.
  • support members 232 may also be constructed as inflatable lumens utilizing, e.g., PET balloons.
  • the one or more pullwires 234 may be tensioned from their proximal ends outside the patient body to pull a corresponding support member 232 into a deployed configuration, as shown in FIG. 16B , to expand imaging hood 12 .
  • deployment catheter 16 may be pulled proximally into a constraining catheter or the pullwires 234 may be simply pushed distally to collapse imaging hood 12 .
  • FIGS. 17A and 17B show yet another variation of imaging hood 240 having at least two or more longitudinally positioned support members 242 supporting the imaging hood membrane.
  • the support members 242 each have cross-support members 244 which extend diagonally between and are pivotably attached to the support members 242 .
  • Each of the cross-support members 244 may be pivotably attached to one another where they intersect between the support members 242 .
  • a jack or screw member 246 may be coupled to each cross-support, member 244 at this intersection point and a torquing member, such as a torque-able wire 248 , may be coupled to each jack or screw member 246 and extend proximally through deployment catheter 16 to outside the patient body.
  • the torqueable wires 248 may be torqued to turn the jack or screw member 246 which in turn urges the cross-support members 244 to angle relative to one another and thereby urge the support members 242 away from one another.
  • the imaging hood 240 may be transitioned from its low-profile, shown in FIG. 17A , to its expanded profile, shown in FIG. 17B , and back into its low-profile by torquing wires 248 .
  • FIGS. 18A and 18B show yet another variation on the imaging hood and its deployment.
  • a distal portion of deployment catheter 16 may have several pivoting members 250 , e.g., two to four sections, which form a tubular shape in its low profile configuration, as shown in FIG. 18A .
  • pivoting members 250 When pivoted radially about deployment catheter 16 , pivoting members 250 may open into a deployed configuration having distensible or expanding membranes 252 extending over the gaps in-between the pivoting members 250 , as shown in FIG. 18B .
  • the distensible membrane 252 may be attached to the pivoting members 250 through various methods, e.g., adhesives, such that when the pivoting members 250 are fully extended into a conical shape, the pivoting members 250 and membrane 252 form a conical shape for use as an imaging hood.
  • the distensible membrane 252 may be made out of a porous material such as a mesh or PTFE or out of a translucent or transparent polymer such as polyurethane, PVC, Nylon, etc.
  • FIGS. 19A and 19B show yet another variation where the distal portion of deployment catheter 16 may be fabricated from a flexible metallic or polymeric material to form a radially expanding hood 254 .
  • a plurality of slots 256 may be formed in a uniform pattern over the distal portion of deployment catheter 16 , as shown in FIG. 19A .
  • the slots 356 may be formed in a pattern such that when the distal portion is urged radially open, utilizing any of the methods described above, a radially expanded and conically-shaped hood 254 may be formed by each of the slots 256 expanding into an opening, as shown in FIG. 19B .
  • a distensible membrane 258 may overlie the exterior surface or the interior surface of the hood 254 to form a fluid-impermeable hood 254 such that the hood 254 may be utilized as an imaging hood.
  • the distensible membrane 258 may alternatively be formed, in each opening 258 to form the fluid-impermeable hood 254 .
  • FIGS. 20A and 20B Yet another configuration for the imaging hood, may be seen in FIGS. 20A and 20B where the imaging hood may be formed from a plurality of overlapping hood, members 260 which overlie one another in an overlapping pattern. When expanded, each of the hood members 260 may extend radially outward relative to deployment catheter 16 to form a conically-shaped imaging hood, as shown in FIG. 20B . Adjacent hood members 260 may overlap one another along an overlapping interface 262 to form a fluid-retaining surface within the imaging hood. Moreover, the hood members 260 may be made from any number of biocompatible materials, e.g., Nitinol, stainless steel, polymers, etc., which are sufficiently strong to optionally retract surrounding tissue from the tissue region of interest.
  • biocompatible materials e.g., Nitinol, stainless steel, polymers, etc.
  • imaging hood 272 may be alternatively, configured to contact the tissue surface at air acute angle.
  • An imaging hood configured for such contact against tissue may also be especially suitable for contact against, tissue surfaces having an unpredictable or uneven anatomical geography.
  • deployment catheter 270 may have an imaging hood 272 that is configured to be especially compliant.
  • imaging hood 272 may be comprised of one or more sections 274 that are configured to fold or collapse, e.g., by utilizing a pleated surface.
  • FIG. 21B when imaging hood 272 is contacted against uneven tissue surface T, sections 274 are able to conform closely against the tissue.
  • These sections 274 may be individually collapsible by utilizing an accordion style construction to allow conformation, e.g., to the trabeculae in the heart or the uneven anatomy that may be found inside the various body lumens.
  • FIG. 22A shows another variation in which an imaging hood 282 is attached to deployment catheter 280 .
  • the contact lip or edge 284 may comprise one or more electrical contacts 286 positioned circumferentially around contact edge 284 .
  • the electrical contacts 286 may be configured to contact the tissue and indicate affirmatively whether tissue contact was achieved, e.g., by measuring the differential impedance between blood and tissue.
  • a processor e.g., processor 98
  • in electrical communication with contacts 286 may be configured to determine what type of tissue is in contact with electrical contacts 286 .
  • the processor 98 may be configured to measure any electrical activity that may be occurring in the underlying tissue, e.g., accessory pathways, for the purposes of electrically mapping the cardiac tissue and subsequently treating, as described below, any arrhythmias which may be detected.
  • FIG. 22B Another variation for ensuring contact between imaging hood 282 and the underlying tissue may be seen in FIG. 22B .
  • This variation may have an inflatable contact: edge 288 around the circumference of imaging hood 282 .
  • the inflatable contact edge 288 may be inflated with a fluid or gas through inflation lumen 289 when the imaging hood 282 is to be placed against a tissue surface having an uneven or varied anatomy.
  • the inflated circumferential surface 288 may provide for continuous contact over the hood edge by conforming against the tissue surface and facilitating imaging fluid retention within hood 282 .
  • various instrumentation may be utilized with the imaging and manipulation system. For instance, after the field within imaging hood 12 has been cleared of the opaque blood and the underlying tissue is visualized through the clear fluid, blood may seep back into the imaging hood 12 and obstruct the view.
  • One method for automatically maintaining a clear imaging field may utilize a transducer, e.g., an ultrasonic transducer 290 , positioned at the distal end of deployment catheter within the imaging hood 12 , as shown in FIG. 23 .
  • the transducer 290 may send an energy pulse 292 into the imaging hood 12 and wait to detect back-scattered energy 294 reflected from debris or blood within the imaging hood 12 . If back-scattered energy is detected, the pump may be actuated automatically to dispense more fluid into the imaging hood until the debris or blood is no longer detected.
  • sensors 300 may be positioned on the imaging hood 12 itself, as shown in FIG. 24A , to detect a number of different parameters.
  • sensors 300 may be configured to detect for the presence of oxygen in the surrounding blood, blood and/or imaging fluid pressure, color of the fluid, within the imaging hood, etc. Fluid color may be particularly useful in detecting the presence of blood within the imaging hood 12 by utilizing a reflective type sensor to detect back reflection from blood. Any reflected light from blood which may be present within imaging hood 12 may be optically or electrically transmitted through deployment catheter 16 and to a red colored filter within control electronics 118 . Any red color which may be detected may indicate the presence of blood and trigger a signal to the physician or automatically actuate the pump to dispense more fluid into the imaging hood 12 to cleat the blood.
  • the hood 12 may include detecting transmitted light through the imaging fluid within imaging hood 12 . If a source of white light, e.g., utilizing LEDs or optical fibers, is illuminated inside imaging hood 12 , the presence of blood may cause the color red to be filtered, through this fluid. The degree or intensity of the red color detected may correspond to the amount of blood present within imaging hood 12 .
  • a red color sensor can simply comprise, in one variation, a phototransistor with a red transmitting filter over it which can establish how much red light is detected, which in turn can indicate the presence of blood, within imaging hood 12 . Once blood is detected, the system may pump more clearing fluid through and enable closed loop feedback control of the clearing fluid pressure and flow level.
  • Any number of sensors may be positioned along the exterior 302 of imaging hood 12 or within the interior 304 of imaging hood 12 to detect parameters not only exteriorly to imaging hood 12 but also within imaging hood 12 .
  • Such a configuration as shown in FIG. 24B , may be particularly useful for automatically maintaining a clear imaging field based upon physical, parameters such as blood pressure, as described above for FIGS. 10A and 10B .
  • one or more light emitting diodes may be utilized to provide lighting within the imaging hood 12 .
  • illumination may be provided by optical fibers routed through deployment catheter 16
  • the use of LEDs over the imaging hood 12 may eliminate the need for additional optical fibers for providing illumination.
  • the electrical wires connected to the one or more LEDs may be routed through or over the hood 12 and along an exterior surface or extruded within deployment catheter 16 .
  • One or more LEDs may be positioned in a circumferential pattern 306 around imaging hood 12 , as shown in FIG. 25A , or in a linear longitudinal pattern 308 along imaging hood 12 , as shown in FIG. 25B .
  • Other patterns, such as a helical or spiral pattern may also be utilized.
  • LEDs may be positioned along a support member forming part of imaging hood 12 .
  • a separate illumination tool 310 may be utilized, as shown in FIG. 26A .
  • An example of such a tool may comprise a flexible intravascular delivery member 312 having a carrier member 314 pivotably connected 316 to a distal end of delivery member 312 .
  • One or more LEDs 318 may be mounted along carrier member 314 .
  • delivery member 312 may be advanced through deployment catheter 16 until carrier member 314 is positioned within imaging hood 12 .
  • carrier member 314 may be pivoted in any number of directions to facilitate or optimize the illumination within the imaging hood 12 , as shown, in FIG. 26B .
  • the LEDs may comprise a single LED color, e.g., white light.
  • LEDs of other colors e.g., red, blue, yellow, etc.
  • sources of infrared or ultraviolet light may be employed to enable imaging beneath the tissue, surface or cause fluorescence of tissue for use in system guidance, diagnosis, or therapy.
  • the imaging assembly may also be utilized to provide a therapeutic platform for treating tissue being visualized.
  • deployment catheter 320 may have imaging hood 322 , as described above, and fluid delivery lumen 324 and imaging lumen 326 .
  • a therapeutic tool such as needle 328 may be delivered, through fluid delivery lumen 324 or in another working lumen and advanced through open area 332 for treating the tissue which is visualized.
  • needle 328 may define one or several ports 330 for delivering drugs therethrough.
  • needle 328 may be advanced and pierced into the underlying tissue where a therapeutic agent may be delivered through ports 330 .
  • needle 328 may be in electrical communication with a power source 334 , e.g., radio-frequency, microwave, etc., for ablating the underlying tissue area of interest.
  • FIG. 28 shows another alternative in which deployment catheter 340 may have imaging hood 342 attached thereto, as above, but with a therapeutic tool 344 in the configuration of a helical tissue piercing device 344 . Also shown and described above in FIGS. 7A and 7B for use in stabilizing the imaging hood relative to the underlying tissue, the helical tissue piercing device 344 may also be utilized to manipulate the tissue for a variety of therapeutic procedures.
  • the helical portion 346 may also define one or several ports for delivery of therapeutic agents therethrough.
  • FIG. 29 shows a deployment catheter 350 having an expandable imaging balloon 352 filled with, e.g., saline 356 .
  • a therapeutic tool 344 as above, may be translatable relative to balloon 352 .
  • a stop 354 may be formed on balloon 352 to prevent the proximal passage of portion 346 past stop 354 .
  • FIGS. 30A and 30B Alternative configurations for tools which may be delivered through deployment catheter 16 for use in tissue manipulation within imaging hood 12 are shown in FIGS. 30A and 30B .
  • FIG. 30A shows one variation of an angled instrument 360 , such as a tissue grasper, which may be configured to have an elongate shaft for intravascular delivery through deployment catheter 16 with a distal end which may be angled relative to its elongate shaft upon deployment into imaging hood 12 .
  • the elongate shaft may be configured to angle itself automatically, e.g., by the elongate shaft being made at least partially from a shape memory alloy, or upon actuation, e.g., by tensioning a pull wire.
  • FIG. 30A shows one variation of an angled instrument 360 , such as a tissue grasper, which may be configured to have an elongate shaft for intravascular delivery through deployment catheter 16 with a distal end which may be angled relative to its elongate shaft upon deployment into imaging hood 12 .
  • FIG. 30B shows another configuration for an instrument 362 being configured to reconfigure its distal portion into an off-axis configuration within imaging hood 12 .
  • the instruments 360 , 362 may be reconfigured into a low-profile shape upon withdrawing them proximally back into deployment catheter 16 .
  • FIG. 31A shows a probe 370 having a distal end effector 372 , which may be reconfigured from, a low-profile shape to a curved profile.
  • the end effector 372 may be configured as an ablation probe utilizing radio-frequency energy, microwave energy, ultrasound energy, laser energy or even cryo-ablation.
  • the end effector 372 may have several electrodes upon it for detecting or mapping electrical signals transmitted through the underlying tissue.
  • an additional temperature sensor such as a thermocouple or thermistor 374 positioned upon an elongate member 376 may be advanced into the imaging hood 12 adjacent to the distal, end effector 372 for contacting and monitoring a temperature of the ablated tissue.
  • FIG. 31B shows an example in the end view of one configuration for the distal end effector 372 which may be simply angled into a perpendicular configuration for contacting the tissue.
  • FIG. 31C shows another example where the end effector may be reconfigured into a curved end effector 378 for increased tissue contact.
  • FIGS. 32A and 32B show another variation of an ablation tool utilized with an imaging hood 12 having an enclosed bottom portion.
  • an ablation probe such as a cryo-ablation probe 380 having a distal end effector 382
  • a cryo-ablation probe 380 having a distal end effector 382
  • the shaft of probe 380 may pass through an opening 386 defined through the membrane 384 .
  • the clear fluid may be pumped into imaging hood 12 , as described above, and the distal end effector 382 may be placed against a tissue region, to be ablated with the imaging hood 12 and the membrane 384 positioned atop or adjacent to the ablated tissue.
  • the imaging fluid may be warmed prior to dispensing into the imaging hood 12 such that the tissue contacted by the membrane 384 may be warmed during the cryo-ablation: procedure.
  • the fluid dispensed into the imaging hood 12 may be cooled such that the tissue contacted by tire membrane 384 and adjacent to the ablation probe during the ablation procedure is likewise cooled.
  • the imaging fluid may be varied in its temperature to facilitate various procedures to be performed upon the tissue, brother cases, the imaging fluid itself may be altered to facilitate various procedures.
  • a deployment catheter 16 and imaging hood 12 may be advanced within a hollow body organ, such as a bladder filled with urine 394 , towards a lesion or tumor 392 on the bladder wall.
  • the imaging hood 12 may be placed entirely over the lesion 392 , or over a portion of the lesion.
  • a cryo-fluid i.e., a fluid which has been cooled to below freezing temperatures of, e.g., water or blood, may be pumped into the imaging hood 12 to cryo-ablate the lesion 390 , as shown in FIG. 33B while avoiding the creation of ice on the instrument or surface of tissue.
  • the cryo-fluid may be warmed naturally by the patient body and ultimately removed.
  • the cryo-fluid may be a colorless and translucent fluid which enables visualization therethrough of the underlying tissue.
  • An example of such a fluid is FluorinertTM (3M, St. Paul, Minn.), which is a colorless and odorless perfluorinated liquid.
  • FluorinertTM 3M, St. Paul, Minn.
  • the use of a liquid such as FluorinertTM enables the cryo-ablation procedure without the formation of ice within or outside of the imaging hood 12 .
  • hyperthermic treatments may also be effected by heating the FluorinertTM liquid to elevated temperatures for ablating the lesion 392 within the imaging hood 12 .
  • FluorinertTM may be utilized in various other parts of the body, such as within the heart.
  • FIG. 34A shows another variation of an instrument which may be utilized with the imaging system.
  • a laser ring generator 400 may be passed through the deployment catheter 16 and partially into imaging hood 12 .
  • a laser ring generator 400 is typically used to create a circular ring of laser energy 402 for generating a conduction block around the pulmonary veins typically in the treatment of atrial fibrillation.
  • the circular ring of laser energy 402 may be generated such that a diameter of the ring 402 is contained within a diameter of the imaging hood 12 to allow for tissue ablation directly upon tissue being imaged.
  • Signals which cause atrial fibrillation typically come from the entry area of the pulmonary veins into the left atrium and treatments may sometimes include delivering ablation energy to the ostia of the pulmonary veins within the atrium.
  • the ablated areas of the tissue may produce a circular scar which blocks the impulses for atrial fibrillation.
  • the imaging fluid may be generally desirable to maintain the integrity and health of the tissue overlying the surface while ablating the underlying tissue. This may be accomplished, for example, by cooling the imaging fluid to a temperature below the body temperature of the patient but which is above the freezing point of blood (e.g., 2° C. to 35° C.).
  • the cooled imaging fluid may thus maintain the surface tissue at the cooled fluid temperature while the deeper underlying tissue remains at the patient body temperature.
  • the laser energy or other types of energy such as radio frequency energy, microwave energy, ultrasound energy, etc.
  • both the cooled tissue surface as well as the deeper underlying tissue will rise in temperature uniformly.
  • the deeper underlying tissue, which was maintained at the body temperature will increase to temperatures which are sufficiently high to destroy the underlying tissue. Meanwhile, the temperature of the cooled surface tissue will also rise but only to temperatures that are near body temperature or slightly above.
  • one example for treatment may include passing deployment catheter 16 across the atrial septum AS and into the left atrium LA of the patient's heart H. Other methods of accessing the left atrium LA may also be utilized.
  • the imaging hood 12 and laser ring generator 400 may be positioned adjacent to or over one or more of the ostium OT of the pulmonary veins PV and the laser generator 400 may ablate the tissue around the ostium OT with the circular ring of laser energy 402 to create a conduction block. Once one or more of the tissue, around the ostium OT have been ablated, the imaging hood 12 may be reconfigured into a low profile for removal from the patient heart H.
  • an extendible cannula 410 having a cannula lumen 412 defined therethrough, as shown in FIG. 35A .
  • the extendible cannula 410 may generally comprise an elongate tubular member which may be positioned within the deployment catheter 16 during delivery and then projected distally through the imaging hood 12 and optionally beyond, as shown in FIG. 35B .
  • the extendible cannula 410 may be projected distally from, the deployment catheter 16 while optionally imaging tire tissue through the imaging hood 12 , as described above.
  • the extendible cannula 410 may be projected distally until its distal end is extended at least partially into the ostium OT.
  • an instrument or energy ablation device may be extended through and out of the cannula lumen 412 for treatment within the ostium OT.
  • the cannula 410 may be withdrawn proximally and removed from the patient body.
  • the extendible cannula 410 may also include an inflatable occlusion balloon at or near its distal end to block the blood flow out of the PV to maintain a clear view of the tissue region.
  • the extendible cannula 410 may define a lumen therethrough beyond the occlusion balloon to bypass at least a portion of the blood that normally exits the pulmonary vein PV by directing the blood through the cannula 410 to exit proximal of the imaging hood.
  • imaging hood 12 may have one or more tubular support members 420 integrated with the hood 12 .
  • Each of the tubular support members 420 may define an access lumen 422 through which one or more instruments or tools may be delivered for treatment upon the underlying tissue.
  • FIG. 7C One particular example is shown and described above for FIG. 7C .
  • one method may include facilitating the initial delivery and placement of a device into the patient's heart, in initially guiding the imaging assembly within the heart chamber to, e.g., the mitral valve MV, a separate guiding probe 430 may be utilized, as shown, in FIGS. 37A and 37B .
  • Guiding probe 430 may, for example, comprise an optical fiber through which, a light source 434 may be used to illuminate a distal tip portion 432 .
  • the tip portion 432 may be advanced into the heart: through, e.g., the coronary sinus CS, until the tip is positioned adjacent to the mitral valve MV.
  • the tip 432 may be illuminated, as shown in FIG. 37A , and imaging assembly 10 may then be guided towards the illuminated tip 432 , which, is visible from within the atrial chamber, towards mitral valve MV.
  • the imaging system may be utilized to facilitate various other procedures.
  • the imaging hood of the device in particular may be utilized.
  • a collapsible membrane or disk-shaped member 440 may be temporarily secured around the contact edge or lip of imaging hood 12 .
  • the imaging hood 12 and the attached member 440 may both be in a collapsed configuration to maintain a low profile for delivery.
  • both the imaging hood 12 and the member 440 may extend into their expanded configurations.
  • the disk-shaped member 440 may be comprised of a variety of materials depending upon the application.
  • member 440 may be fabricated from a porous polymeric material infused with a drug eluting medicament 442 for implantation against a tissue surface for slow infusion of the medicament into tire underlying tissue.
  • the member 440 may be fabricated from a non-porous material, e.g., metal or polymer, for implantation and closure of a wound or over a cavity to prevent fluid leakage.
  • the member 440 may be made from a distensible material which is secured to imaging hood 12 in an expanded condition. Once implanted or secured on a tissue surface or wound, the expanded member 440 may be released from imaging hood 12 . Upon release, the expanded member 440 may shrink to a smaller size while approximating the attached underlying tissue, e.g., to close a wound or opening.
  • One method for securing the disk-shaped member 440 to a tissue surface may include a plurality of tissue anchors 444 , e.g., barbs, hooks, projections, etc., which are attached to a surface of the member 440 .
  • Other methods of attachments may include adhesives, suturing, etc.
  • the imaging hood 12 may be deployed in its expanded configuration with member 440 attached thereto with the plurality of tissue anchors 444 projecting distally.
  • the tissue anchors 444 may be urged into a tissue region to be treated 446 , as seen in FIG. 39A , until the anchors 444 are secured in the tissue and member 440 is positioned directly against the tissue, as shown in FIG. 39B .
  • a pullwire may be actuated to release the member 440 from the imaging hood 12 and deployment catheter 16 may be withdrawn proximally to leave member 440 secured against the tissue 446 .
  • FIG. 40A illustrates an imaging hood 12 having a deployable anchor assembly 450 attached to the tissue contact edge 22 .
  • FIG. 40B illustrates the anchor assembly 450 detached from the imaging hood 12 for clarity.
  • the anchor assembly 450 may be seen as having a plurality of discrete tissue anchors 456 , e.g., barbs, hooks, projections, etc., each having a suture retaining end, e.g., an eyelet or opening 458 in a proximal end of the anchors 456 .
  • a suture member or wire 452 may be slidingly connected to each anchor 456 through the openings 458 and through a cinching element 454 , which may be configured to slide uni-directionally over the suture or wire 452 to approximate each of the anchors 456 towards one another.
  • Each of the anchors 456 may be temporarily attached to the imaging hood 12 through a variety of methods. For instance, a pullwire or retaining wire may hold each of the anchors within a receiving ring around the circumference of the imaging hood 12 . When the anchors 456 are released, the pullwire or retaining wire may be tensioned from its proximal end outside the patient body to thereby free the anchors 456 from the imaging hood 12 .
  • FIGS. 41A to 41 D One example for use of the anchor assembly 450 is shown in FIGS. 41A to 41 D for closure of an opening or wound 460 , e.g., patent foramen ovale (PFO).
  • the deployment catheter 16 and imaging hood 12 may be delivered intravascularly into, e.g., a patient heart. As the imaging hood 12 is deployed into its expanded configuration, the imaging hood 12 may be positioned adjacent to the opening or wound 460 , as shown in FIG. 41A . With the anchor assembly 450 positioned upon the expanded imaging hood 12 , deployment catheter 16 may be directed to urge the contact edge of imaging hood 12 and anchor assembly 450 into the region surrounding the tissue opening 460 , as shown in FIG. 41B .
  • the anchors may be released from imaging hood 12 leaving the anchor assembly 450 and suture member 452 trailing from the anchors, as shown in FIG. 41C .
  • the suture or wire member 452 may be tightened by pulling it proximally from outside the patient body to approximate the anchors of anchor assembly 450 towards one another in a purse-string manner to close the tissue opening 462 , as shown in FIG. 41D .
  • the cinching element 454 may also be pushed distally over the suture or wire member 452 to prevent the approximated-anchor assembly 450 from loosening or widening.
  • FIG. 42 Another example for an alternative use is shown in FIG. 42 , where the deployment catheter 16 and deployed imaging hood 12 may be positioned within a patient body for drawing blood 472 into deployment catheter 16 .
  • the drawn blood 472 may be pumped through a dialysis unit 470 located externally of the patient body for filtering the drawn blood 472 and the filtered blood may be reintroduced back into the patient.
  • FIGS. 43A and 43B show a variation of the deployment catheter 480 having a first deployable hood 482 and a second deployable hood 484 positioned distal to the first hood 482 .
  • the deployment catheter 480 may also have a side-viewing imaging element 486 positioned between the first and second hoods 482 , 484 along the length of the deployment catheter 480 .
  • such a device may be introduced through a lumen 488 of a vessel VS, where one or both hoods 482 , 484 may be expanded to gently contact the surrounding walls of vessel VS.
  • the clear imaging fluid may be pumped in the space defined between the hoods 482 , 484 to displace any blood and to create an imaging space 490 , as shown in FIG. 43B .
  • the imaging element 486 may be used to view the surrounding tissue surface contained between hoods 482 , 484 .
  • Other instruments or tools may be passed through deployment catheter 480 and through one or more openings defined along the catheter 480 for additionally performing therapeutic procedures upon the vessel wall.
  • FIGS. 44A to 45 B show side and end views of deployment catheter 500 having a side-imaging balloon 502 in an un-inflated low-profile configuration.
  • a side-imaging element 504 may be positioned within a distal portion of the catheter 500 where the balloon 502 is disposed.
  • balloon 502 When balloon 502 is inflated, it may expand radially to contact the surrounding tissue, but where the imaging element 504 is located, a visualization field 506 may be created by the balloon 502 , as shown in the side, top, and end views of FIGS. 45A to 45 B, respectively.
  • the visualization field 506 may simply be a cavity or channel which is defined within the inflated balloon 502 such that the visualization element 504 is provided an image of the area within field 506 which is clear and unobstructed by balloon 502 .
  • deployment catheter 500 may be advanced intravascularly through vessel lumen 488 towards a lesion or tumor 508 to be visualized and/or treated.
  • deployment catheter 500 may be positioned adjacently to the lesion 508 and balloon 502 may be inflated such that the lesion 508 is contained within the visualization field 506 .
  • clear fluid may be pumped into visualization field 506 through deployment catheter 500 to displace any blood or opaque fluids from the field 506 , as shown in the side and end views of FIGS. 46A and 46B , respectively.
  • the lesion 508 may then be visually inspected and treated by passing any number of instruments through deployment catheter 500 and into field 506 .
  • the catheter may be manually controlled or robotically-controlled, as mentioned above.
  • robotically-controlled catheter systems which utilize precision motion control mechanisms are shown and described in U.S. Pat. App. 2006/0084945 A1 and U.S. Pat. No. 7,090,683, each of which is incorporated herein by reference in its entirety.
  • a visualization hood may be attached or coupled to the distal end of a catheter articulated or controlled by precision motion control mechanisms.
  • the articulatable neck portion of the shaft located proximally of the visualization hood, may be comprised of an assembly of links fabricated, e.g., from stainless steel, plastics, etc., that allow the neck portion to be articulated in multiple planes.
  • One or more, e.g., four, pullwires may be routed through the neck and/or shaft such that they terminate at the hood attachment, while the proximal end or ends of the pullwires may be routed through the links to a proximal end of the catheter. Combinations of retraction and/or extension motions of these pullwires may be utilized to steer the neck portion to articulate the hood in multiple directions as desired by the operator.
  • the proximal ends of the pullwires are threaded through a pulley assembly and terminated in rotatable spools. Rotating these spools will either retract the pullwires or release more slack into the catheter to enable steering as appropriate.
  • the pullwire spools are further driven by control elements such, as low speed motors, which, in turn, may be driven by a central processing unit. Precise and consistent, low speed rotation of the spools controlled by the central processing unit and the motors will enable the pullwires to be retracted or released with high precision. This will translate into precision articulation and motion control of the tissue visualization hood.
  • FIG. 47A an example of a robotic guide instrument 600 is illustrated having two control element interface assemblies configured to drive, e.g., four control elements 606 , e.g., pullwires.
  • Rotation of the pulleys in a first direction may spool and proximally displace one control element 606
  • unspooling in a second opposite direction may distally displace a complementary control element 606 to deflect the distal end of the deployment catheter 14 in the opposite direction.
  • Tension may be maintained in the control elements 606 via pre-tensioning or pre-stressing the elements to prevent excess slack.
  • Tension may also be maintained, on the control elements 606 using a slotted guide instrument base 602 which forms one or more slots 604 through which the control elements 606 may remain taut.
  • FIG. 47B illustrates the robotic guide instrument 600 having hood 12 positioned upon deployment catheter 16 with an inflatable balloon or membrane 608 optionally disposable within or upon hood 12 and an instrument advanced through catheter 16 and into hood 12 .
  • the robotic guide instrument 600 and optionally the instruments advanced through hood 12 , may be controlled via a computer or processor 612 to control the articulation of the hood 12 as well as other functions.
  • the treatment instrument may include any number of instruments, e.g., ablation tools, a piercing needle 610 , etc., which may be advanced through the hood for treating the underlying tissue. Examples of instruments as well as alternative configurations for hood 12 are shown and described in further detail in the following U.S. patent application Ser. Nos. 11/775,771 and 11/775,837 both filed Jul. 10, 2007, and Ser. No. 11/828,267 filed Jul. 25, 2007, each of which is incorporated herein by reference in its entirety.
  • FIG. 47C illustrates an example of how a robotic guide instrument may be utilized with a visualization system.
  • a user may interface with input device 651 , which may utilize any number of different interfaces, e.g., handle, joystick, etc., by which the user may transmit desired, commands to processor 631 .
  • Processor 631 may receive the commands and transmit the appropriate drive signals to the catheter and computer-controlled guidance assembly 639 which may then control the hood, imaging systems, fluid purging systems, etc. in accordance with the received commands from the user.
  • the resulting force or tracking feedback may be optionally sensed by guidance assembly 639 and transmitted back to processor 631 , which in turn may signal or indicate to the user via force feedback through input device 651 or some other force or visual feedback.
  • the image data captured by the imaging element within or along hood 12 may also be received by guidance assembly 639 and transmitted to processor 631 , which may receive foe image data for processing, and display upon a tissue surface image display 649 to the user.
  • Catheter and computer-controlled guidance assembly 639 may comprise several sub-systems for controlling each of a number of different functions, for instance (amongst other sub-systems), an articulation drive 641 for controlling a movement of the catheter 16 and/or hood 12 , a movement tracking system 643 for tracking a position and/or orientation of the catheter 16 and/or hood 12 within the patient body, an imaging element system 645 for controlling the visualization features, as well as a blood displacement system 647 for controlling and/or tracking an infusion of transparent, fluid into the hood 12 .
  • an articulation drive 641 for controlling a movement of the catheter 16 and/or hood 12
  • a movement tracking system 643 for tracking a position and/or orientation of the catheter 16 and/or hood 12 within the patient body
  • an imaging element system 645 for controlling the visualization features
  • a blood displacement system 647 for controlling and/or tracking an infusion of transparent, fluid into the hood 12 .
  • Processor 631 may also be configured to handle several different processing functions to process various data. For instance, processor 631 may be configured to input commands registered with tissue surface images 633 as received from input device 651 , as well as process catheter position data 635 based, upon catheter tracking feedback, signals as received from the movement tracking system 643 from guidance assembly 639 . Moreover, processor 631 may be configured to process desired catheter articulations 637 in accordance with the commands received from the input device 651 such that drive signals are generated by processor 631 and transmitted to the articulation drive 641 in guidance assembly 639 to control the movements of the catheter and/or hood in a desired manner.
  • FIG. 48A illustrates a perspective view of a variation of a robotic control assembly showing base 602 having four proximal drive assemblies 630 attached thereupon where each assembly 630 may control a corresponding control element, e.g., pullwire, for controlling an articulation of hood 12 positioned upon deployment catheter 16 .
  • Delivery catheter or sheath 14 may be attached or otherwise coupled to base 602 or to sheath instrument 632 having an instrument base 636 , which may also have a drive assembly 630 rotatably positioned thereon.
  • control elements attached to their respective drive assembly 630 may each extend through delivery catheter 14 and couple to the hood 12 , as described below, to bend, the distal end of the deployment catheter 16 and/or hood 12 itself in any number of directions by displacing one of the control elements in the proximal direction to deflect the distal end of the catheter member in the predetermined direction.
  • Catheter 14 may be coupled to instrument base 636 such that, the drive assembly 630 may be used to control a retraction or advancement of the catheter 14 relative to hood 12 to control the expansion or collapse of hood 12
  • FIG. 48B shows a detail perspective view of the distal end of catheter 16 extending from delivery catheter 14 and articulation of the hood 12 relative to the catheter 16
  • hood 12 may utilize imaging element 620 , e.g., CMOS, CCD imager, etc., positioned off axis relative to a longitudinal axis of catheter 16 and attached along one or more support struts 622 within hood 12 .
  • Hood 12 may be connected to hood base 640 which is pivotable in a first plane via hinge or pivot 642 .
  • Flood base 640 may itself be pivotable in a second plane via hinge or pivot 644 and the distal end of deployment catheter 16 may further define an articulatable section 638 , which may allow its distal, end to articulate within a plane when urged by the one or more control elements.
  • FIG. 48C illustrates a perspective view of another variation of a robotic control, assembly having an inflatable imaging balloon 653 assembly.
  • imaging balloon 653 may be positioned upon articulatable deployment catheter 16 and may further include a separate anchoring balloon 655 positioned, upon support catheter 657 distally of imaging balloon 653 .
  • Support catheter 657 may extend through both anchoring balloon 655 and imaging balloon 653 and define a lumen 659 therethrough for accessing the tissue regions with, any number of instruments 667 .
  • support catheter 657 and anchoring balloon 655 in its deflated state
  • support catheter 657 may be independently translatable with, respect to imaging balloon 653 (which may be inflated prior to, during, or after anchoring of the anchoring balloon 655 ) to allow for positional adjustment between imaging balloon 653 and the tissue surrounding the ostium.
  • Imaging balloon 653 may be inflated with a transparent fluid or gas, as described above, and may be further supported structurally by one or more support struts 665 extending distally from catheter 16 within or along a proximal portion of imaging balloon 653 .
  • support struts 665 may be collapsed along with imaging balloon 653 into a low-profile configuration and when deployed, balloon 653 may be inflated and support struts 665 may extend radially relative to catheter 16 to support imaging balloon 653 .
  • support struts 665 may also support, one or more light sources 661 , e.g., light emitting diodes, optical fibers, etc. to provide illumination through imaging balloon 653 for viewing the underlying contacted tissue.
  • Imaging element 663 as above, may also be supported along or upon a support strut 665 for viewing the tissue region through balloon 653 as well.
  • each assembly 630 may comprise an axle 650 about which assembly 630 may rotate in a first direction to spool, and thus proximally displace an attached control element 606 to deflect the distal end of catheter 16 is a first direction, or rotate in a second opposite direction to unspool, and thus distally displace the attached control element 606 to deflect the distal end of catheter 16 in a second opposite direction.
  • FIG. 50 shows a partial disassembled perspective view of the instrument driver 660 assembly illustrating the main housing structure 670 underlying the assembly. As illustrated, cams and motors may be controlled by one or more electronics boards 672 which may be coupled to the main housing structure 670 .
  • FIG. 52A illustrates a perspective assembly view of a mechanism which provides precision steering and articulation of the hood 12 .
  • a precision control drive unit 680 may be attached to delivery catheter 14 and/or deployment catheter 16 for providing articulation control.
  • FIG. 52B illustrates a detailed perspective view of the distal end of one variation of deployment catheter 16 having the articulatable section 638 .
  • Hinge or pivot 642 and 644 may provide for articulation in at least two planes transverse to one another for viewing tissue structures via imaging element 620 positioned within hood 12 , as described above.
  • FIG. 53 illustrates an example of a simplified assembly view of the mechanisms within control drive unit 680 for controlling the articulation of hood 12 .
  • one or more pullwires 682 may be routed through catheter 14 to hood 12 with their proximal ends coupled to one or more cams 684 or gears. These cams 684 may be rotatably coupled to one or more drive wheels 686 , which are in turn in communication through control cables 688 to (optional) gearing 692 of motor driver 690 .
  • FIGS. 54A and 54B show an assembled view and exploded assembly view, respectively.
  • hood 12 having imaging element 620 positioned therewithin in an off-axis location, may be coupled or otherwise attached to hood base 640 , which itself is pivotably coupled via hood mating portion 706 connected to receiving portion 708 via pin 710 to allow hood 12 to articulate within a first plane.
  • Receiving portion 708 may also be pivotably coupled to receiving portion 702 via pin 704 to allow hood 12 to articulate within a second plane transverse to the first plane.
  • the receiving portion 708 may also have one or more pullwire termination points 700 to which one or more pullwires 682 may be terminated.
  • FIGS. 55A and 55C shows another variation where a pair of pullwires 682 may steer a first planarly articulatable spine section 720 located near or at the distal end of deployment catheter 16 .
  • a second pair of pullwires 682 may steer hood base 640 and hood 12 in a second plane transverse to the first plane.
  • the steerable spine section 720 may comprise a spine segment 722 having multiple cut-outs or reduced sections 724 along either side of the spine segment 722 such that the spine section 720 may bend in a plane by flexing to either side of the reduced sections 724 while maintaining structural integrity by the spine segment 722 , as illustrated in the detail view of FIG. 55B .
  • Spine section 720 may be comprised of various materials, e.g., stainless steel, PEEK or hard plastics, through machining, molding or metal injection molding. Moreover, stainless steel cables, Nitinol, elgiloy, or tungsten wires can be used for pullwires.
  • the section 720 can be alternatively constructed as bump links, pinned links, ring links, laser cut tubes, fish bone spine links, silt tubes or double durometer tubes, etc., may also be steered using various mechanisms such as single bend steering, double bend steering with two or more pullwires, multi-way bend steering, and/or steering through multiple variations of catheter-sheath interactions.
  • FIGS. 56A and 56C illustrate yet another variation of steering mechanisms in the perspective assembly and exploded assembly views.
  • a fully articulatable spine section 730 may be included near or at the distal end of deployment, catheter 16 , as above, where the section 730 includes a central spine 734 having multiple cut-outs or reduced sections 732 circumferentially defined about central spine 734 , as illustrated in FIG. 56B .
  • Having the reduced sections 732 defined, entirely around spine 734 enables full articulation of hood 12 about spine 734 rather than being limited for movement within a plane.
  • the computer may also track the movement of hood 12 within a patient body, e.g., within the left atrial chamber of the heart, such that the location, and position relative to an anatomical landmark, e.g., the pulmonary veins, are known, at any given time.
  • Other alternative mechanisms may also be utilized to track and/or record the position of hood 12 within the body at any given time.
  • FIG. 57A shows a perspective view of one such variation where a ferromagnetic ring 740 may be attached circumferentially around the lip of hood 12 .
  • a ferromagnetic ring 740 may be attached circumferentially around the lip of hood 12 .
  • Such a configuration may be utilized in conjunction with conventional magnetic navigation, systems, such as the NIOBE® system developed by Stereotaxis. Inc. (Saint Louis, Mo.), as illustrated in the perspective view of FIG. 57B .
  • An example of such a magnetic navigation system is shown and described in U.S. Pat. No. 7,019,610 (Creighton et al.) which is incorporated herein by reference in its entirety.
  • an arrangement of two magnets 746 , 748 may be positioned externally to the patient.
  • the two magnets 746 , 748 may swing into position on each side of the patient creating a magnetic field that directs and digitally controls either the distal tip of the tissue visualization catheter or, in this case, the ferromagnetic ring 740 positioned about the lip of hood 12 .
  • the system automatically controls the catheter advancement and retraction of the visualization catheter, eliminating any pulling or pushing on the device. This may be particularly advantageous when the tissue visualization catheter is threaded through tortuous pathways where force transmission is greatly reduced, consequently affecting accuracy in navigational control that requires the pushing or pulling of the sheath or navigation that requires steering internal pullwires.
  • FIG. 58 shows a perspective view of yet another variation of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood 12 through the use of existing ultrasound technologies as described in, e.g., U.S. Pat. No. 5,515,853, which is incorporated herein by reference in its entirety.
  • a first 750 and second 752 ultrasound signal transducer may be symmetrically attached, to the hood 12 around the circumference of the lip of hood 12
  • a third ultrasound transducer 754 may be placed between, the tip of the deployment catheter 16 and the proximal end of the hood 12 .
  • a ferromagnetic ring or an electromagnetic coil 740 that is able to interact with a magnetic field to pull the hood towards a tissue surface may also be attached to the circumference of the hood 12 .
  • the struts 758 supporting hood 12 may be made of a ferromagnetic material where one or more of the struts 758 may have electromagnetic coils 756 wound around the struts 758 , as shown in the perspective view of FIG. 59 .
  • a ferromagnetic disc 760 positioned upon a support member 762 extending through hood 12 may also be utilized, as shown in the perspective view of FIG. 60 .
  • a circumferential balloon 742 which is inflatably positioned within hood 12 and which defines a lumen or channel 744 through the inflated balloon 742 may be optionally utilized.
  • a balloon 742 is described in further detail in U.S. Pat. App. 11/775,771 filed Jul. 10, 2007, which is incorporated herein by reference in its entirety.
  • Position sensor assembly 770 may generally comprise a plate 772 made of radio-transparent material which may be positioned externally of a patient along a skin surface proximate or adjacent to where the hood 12 is to be controlled or tracked within the patient body.
  • Plate 772 may have three or more ultrasound transducers 778 , 780 , 782 positioned along the plate surface separated by a known distance from one another.
  • An electromagnet 776 attached to handle 774 may be slidably positioned within plate 772 for controlling a position of hood 12 within the patient body, as described below.
  • each of the ultrasound transducers 750 , 752 , 754 positioned along hood 12 may communicate with the ultrasound transducers 778 , 780 , 782 on the plate 772 to determine their relative distances from one other by measuring the time between transmission and detection of the ultrasound signals, as illustrated in FIG. 62 .
  • the position of each transducer along hood 12 relative to each transducer along plate 772 , the three-dimensional orientation and position of the hood 12 within the patient body may be computationally determined by a processor and displayed graphically or otherwise to the user.
  • the user may determine an orientation of the hood 12 , for instance if the hood 12 is facing the external plate 772 within the patient body, when 750 and 752 are of equal distance to the plate 772 .
  • the position of the hood 12 can be determined.
  • knowing which quadrant 790 , 792 , 794 , 796 of the plate the hood 12 is relatively positioned may be utilized in differentiating between particular anatomical features, e.g., determining which of the four pulmonary veins the user may be viewing in a patient's heart utilizing the imaging element within hood 12 , as described above.
  • the ferromagnetic element located on the hood 12 may be drawn via magnetic attraction towards the externally located plate 772 such that hood 12 is consequently drawn against the internal tissue surface.
  • hood 12 may be positioned or articulated against the tissue surface by the externally located handle 774 and electromagnet 776 to facilitate movement of the hood 12 along tissue walls.
  • FIGS. 63A to 63 C shows hood 12 having circumferential ferromagnetic ring 740 positioned thereon located within the left atrium LA of heart H.
  • a layer of ultrasound coupling gel may be applied between tire skin S and the external plate 772 , to ensure that ultrasound signals are conducted efficiently.
  • the orientation and position of the hood 12 may be determined via triangulation relative to plate assembly 770 , as shown in FIG. 63A .
  • the movable electromagnet 776 in the external plate 772 can be magnetized, e.g., by stepping on a foot pedal, to draw the electromagnetic ring 740 mid hood 12 towards the tissue wall, as shown in FIG. 63B .
  • handle 774 and electromagnet 776 may be moved in a direction 800 within plate 772 to “walk” or move hood 12 along the tissue wall in a corresponding direction 800 ′. While hood 12 is drawn against the tissue wall, the open area may be purged of blood and the underlying tissue may be viewed through imaging element 620 , as described above.
  • FIG. 64 illustrates an example where rather than utilizing ultrasound transducers along an externally located plate, a catheter 810 having at least three transducers 812 , 814 , 816 at known distances from one another may be intravascularly advanced, e.g., into the coronary sinus CS of a patient heart and positioned such that the transducers are located about the mitral valve.
  • Temporarily positioning the transducers 812 , 814 , 816 within the coronary sinus CS, where they are in closer proximity with the transducers on the hood 12 may reduce the loss of ultrasound signals to the environment as compared to having-transducers placed outside the body.
  • having the transducers communicating within the body also removes the need for ultrasound coupling gel to be applied, on the patient's skin.

Abstract

Precision control systems for tissue visualization and manipulation assemblies are described herein where such devices may utilise a variety of apparatus and methods for facilitating advancement, articulation, control, navigation, etc. of systems which may be used to visual and/or treat tissue regions. Additionally, methods and devices for enhancing navigation of the device through a patient body are also described.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of priority to U.S. Prov. Pat. App. 60/824,421 filed Sep. 1, 2006 and to U.S. Prov. Pat. App. 60/916,640 filed. May 8, 2007, each of which is incorporated herein by reference in its entirety.
  • FIELD OF THE INVENTION
  • The present invention relates generally to medical devices used for accessing, visualizing, and/or treating regions of tissue within a body. More particularly, the present invention relates to systems for controlling and navigating devices used to directly visualize and/or manipulate tissue regions within a body lumen which are generally difficult to access and/or image.
  • BACKGROUND OF THE INVENTION
  • Conventional devices for visualizing interior regions of a body lumen are known. For example, ultrasound devices have been used to produce images from within a body in vivo. Ultrasound has been used both with, and without contrast agents, which typically enhance ultrasound-derived images.
  • Other conventional methods have utilized catheters or probes having position sensors deployed within the body lumen, such as the interior of a cardiac chamber. These types of positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.
  • Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging. Other conventional balloons utilize a cavity, or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.
  • However, such imaging balloons have many inherent disadvantages. For instance, such balloons generally require that the balloon be inflated to a relatively large size which may undesirably displace surrounding tissue and interfere with fine positioning of the imaging system against the tissue. Moreover, the working area created by such inflatable balloons are generally cramped and limited in size. Furthermore, inflated balloons may be susceptible to pressure changes in the surrounding fluid. For example, if the environment surrounding the inflated balloon undergoes pressure changes, e.g., during systolic and diastolic pressure cycles; in a beating heart, the constant pressure change may affect, the inflated balloon volume and its positioning to produce unsteady or undesirable conditions for optimal tissue imaging.
  • Accordingly, these types of imaging modalities are generally unable to provide desirable images useful for sufficient diagnosis and therapy of the endoluminal structure, due in part to factors such as dynamic forces generated by the natural movement of the heart. Moreover, anatomic structures within, the body can occlude or obstruct the image acquisition process. Also, the presence and movement of opaque bodily fluids such as blood generally make in vivo imaging of tissue regions within the heart difficult.
  • Other external imaging modalities are also conventionally utilized. For example, computed tomography (CT) and magnetic resonance imaging (MRI) are typical modalities which are widely used to obtain images of body lumens such as the interior chambers of the heart. However, such imaging modalities fail to provide real-time imaging for infra-operative therapeutic procedures. Fluoroscopic imaging, for instance, is widely used to identify anatomic landmarks within the heart and other regions of fire body. However, fluoroscopy fails to provide an accurate image of the tissue quality or surface and also fails to provide for instrumentation for performing tissue manipulation or other therapeutic procedures upon the visualized tissue regions. In addition, fluoroscopy provides a shadow of tire intervening tissue onto a plate or sensor when it may be desirable to view the intraluminal surface of the tissue to diagnose pathologies or to perform some form of therapy on it.
  • Thus, a tissue imaging system which is able to provide real-time in vivo images of tissue regions within body lumens such as the heart through opaque media such as blood and which also provide instruments for therapeutic procedures upon the visualized tissue are desirable.
  • BRIEF SUMMARY OF THE INVENTION
  • A tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below. Generally, such a tissue imaging and manipulation apparatus comprises ah optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.
  • The deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field is defined by the imaging hood. The open area is the area within which the tissue region of interest may be imaged. The imaging hood may also define an atraumatic contact lip or edge for placement or abutment against the tissue region of interest. Moreover, the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control
  • The deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.
  • In operation, after the imaging hood has been deployed, fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open area completely and displaces any blood from within the open area. The fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, Fluorinert™, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. The fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.
  • In an exemplary variation for imaging tissue surfaces within a heart chamber containing blood, the tissue imaging and treatment system may generally comprise a catheter body having a lumen defined therethrough, a visualization element disposed adjacent the catheter body, the visualization element having a field of view, a transparent fluid source in fluid communication with the lumen, and a barrier or membrane extendable from the catheter body to localize, between the visualization element and the field of view, displacement of blood by transparent fluid that flows from the lumen, and a piercing instrument translatable through the displaced blood for piercing into the tissue surface within the field of view.
  • The imaging hood may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools which may be deployed through the deployment catheter.
  • Moreover, the imaging hood may be utilized with various catheter control assemblies to provide for precise catheter motion. For instance, robotically-controlled catheter systems may be utilized with, the imaging hood and various instruments delivered through the hood. Alternatively, magnetic navigational systems may also be utilized to control and/or locate a hood within the patient body.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A shows a side view of one variation of a tissue imaging apparatus during deployment from a sheath or delivery catheter.
  • FIG. 1B shows the deployed tissue imaging apparatus of FIG. 1A having an optionally expandable hood or sheath attached to an imaging and/or diagnostic catheter.
  • FIG. 1C shows an end view of a deployed imaging apparatus.
  • FIGS. 1D to 1F show the apparatus of FIGS. 1A to 1C with an additional lumen, e.g. for passage of a guidewire therethrough.
  • FIGS. 2A and 2B show one example of a deployed tissue imager positioned against or adjacent to the tissue to be imaged and a flow of fluid, such as saline, displacing blood from within the expandable hood.
  • FIG. 3A shows an articulatable imaging assembly which may be manipulated, via push-pull wires or by computer control.
  • FIGS. 3B and 3C show steerable instruments, respectively, where an articulatable delivery catheter may be steered within the imaging hood or a distal portion of the deployment catheter itself may be steered.
  • FIGS. 4A to 4C show side and cross-sectional end views, respectively, of another variation having an off-axis imaging capability.
  • FIG. 5 shows an illustrative view of an example of a tissue imager advanced intravascularly within a heart for imaging tissue regions within an atrial chamber.
  • FIGS. 6A to 6C illustrate deployment catheters having one or more optional inflatable balloons or anchors for stabilizing the device during a procedure.
  • FIGS. 7A and 7B illustrate a variation of an anchoring mechanism such as a helical tissue piercing device for temporarily stabilizing the imaging hood relative to a tissue surface.
  • FIG. 7C shows another variation for anchoring the imaging hood having one or more tubular support members integrated with the imaging hood; each support members may define a lumen therethrough for advancing a helical tissue anchor within.
  • FIG. 8A shows an illustrative example of one variation of how a tissue imager may be utilized with an imaging device.
  • FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system.
  • FIGS. 9A to 9C illustrate an example of capturing several images of the tissue at multiple regions.
  • FIGS. 10A and 10B show charts illustrating how fluid pressure within the imaging hood may be coordinated with the surrounding blood pressure; the fluid pressure in the imaging hood may be coordinated with the blood pressure or it may be regulated based, upon pressure feedback from the blood.
  • FIG. 11A shows a side view of another variation of a tissue imager having an imaging balloon within an expandable hood.
  • FIG. 11B shows another variation of a tissue imager utilizing a translucent or transparent imaging balloon.
  • FIG. 12A shows another variation in which a flexible expandable or distensible membrane may be incorporated within the imaging hood to alter the volume of fluid dispensed.
  • FIGS. 12B and 12C show another variation in which, the imaging hood may be partially or selectively deployed from the catheter to alter the area of the tissue being visualized as well as the volume of the dispensed fluid.
  • FIGS. 13A and 13B show exemplary side and cross-sectional views, respectively, of another variation, in which the injected fluid may be drawn back into the device for minimizing fluid input into a body being treated.
  • FIGS. 14A to 14D show various configurations and methods for configuring an imaging hood into a low-profile for delivery and/or deployment.
  • FIGS. 15A and 15B show an imaging hood having an helically expanding frame or support.
  • FIGS. 16A and 16B show another imaging hood having one or more hood support members, which, are pivotably attached at their proximal ends to deployment catheter, integrated with a hood membrane.
  • FIGS. 17A and 17B show yet another variation of the imaging hood having at least two or more longitudinally positioned support members supporting the imaging hood membrane where the support members are movable relative to one another via a torquing or pulling or pushing force.
  • FIGS. 18A and 18B show another variation where a distal portion of the deployment catheter may have several pivoting members which form a tubular shape in its low profile configuration.
  • FIGS. 19A and 19B show another variation where the distal portion, of deployment catheter may be fabricated from a flexible metallic or polymeric material to form a radially expanding hood.
  • FIGS. 20A and 20B show another variation where the imaging hood may be formed from a plurality of overlapping hood members which overlie one another in an overlapping pattern.
  • FIGS. 21A and 21B show another example of an expandable hood which is highly conformable against tissue anatomy with varying geography.
  • FIG. 22A shows yet another example of an expandable hood having a number of optional electrodes placed about the contact edge or lip of the hood for sensing tissue contact or detecting arrhythmias.
  • FIG. 22B shows another variation for conforming the imaging hood against the underlying tissue where an inflatable contact edge may be disposed around the circumference of the imaging hood.
  • FIG. 23 shows a variation of the system which may be instrumented with a transducer for detecting the presence of blood seeping back into the imaging hood.
  • FIGS. 24A and 24B show variations of the imaging hood instrumented with sensors for detecting, various physical parameters; the sensors may be instrumented around the outer surface of the imaging hood and also within the imaging hood.
  • FIGS. 25A and 25B show a variation where the imaging hood may have one or more LEDs over the hood itself for providing illumination of the tissue to be visualized.
  • FIGS. 26A and 26B show another variation in which a separate illumination tool having one or more LEDs mounted thereon may be utilized within the imaging hood.
  • FIG. 27 shows one example of how a therapeutic tool may be advanced through the tissue imager for treating a tissue region of interest.
  • FIG. 28 shows another example of a helical therapeutic tool for treating the tissue region of interest.
  • FIG. 29 shows a variation, of how a therapeutic tool may be utilized with an expandable imaging balloon.
  • FIGS. 30A and 30B show alternative configurations for therapeutic instruments which may be utilized; one variation is shown having an angled instrument arm and another variation is shown with an off-axis instrument arm.
  • FIGS. 31A to 31C show side and end views, respectively, of an imaging system which may be utilized with an ablation probe.
  • FIGS. 32A and 32B show side and end views, respectively, of another variation of the imaging hood with an ablation probe, where the imaging hood may be enclosed, for regulating a temperature of the underlying tissue.
  • FIGS. 33A and 33B show an example in which the imaging fluid itself may be altered in temperature to facilitate various procedures upon the underlying tissue.
  • FIGS. 34A and 34B show an example of a laser ring generator which may be utilized with the imaging system and an example for applying the laser ring generator within the left, atrium of a heart for treating atrial fibrillation.
  • FIGS. 35A to 35C show an example of an extendible cannula generally comprising an elongate tubular member which may be positioned within the deployment catheter during delivery and then projected distally through the imaging hood and optionally beyond.
  • FIGS. 36A and 36B show side and end views, respectively, of an imaging hood having one or more tubular support members integrated with the hood for passing instruments or tools therethrough for treatment upon the underlying tissue.
  • FIGS. 37A and 37B illustrate how an imaging device may be guided within a heart chamber to a region, of interest utilizing a lighted probe positioned temporarily within, e.g., a lumen of the coronary sinus.
  • FIGS. 38A and 38B show an imaging hood having a removable disk-shaped member for implantation upon the tissue surface.
  • FIGS. 39A to 39C show one method for implanting the removable disk of FIGS. 38A and 38B.
  • FIGS. 40A and 40B illustrate an imaging hood having a deployable anchor assembly attached to the tissue contact edge and an assembly view of the anchors and the suture or wire connected to the anchors, respectively
  • FIGS. 41A to 41D show one method for deploying the anchor assembly of FIGS. 40A and 40B for closing an opening or wound.
  • FIG. 42 shows another variation in which the imaging system may be fluidly coupled to a dialysis unit for filtering a patient's blood.
  • FIGS. 43A and 43B show a variation of the deployment catheter having a first deployable hood and a second deployable hood positioned distal to the first hood: the deployment catheter may also have a side-viewing imaging element positioned between the first and second hoods for imaging tissue between the expanded hoods.
  • FIGS. 44A and 44B show side and end views, respectively, of a deployment catheter having a side-imaging balloon in an un-inflated low-profile configuration.
  • FIGS. 45A to 45C show side, top, and end views, respectively, of the inflated balloon, of FIGS. 44A and 44B defining a visualization field in the inflated balloon.
  • FIGS. 46A and 46B show side and cross-sectional end views, respectively, for one method of use in visualizing a lesion upon a vessel wall within the visualisation field of the inflated balloon from FIGS. 45A to 45C.
  • FIGS. 47A and 47B show assembly views of examples of a robotically-controlled guide instrument for precisely controlling a position of a hood.
  • FIG. 47C illustrates an example of how a robotic guide instrument may be utilized with a visualization system.
  • FIGS. 48A and 48B show perspective views of a variation of a robotic control assembly showing base having four proximal drive assemblies and the imaging hood positioned at a distal end of the catheter.
  • FIG. 48C illustrates a perspective view of another variation of a robotic control assembly having an inflatable imaging balloon assembly.
  • FIG. 49 shows a partially disassembled perspective view of the precision control driver.
  • FIG. 50 shows a perspective assembly view of the guide instrument mounted upon an instrument driver.
  • FIG. 51 shows the partially disassembled perspective view of the catheter instrument driver.
  • FIGS. 52A and 52B show perspective views of another variation of the tissue visualization catheter with precision control steering.
  • FIG. 53 illustrates an example of a simplified assembly view of the mechanisms within, the control drive unit for controlling the articulation of hood.
  • FIGS. 54A and 54B show an assembled view and exploded assembly view, respectively, of a tissue visualization hood having a pivotably articulating steering assembly.
  • FIGS. 55A to 55C show an assembled view, detailed spine, and exploded assembly view, respectively, of a tissue visualization hood utilizing steerable spine segments.
  • FIGS. 56A to 56C show another variation in an assembled view, detailed spine, and exploded assembly view, respectively, of a tissue visualization hood also utilizing steerable spine segments.
  • FIG. 57A shows a perspective view of a hood having a ferromagnetic ring attached circumferentially around the lip of the hood.
  • FIG. 57B shows a perspective view of an example of a magnetic navigation system, which, may be used to steer the imaging hood through the patient body.
  • FIG. 58 shows a perspective view of another variation, of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood via ultrasound transducers and having a magnetic ring circumferentially positioned about the lip of the hood.
  • FIG. 59 shows a perspective view of another variation of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood via ultrasound, transducers and having electromagnetic coils wound about one or more struts.
  • FIG. 60 shows a perspective view of another variation of the tissue visualization catheter having a ferromagnetic disc positioned within the hood.
  • FIG. 61 shows a perspective view of a position sensor assembly which may be utilized to detect, an orientation and/or location of the hood within the body as well as to draw the hood against an internal tissue region.
  • FIG. 62 illustrates an example of triangulation of the transducers to determine the orientation and position of the hood within a patient body.
  • FIGS. 63A to 63C illustrate an example for orienting and drawing a hood within a left atrial chamber against the tissue surface to “walk” the hood along the tissue wall to visually survey the underlying surface.
  • FIG. 64 illustrates another example where a catheter having several transducers may be positioned within, the coronary sinus to communicate with the hood.
  • DETAILED DESCRIPTION OF THE INVENTION
  • A tissue-imaging and manipulation apparatus described below is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and instruments for performing various procedures upon the imaged tissue regions. Such an apparatus may be utilized for many procedures, e.g., facilitating transseptal access to the left, atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures.
  • One variation of a tissue access and imaging apparatus is shown in the detail perspective views of FIGS. 1A to 1C. As shown in FIG. 1A, tissue imagine and manipulation assembly 10 may be delivered intravascularly through the patient's body in a low-profile configuration via a delivery catheter or sheath 14. In the case of treating tissue, such as the mitral valve located at the outflow tract of the left atrium of the heart, it is generally desirable to enter or access the left atrium while minimizing trauma to the patient. To non-operatively effect such access, one conventional approach involves puncturing the intra-atrial septum from the right atrial chamber to the left atrial, chamber in a procedure commonly called a transseptal procedure or septostomy. For procedures such as percutaneous valve repair and replacement, transseptal access to the left, atrial chamber of the heart may allow for larger devices to be introduced into the venous system than can generally be introduced percutaneously into the arterial system.
  • When the imaging and manipulation assembly 10 is ready to be utilized for imaging tissue. Imaging hood 12 may be advanced relative to catheter 14 and deployed from a distal, opening of catheter 14, as shown by the arrow. Upon deployment, imaging hood 12 may be unconstrained to expand, or open into a deployed imaging configuration, as shown in FIG. 1B. Imaging hood 12 may be fabricated from a variety of pliable or conformable biocompatible material including but not limited to, e.g., polymeric, plastic, or woven materials. One example of a woven material is Kevlar® (E. I. du Font de Nemours, Wilmington, Del.), which is an aramid and which can be made into thin, e.g., less than 0.001 in., materials which maintain enough integrity for such applications described herein. Moreover, the imaging hood 12 may be fabricated from a translucent or opaque material and in a variety of different colors to optimize or attenuate any reflected lighting from surrounding fluids or structures, i.e., anatomical or mechanical structures or instruments. In either case, imaging hood 12 may be fabricated into a uniform structure or a scaffold-supported structure, in which case a scaffold made of a shape memory alloy, such as Nitinol or a spring steel, or plastic, etc., may be fabricated and covered with the polymeric, plastic, or woven, material. Hence, imaging hood 12 may comprise any of a wide variety of barriers or membrane structures, as may generally be used to localize displacement of blood or the like from a selected volume of a body lumen or heart chamber. In exemplary embodiments, a volume within an inner surface 13 of imaging hood 12 will be significantly less than a volume of the hood 12 between inner surface 13 and outer surface 11.
  • Imaging hood 12 may be attached at interface 24 to a deployment catheter 16 which may be translated independently of deployment catheter or sheath 14. Attachment of interface 24 may be accomplished through any number of conventional methods. Deployment catheter 16 may define a fluid delivery lumen 18 as well as an imaging lumen 20 within which, an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, imaging hood 12 may expand into any number of shapes, e.g., cylindrical, corneal as shown, semi-spherical, etc., provided that an open area or field 26 is defined by imaging hood 12. The open area 26 is the area within which the tissue region of interest may be imaged. Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest. Moreover, the diameter of imaging hood 12 at its maximum fully deployed diameter, e.g., at contact lip or edge 22, is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16). For instance, the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter of deployment catheter 16. FIG. 1C shows an end view of the imaging hood 12 in its deployed configuration. Also shown are the contact lip or edge 22 and fluid delivery lumen 18 and imaging lumen 20.
  • The imaging and manipulation assembly 10 may additionally define a guidewire lumen therethrough, e.g., a concentric or eccentric lumen, as shown in the side and end views, respectively, of FIGS. 1D to 1F. The deployment catheter 16 may define guidewire lumen 19 for facilitating the passage of the system over or along a guidewire 17, which may be advanced intravascularly within a body lumen. The deployment catheter 16 may then be advanced over the guidewire 17, as generally known in the art.
  • In operation, after imaging hood 12 has been deployed, as in FIG. 1B, and desirably positioned against the tissue region to be imaged along contact edge 22, the displacing fluid may be pumped at positive pressure through fluid delivery lumen 18 until the fluid fills open area 26 completely and displaces any fluid 28 from within open area 26. The displacing fluid flow may be laminarized to improve its clearing effect and to help prevent blood from re-entering the imaging hood 12. Alternatively, fluid flow may be started before the deployment takes place. The displacing fluid, also described herein as imaging fluid, may comprise any biocompatible fluid, e.g., saline, water, plasma, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. Alternatively or additionally, any number of therapeutic drugs may be suspended within the fluid or may comprise the fluid itself which is pumped into open area 26 and which is subsequently passed into and through the heart and the patient body.
  • As seen in the example of FIGS. 2A and 2B, deployment catheter 16 may be manipulated to position deployed imaging hood 12 against or near the underlying tissue region of interest to be imaged, in this example a portion of annulus A of mitral valve MV within the left atrial chamber. As the surrounding blood 30 flows around imaging hood 12 and within open area 26 defined within imaging hood 12, as seen in FIG. 2A, the underlying annulus A is obstructed by the opaque blood 30 and is difficult to view through the imaging lumen 20. The translucent fluid 28, such as saline, may then be pumped through fluid delivery lumen 18, intermittently or continuously, until the blood 30 is at least partially, and preferably completely, displaced from within open area 26 by fluid 28, as shown in FIG. 2B.
  • Although contact edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of clear fluid 28 from open area 26 may be maintained to inhibit significant backflow of blood 30 back into open area 26. Contact, edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contact, edge 22 conform to an uneven or rough underlying anatomical tissue surface. Once the blood 30 has been displaced from imaging hood 12, an image may then be viewed of the underlying tissue through the clear fluid 30. This image may then be recorded or available for real-time viewing for performing a therapeutic procedure. The positive (low of fluid 28 may be maintained continuously to provide for clear viewing of the underlying tissue. Alternatively, the fluid 28 may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow 28 may cease and blood 30 may be allowed to seep or flow back into imaging hood 12. This process may be repeated a number of times at the same tissue region or at multiple tissue regions.
  • In desirably positioning the assembly at various regions within the patient body, a number of articulation and manipulation controls may be utilized. For example, as shown in the articulatable imaging assembly 40 in FIG. 3A, one or more push-pull wires 42 may be routed through deployment catheter 16 for steering the distal end portion of the device in various directions 46 to desirably position the imaging hood 12 adjacent to a region of tissue to be visualized. Depending upon the positioning and the number of push-pull wires 42 utilized, deployment catheter 16 and imaging hood 12 may be articulated into any number of configurations 44. The push-pull wire or wires 42 may be articulated via their proximal ends from outside the patient body manually utilizing one or more controls. Alternatively, deployment catheter 16 may be articulated by computer control, as further described below.
  • Additionally or alternatively, an articulatable delivery catheter 48, which may be articulated via one or more push-pull wires and having an imaging lumen, and one or more working lumens, may be delivered through the deployment catheter 16 and into imaging hood 12. With a distal portion of articulatable delivery catheter 48 within imaging hood 12, the clear displacing fluid may be pumped through delivery catheter 48 or deployment catheter 16 to clear the field within imaging hood 12. As shown in FIG. 3B, the articulatable delivery catheter 48 may be articulated within the imaging hood to obtain a better image of tissue adjacent to the imaging hood 12. Moreover, articulatable delivery catheter 48 may be articulated to direct an instrument or tool, passed through the catheter 48, as described in detail below, to specific areas of tissue imaged through imaging hood 12 without having to reposition deployment catheter 16 and re-clear the imaging field within hood 12.
  • Alternatively, rather than passing an articulatable delivery catheter 48 through the deployment catheter 16, a distal portion of the deployment catheter 16 itself may comprise a distal, end 49 which is articulatable within imaging hood 12, as shown in FIG. 3C. Directed imaging, instrument delivery, etc., may be accomplished directly through one of more lumens within deployment catheter 16 to specific regions of the underlying tissue imaged within imaging hood 12.
  • Visualization within the imaging hood 12 may be accomplished through an imaging lumen 20 defined through deployment catheter 16, as described above. In such a configuration, visualization is available in a straight-line manner, i.e., images are generated from the field distally along a longitudinal axis defined by the deployment catheter 16. Alternatively or additionally, an articulatable imaging assembly having a pivotable support member 50 may be connected to, mounted to, or otherwise passed through deployment catheter 16 to provide for visualization off-axis relative to the longitudinal axis defined by deployment catheter 16, as shown in FIG. 4A. Support member 50 may have an imaging element 52, e.g., a CCD or CMOS imager or optical fiber, attached at its distal end with its proximal end connected to deployment catheter 16 via a pivoting connection 54.
  • If one or more optical fibers are utilized for imaging, the optical fibers 58 may be passed through deployment catheter 16, as shown in the cross-section of FIG. 4B, and routed through the support member 50. The use of optical fibers 58 may provide for increased diameter sizes of the one or several lumens 56 through deployment catheter 16 for the passage of diagnostic and/or therapeutic tools therethrough. Alternatively, electronic chips, such as a charge coupled device (CCD) or a CMOS imager, which are typically known, may be utilized in place of the optical fibers 58, in which case the electronic imager may be positioned in the distal portion of the deployment catheter 16 with, electric wires being routed proximally through the deployment catheter 16. Alternatively, the electronic imagers may be wirelessly coupled to a receiver for the wireless transmission of images. Additional optical fibers or light emitting diodes (LEDs) can be used to provide lighting for the image or operative theater, as described below in further detail. Support member 50 may be pivoted via connection 54 such that the member 50 can be positioned in a low-profile configuration within channel or groove 60 defined in a distal portion of catheter 16, as shown in the cross-section of FIG. 4C. During intravascular delivery of deployment catheter 16 through the patient body, support member 50 can be positioned within channel or groove 60 with imaging hood 12 also in its low-profile configuration. During visualization, imaging hood 12 may be expanded into its deployed configuration and support member 50 may be deployed into its off-axis configuration for imaging the tissue adjacent to hood 12, as in FIG. 4A. Other configurations for support member 50 for off-axis visualization may be utilized, as desired.
  • FIG. 5 shows an illustrative cross-sectional view of a heart H having tissue regions of interest being viewed via an imaging assembly 10. In this example, delivery catheter assembly 70 may be introduced percutaneously into the patient's vasculature and advanced through the superior vena cava SVC and into the right atrium RA. The delivery catheter or sheath 72 may be articulated through the atrial septum AS and into the left atrium LA for viewing or treating the tissue, e.g., the annulus A, surrounding the mitral valve MY. As shown, deployment catheter 16 and imaging hood 12 may be advanced out of delivery catheter 72 and brought into contact or in proximity to the tissue region of interest. In other examples, delivery catheter assembly 70 may be advanced through the inferior vena cava IVC, if so desired. Moreover, other regions of the heart H. e.g., the right ventricle RV or left ventricle LV, may also be accessed and imaged or treated by imaging assembly 10.
  • In accessing regions of the heart H or other parts of the body, the delivery catheter or sheath 14 may comprise a conventional intra-vascular catheter or an endoluminal delivery device. Alternatively, robotically-controlled delivery catheters may also be optionally utilized with the imaging assembly described herein, in which case a computer-controller 74 may be used to control the articulation and positioning of the delivery catheter 14. An example of a robotically-controlled delivery catheter which may be utilized is described in further detail in US Pat. Pub. 2002/0087169 A1 to Brock et al. entitled “Flexible Instrument”, which is incorporated herein by reference in its entirety. Other robotically-controlled delivery catheters manufactured by Hansen Medical, Inc. (Mountain View, Calif.) may also be utilized with the delivery catheter 14, as described in further detail below.
  • To facilitate stabilization of the deployment catheter 16 during a procedure, one or more inflatable balloons or anchors 76 may be positioned along the length of catheter 16, as shown in FIG. 6A. For example, when utilizing a transseptal approach across the atrial septum AS into the left atrium LA, the inflatable balloons 76 may be inflated from a low-profile into their expanded configuration to temporarily anchor or stabilize the catheter 16 position relative to the heart H. FIG. 6B shows a first balloon 78 inflated while FIG. 6G also shows a second balloon 80 inflated proximal to the first balloon 78. In such a configuration, the septal wall AS may be: wedged or sandwiched between the balloons 78, 80 to temporarily stabilize the catheter 16 and imaging hood 12. A single balloon 78 or both balloons 78, 80 may be used. Other alternatives may utilize expandable mesh members, malecots, or any other temporary expandable structure. After a procedure has been accomplished, the balloon assembly 76 may be deflated or re-configured into a low-profile for removal of the deployment catheter 16.
  • To further stabilize a position of the imaging hood 12 relative to a tissue surface to be imaged, various anchoring mechanisms may be optionally employed for temporarily holding the imaging hood 12 against the tissue. Such anchoring mechanisms may be particularly useful for imaging tissue which is subject to movement, e.g., when imaging tissue within the chambers of a beating heart. A tool delivery catheter 82 having at least one instrument lumen and an optional visualization lumen may be delivered through deployment catheter 16 and into an expanded imaging hood 12. As the imaging hood 12 is brought into contact against a tissue surface T to be examined, anchoring mechanisms such as a helical tissue piercing device 84 may be passed through the tool delivery catheter 82, as shown in FIG. 7A, and into imaging hood 12.
  • The helical tissue engaging device 84 may be torqued from its proximal end outside the patient body to temporarily anchor itself into the underlying tissue surface T. Once embedded within the tissue T, the helical tissue engaging device 84 may be pulled proximally relative to deployment catheter 16 while the deployment catheter 16 and imaging hood 12 are pushed distally, as indicated by the arrows in FIG. 7B, to gently force the contact edge or lip 22 of imaging hood against the tissue T. The positioning of the tissue engaging device 84 may be locked temporarily relative to the deployment catheter 16 to ensure secure positioning of the imaging hood 12 during a diagnostic or therapeutic procedure within the imaging hood 12. After a procedure, tissue engaging device 84 may be disengaged from the tissue by torquing its proximal end in the opposite direction to remove the anchor form the tissue T and the deployment catheter 16 may be repositioned to another region of tissue where the anchoring process may be repeated or removed from the patient body. The tissue engaging device 84 may also be constructed from other known tissue engaging devices such as vacuum-assisted engagement or grasper-assisted engagement tools, among others.
  • Although a helical anchor 84 is shown, this is intended to be illustrative and other types of temporary anchors may be utilized, e.g., hooked or barbed anchors, graspers, etc. Moreover, the tool delivery catheter 82 may be omitted entirely and the anchoring device may be delivered directly through a lumen defined through the deployment catheter 16.
  • In another variation where the tool delivery catheter 82 may be omitted entirely to temporarily anchor imaging hood 12, FIG. 7C shows an imaging hood 12 having one or more tubular support members 86, e.g., four support members 86 as shown, integrated with the imaging hood 12. Tire tubular support members 86 may define lumens therethrough each having helical tissue engaging devices 88 positioned within. When an expanded imaging hood 12 is to be temporarily anchored to the tissue, the helical tissue engaging devices 88 may be urged distally to extend front imaging hood 12 and each may be torqued from its proximal end to engage the underlying tissue T. Each of the helical tissue engaging devices 88 may be advanced through the length of deployment catheter 16 or they may be positioned within tubular support members 86 during tire delivery and deployment of imaging hood 12. Once the procedure within imaging hood 12 is finished, each of the tissue engaging devices 88 may be disengaged from the tissue and the imaging hood 12 may be repositioned to another region of tissue or removed from the patient body.
  • An illustrative example is shown in FIG. 8A of a tissue imaging assembly connected to a fluid delivery system 90 and to an optional processor 98 and image recorder and/or viewer 100. The fluid, delivery system 90 may generally comprise a pump 92 and an optional valve 94 for controlling the flow rate of the fluid into the system. A fluid reservoir 96, fluidly connected to pump 92, may hold, the fluid to be pumped through imaging hood 12. An optional central processing unit or processor 98 may be in electrical communication with fluid delivery system 90 for controlling flow parameters such as the flow rate and/or velocity of the pumped fluid. The processor 98 may also be in electrical communication with an image recorder and/or viewer 100 for directly viewing the images of tissue received from within imaging hood 12. Imager recorder and/or viewer 100 may also be used not only to record the image but also the location of the viewed tissue region, if so desired.
  • Optionally, processor 98 may also be utilized to coordinate the fluid flow and the image capture. For instance, processor 98 may be programmed to provide for fluid flow from reservoir 96 until the tissue area has been, displaced of blood to obtain a clear image. Once the image has been determined to be sufficiently clear, either visually by a practitioner or by computer, an image of the tissue may be captured automatically by recorder 100 and pump 92 may be automatically stopped or slowed by processor 98 to cease the fluid flow into the patient. Other variations for fluid delivery and image capture are, of course, possible and the aforementioned configuration is intended only to be illustrative and not limiting.
  • FIG. 8B shows a further illustration of a hand-held variation of the fluid delivery and tissue manipulation system 110. In this variation, system 110 may have a housing or handle assembly 112 which can be held or manipulated by the physician from outside the patient body. The fluid reservoir 114, shown in this variation as a syringe, can be fluidly coupled to the handle assembly 112 and actuated via a pumping mechanism 116, e.g., lead screw. Fluid reservoir 114 may be a simple reservoir separated from the handle assembly 112 and fluidly coupled to handle assembly 112 via one or more tubes. The fluid flow rate and other mechanisms may be metered by the electronic controller 118.
  • Deployment of imaging hood 12 may be actuated by a hood deployment switch 120 located on the handle assembly 112 while dispensation of the fluid from reservoir 114 may be actuated by a fluid deployment switch 122, which can be electrically coupled to the controller 118. Controller 118 may also be electrically coupled to a wired or wireless antenna 124 optionally integrated with the handle assembly 112, as shown in the figure. The wireless antenna 124 can be used to wirelessly transmit images captured from, the imaging hood 12 to a receiver, e.g., via Bluetooth® wireless technology (Bluetooth SIG, Inc., Bellevue, Wash.), RF, etc., for viewing on a monitor 128 or for recording for later viewing.
  • Articulation control of the deployment catheter 16, or a delivery catheter or sheath 14 through which the deployment catheter 16 may be delivered, may be accomplished by computer control, as described above, in which case an additional controller may be utilized, with handle assembly 112. In the case of manual articulation, handle assembly 112 may incorporate one or more articulation controls 126 for manual manipulation, of the position of deployment catheter 16. Handle assembly 112 may also define one or more instrument, ports 130 through which a number of intravascular tools may be passed for tissue manipulation and treatment within imaging hood 12, as described further below. Furthermore, in certain procedures, fluid or debris may be sucked into imaging hood 12 for evacuation from the patient body by optionally fluidly coupling a suction pump 132 to handle assembly 112 or directly to deployment catheter 16.
  • As described above, fluid may be pumped continuously into imaging hood 12 to provide for clear viewing of the underlying tissue. Alternatively, fluid may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point: the fluid flow may cease and the blood may be allowed to seep or flow back into image hood 12. FIGS. 9A to 9C illustrate an example of capturing several, images of the tissue at multiple regions. Deployment catheter 16 may be desirably positioned and imaging hood 12 deployed and brought into position against a region of tissue to be imaged, in this example the tissue surrounding a mitral valve MV within the left atrium of a patient's heart. The imaging hood 12 may be optionally anchored to the tissue, as described above, and then cleared by pumping the imaging fluid into the hood 12. Once sufficiently clear, the tissue may be visualized and the image captured by control electronics 118. The first captured image 140 may be stored and/or transmitted wirelessly 124 to a monitor 128 for viewing by the physician, as shown in FIG. 9A.
  • The deployment catheter 16 may be then repositioned to an adjacent portion of mitral valve MV, as shown in FIG. 9B, where the process may be repeated to capture a second image 142 for viewing and/or recording. The deployment catheter 16 may again be repositioned to another region of tissue, as shown in FIG. 9C, where a third image 144 may be captured for viewing and/or recording. This procedure may be repeated as many times as necessary for capturing a comprehensive image of the tissue surrounding mitral valve MV, or any other tissue region. When the deployment catheter 16 and imaging hood 12 is repositioned from tissue region to tissue region, the pump may be stopped, during positioning and blood or surrounding fluid may be allowed to enter within imaging hood 12 until the tissue is to be imaged, where the imaging hood 12 may be cleared, as above.
  • As mentioned, above, when the imaging hood 12 is cleared by pumping the imaging fluid within for clearing the blood or other bodily fluid, the fluid may be pumped continuously to maintain the imaging fluid within the hood 12 at a positive pressure or it may be pumped under computer control for slowing or stopping the fluid flow into the hood 12 upon detection of various parameters or until a clear image of the underlying tissue is obtained. The control electronics 118 may also be programmed to coordinate the fluid flow into the imaging hood 12 with various physical parameters to maintain a clear image within imaging hood 12.
  • One example is shown in FIG. 10A which shows a chart 150 illustrating how fluid pressure within the imaging hood 12 may be coordinated with the surrounding blood pressure. Chart 150 shows the cyclical blood pressure 156 alternating between, diastolic pressure 152 and systolic pressure 154 over time T due to the beating motion of the patient heart. The fluid pressure of the imaging fluid, indicated by plot 160, within imaging hood 12 may be automatically timed to correspond to the blood pressure changes 160 such that an increased pressure is maintained within imaging hood 12 which is consistently above the blood pressure 156 by a slight increase ΔP, as illustrated by the pressure difference at the peak systolic pressure 158. This pressure difference, ΔP, may be maintained within imaging hood 12 over the pressure variance of the surrounding blood pressure to maintain a positive imaging fluid pressure within imaging hood 12 to maintain a clear view of the underlying tissue. One benefit of maintaining a constant ΔP is a constant flow and maintenance of a clear field.
  • FIG. 10B shows a chart 162 illustrating another variation for maintaining a clear view of the underlying tissue where one or more sensors within the imaging hood 12, as described in further detail below, may be configured to sense, pressure changes within the imaging hood 12 and to correspondingly increase the imaging fluid pressure within imaging hood 12. This may result in a time delay, ΔT, as illustrated by the shifted fluid pressure 160 relative to the cycling blood pressure 156, although the time delays ΔT may be negligible in maintaining the clear image of the underlying tissue. Predictive software algorithms can also be used to substantially eliminate this time delay by predicting when the next pressure wave peak will arrive and by increasing the pressure ahead of the pressure wave's arrival by an amount of time equal to the aforementioned time delay to essentially cancel the time delay out.
  • The variations in fluid pressure within imaging hood 12 may be accomplished in part due to the nature of imaging hood 12. An inflatable balloon, which is conventionally utilized for imaging tissue, may be affected, by the surrounding blood pressure changes. On the other hand, an imaging hood 12 retains a constant volume therewithin and is structurally unaffected by the surrounding blood pressure changes, thus allowing for pressure increases therewithin. The material that hood 12 is made from may also contribute to the manner in which the pressure is modulated within this hood 12. A stiffer hood material, such as high durometer polyurethane or Nylon, may facilitate the maintaining of an open hood when deployed. On the other hand, a relatively lower durometer or softer material, such as a low durometer PVC or polyurethane, may collapse from the surrounding fluid pressure and may not adequately maintain a deployed or expanded hood.
  • Turning now to the imaging hood, other variations of the tissue imaging assembly may be utilized, as shown in FIG. 11A, which shows another variation comprising an additional imaging balloon 172 within an imaging hood 174. In this variation, an expandable balloon 172 having a translucent skin may be positioned within imaging hood 174. Balloon 172 may be made from any distensible biocompatible material having sufficient translucent properties which allow for visualization therethrough. Once the imaging hood 174 has been deployed against the tissue region of interest, balloon 172 may be filled with a fluid, such as saline, or less preferably a gas, until balloon 172 has been expanded until the blood has been sufficiently displaced. The balloon 172 may thus be expanded proximal to or into contact against the tissue region to be viewed. The balloon 172 can also be tilled with contrast media to allow it to be viewed on fluoroscopy to aid in its positioning. The imager, e.g., fiber optic, positioned within deployment catheter 170 may then be utilized to view the tissue region through the balloon 172 and any additional fluid which may be pumped into imaging hood 174 via one or more optional fluid ports 176, which may be positioned proximally of balloon 172 along a portion of deployment catheter 170. Alternatively, balloon 172 may define one or more holes over its surface which allow for seepage or passage of the fluid contained therein to escape and displace the blood from within: imaging hood 174.
  • FIG. 11B shows another alternative in which balloon 180 may be utilized alone. Balloon 180, attached to deployment catheter 178, may be filled with fluid, such as saline or contrast media, and is preferably allowed to come into direct contact with the tissue region to be imaged.
  • FIG. 12A shows another alternative in which deployment catheter 16 incorporates imaging hood 12, as above, and includes an additional flexible membrane 182 within imaging hood 12. Flexible membrane 182 may be attached at a distal end of catheter 16 and optionally at contact edge 22. Imaging hood 12 may be utilized, as above, and membrane 182 may be deployed from catheter 16 in vivo or prior to placing catheter 16 within a patient to reduce the volume within imaging hood 12. The volume may be reduced or minimized to reduce the amount of fluid dispensed for visualization or simply reduced depending upon the area of tissue to be visualized.
  • FIGS. 12B and 12C show yet another alternative in which imaging hood 186 may be withdrawn proximally within deployment catheter 184 or deployed distally from catheter 186, as shown, to vary the volume of imaging hood 186 and thus the volume of dispensed fluid. Imaging hood 186 may be seen in FIG. 12B as being partially deployed from, e.g., a circumferentially defined lumen within catheter 184, such as annular lumen 188. The underlying tissue may be visualized with imaging hood 186 only partially deployed. Alternatively, imaging hood 186′ may be fully deployed, as shown in FIG. 12C, by urging hood 186′ distally out from annular lumen 188. In this expanded configuration, the area of tissue to be visualized may be increased as hood 186′ is expanded circumferentially.
  • FIGS. 13A and 13B show perspective and cross-sectional side views, respectively, of yet another variation of imaging assembly which may utilize a fluid suction system for minimizing the amount of fluid injected into the patient's heart or other body lumen during tissue visualization. Deployment catheter 190 in this variation may define an inner tubular member 196 which may be integrated with deployment catheter 190 or independently translatable. Fluid delivery lumen 198 defined through member 196 may be fluidly connected to imaging hood 192, which may also define one or more open channels 194 over its contact lip region. Fluid pumped through fluid delivery lumen 198 may thus fill open area 202 to displace any blood or other fluids or objects therewithin. As the clear fluid is forced out of open area 202, it may be sucked or drawn immediately through one or more channels 194 and back into deployment catheter 190. Tubular member 196 may also define one or more additional working channels 200 for the passage of any fools or visualization devices.
  • In deploying the imaging hood in the examples described herein, the imaging hood may take on any number of configurations when positioned or configured for a low-profile delivery within the delivery catheter, as shown in the examples of FIGS. 14A to 14D. These examples are intended to be illustrative and are not intended to be limiting in scope. FIG. 14A shows one example in which imaging hood 212 may be compressed within catheter 210 by folding hood 212 along a plurality of pleats. Hood 212 may also comprise scaffolding or frame 214 made of a super-elastic or shape memory material or alloy, e.g. Nitinol, Elgiloy, shape memory polymers, electroactive polymers, or a spring stainless steel. The shape memory material may act to expand or deploy imaging hood 212 into its expanded configuration when urged in the direction of the arrow from the constraints of catheter 210.
  • FIG. 14B shows another example in which imaging hood 216 may be expanded or deployed from catheter 210 from a folded and overlapping configuration. Frame or scaffolding 214 may also be utilized in this example. FIG. 14C shows yet another example in which imaging hood 218 may be rolled. Inverted, or everted upon itself for deployment, in yet another example, FIG. 14D shows a configuration in which imaging hood 220 may be fabricated from an extremely compliant material which allows for hood 220 to be simply compressed into a low-profile shape. From this low-profile compressed shape, simply releasing hood 220 may allow for it to expand into its deployed configuration, especially if a scaffold or frame of a shape memory or superelastic material, e.g., Nitinol, is utilized in its construction.
  • Another variation for expanding the imaging hood is shown in FIGS. 15A and 15B which illustrates an helically expanding frame or support 230. In its constrained low-profile configuration, shown in FIG. 15A, helical frame 230 may be integrated with, the imaging hood 12 membrane. When free to expand, as shown in FIG. 15B, helical frame 230 may expand, into a conical or tapered shape. Helical frame 230 may alternatively be made out of heat-activated Nitinol to allow it to expand upon application of a current.
  • FIGS. 16A and 16B show yet another variation in which imaging hood 12 may comprise one or more hood support members 232 integrated with the hood membrane. These longitudinally attached support members 232 may be pivotably attached at their proximal ends to deployment catheter 16. One or more pullwires 234 may be routed through the length of deployment catheter 16 and extend, through one or more openings 238 defined in deployment, catheter 16 proximally to imaging hood 12 into attachment with a corresponding support member 232 at a pullwire attachment point 236. The support, members 232 may be fabricated from a plastic or metal, such as stainless steel. Alternatively, the support members 232 may be made from a superelastic or shape memory alloy, such as Nitinol, which may self-expand into its deployed configuration without the use or need of pullwires. A heat-activated Nitinol may also be used which expands upon the application of thermal energy or electrical, energy. In another alternative, support members 232 may also be constructed as inflatable lumens utilizing, e.g., PET balloons. From its low-profile delivery configuration shown in FIG. 16A, the one or more pullwires 234 may be tensioned from their proximal ends outside the patient body to pull a corresponding support member 232 into a deployed configuration, as shown in FIG. 16B, to expand imaging hood 12. To reconfigure imaging hood 12 back into its low profile, deployment catheter 16 may be pulled proximally into a constraining catheter or the pullwires 234 may be simply pushed distally to collapse imaging hood 12.
  • FIGS. 17A and 17B show yet another variation of imaging hood 240 having at least two or more longitudinally positioned support members 242 supporting the imaging hood membrane. The support members 242 each have cross-support members 244 which extend diagonally between and are pivotably attached to the support members 242. Each of the cross-support members 244 may be pivotably attached to one another where they intersect between the support members 242. A jack or screw member 246 may be coupled to each cross-support, member 244 at this intersection point and a torquing member, such as a torque-able wire 248, may be coupled to each jack or screw member 246 and extend proximally through deployment catheter 16 to outside the patient body. From outside the patient body, the torqueable wires 248 may be torqued to turn the jack or screw member 246 which in turn urges the cross-support members 244 to angle relative to one another and thereby urge the support members 242 away from one another. Thus, the imaging hood 240 may be transitioned from its low-profile, shown in FIG. 17A, to its expanded profile, shown in FIG. 17B, and back into its low-profile by torquing wires 248.
  • FIGS. 18A and 18B show yet another variation on the imaging hood and its deployment. As shown, a distal portion of deployment catheter 16 may have several pivoting members 250, e.g., two to four sections, which form a tubular shape in its low profile configuration, as shown in FIG. 18A. When pivoted radially about deployment catheter 16, pivoting members 250 may open into a deployed configuration having distensible or expanding membranes 252 extending over the gaps in-between the pivoting members 250, as shown in FIG. 18B. The distensible membrane 252 may be attached to the pivoting members 250 through various methods, e.g., adhesives, such that when the pivoting members 250 are fully extended into a conical shape, the pivoting members 250 and membrane 252 form a conical shape for use as an imaging hood. The distensible membrane 252 may be made out of a porous material such as a mesh or PTFE or out of a translucent or transparent polymer such as polyurethane, PVC, Nylon, etc.
  • FIGS. 19A and 19B show yet another variation where the distal portion of deployment catheter 16 may be fabricated from a flexible metallic or polymeric material to form a radially expanding hood 254. A plurality of slots 256 may be formed in a uniform pattern over the distal portion of deployment catheter 16, as shown in FIG. 19A. The slots 356 may be formed in a pattern such that when the distal portion is urged radially open, utilizing any of the methods described above, a radially expanded and conically-shaped hood 254 may be formed by each of the slots 256 expanding into an opening, as shown in FIG. 19B. A distensible membrane 258 may overlie the exterior surface or the interior surface of the hood 254 to form a fluid-impermeable hood 254 such that the hood 254 may be utilized as an imaging hood. Alternatively, the distensible membrane 258 may alternatively be formed, in each opening 258 to form the fluid-impermeable hood 254. Once tire imaging procedure has been completed, hood 254 may be retracted into its low-profile configuration.
  • Yet another configuration for the imaging hood, may be seen in FIGS. 20A and 20B where the imaging hood may be formed from a plurality of overlapping hood, members 260 which overlie one another in an overlapping pattern. When expanded, each of the hood members 260 may extend radially outward relative to deployment catheter 16 to form a conically-shaped imaging hood, as shown in FIG. 20B. Adjacent hood members 260 may overlap one another along an overlapping interface 262 to form a fluid-retaining surface within the imaging hood. Moreover, the hood members 260 may be made from any number of biocompatible materials, e.g., Nitinol, stainless steel, polymers, etc., which are sufficiently strong to optionally retract surrounding tissue from the tissue region of interest.
  • Although it is generally desirable to have an imaging hood contact against a tissue surface in a normal orientation, the imaging hood may be alternatively, configured to contact the tissue surface at air acute angle. An imaging hood configured for such contact against tissue may also be especially suitable for contact against, tissue surfaces having an unpredictable or uneven anatomical geography. For instance, as shown in the variation of FIG. 21A, deployment catheter 270 may have an imaging hood 272 that is configured to be especially compliant. In this variation, imaging hood 272 may be comprised of one or more sections 274 that are configured to fold or collapse, e.g., by utilizing a pleated surface. Thus, as shown in FIG. 21B, when imaging hood 272 is contacted against uneven tissue surface T, sections 274 are able to conform closely against the tissue. These sections 274 may be individually collapsible by utilizing an accordion style construction to allow conformation, e.g., to the trabeculae in the heart or the uneven anatomy that may be found inside the various body lumens.
  • In yet another alternative, FIG. 22A shows another variation in which an imaging hood 282 is attached to deployment catheter 280. The contact lip or edge 284 may comprise one or more electrical contacts 286 positioned circumferentially around contact edge 284. The electrical contacts 286 may be configured to contact the tissue and indicate affirmatively whether tissue contact was achieved, e.g., by measuring the differential impedance between blood and tissue. Alternatively, a processor, e.g., processor 98, in electrical communication with contacts 286 may be configured to determine what type of tissue is in contact with electrical contacts 286. In yet another alternative, the processor 98 may be configured to measure any electrical activity that may be occurring in the underlying tissue, e.g., accessory pathways, for the purposes of electrically mapping the cardiac tissue and subsequently treating, as described below, any arrhythmias which may be detected.
  • Another variation for ensuring contact between imaging hood 282 and the underlying tissue may be seen in FIG. 22B. This variation may have an inflatable contact: edge 288 around the circumference of imaging hood 282. The inflatable contact edge 288 may be inflated with a fluid or gas through inflation lumen 289 when the imaging hood 282 is to be placed against a tissue surface having an uneven or varied anatomy. The inflated circumferential surface 288 may provide for continuous contact over the hood edge by conforming against the tissue surface and facilitating imaging fluid retention within hood 282.
  • Aside from the imaging hood, various instrumentation may be utilized with the imaging and manipulation system. For instance, after the field within imaging hood 12 has been cleared of the opaque blood and the underlying tissue is visualized through the clear fluid, blood may seep back into the imaging hood 12 and obstruct the view. One method for automatically maintaining a clear imaging field may utilize a transducer, e.g., an ultrasonic transducer 290, positioned at the distal end of deployment catheter within the imaging hood 12, as shown in FIG. 23. The transducer 290 may send an energy pulse 292 into the imaging hood 12 and wait to detect back-scattered energy 294 reflected from debris or blood within the imaging hood 12. If back-scattered energy is detected, the pump may be actuated automatically to dispense more fluid into the imaging hood until the debris or blood is no longer detected.
  • Alternatively, one or more sensors 300 may be positioned on the imaging hood 12 itself, as shown in FIG. 24A, to detect a number of different parameters. For example, sensors 300 may be configured to detect for the presence of oxygen in the surrounding blood, blood and/or imaging fluid pressure, color of the fluid, within the imaging hood, etc. Fluid color may be particularly useful in detecting the presence of blood within the imaging hood 12 by utilizing a reflective type sensor to detect back reflection from blood. Any reflected light from blood which may be present within imaging hood 12 may be optically or electrically transmitted through deployment catheter 16 and to a red colored filter within control electronics 118. Any red color which may be detected may indicate the presence of blood and trigger a signal to the physician or automatically actuate the pump to dispense more fluid into the imaging hood 12 to cleat the blood.
  • Alternative methods for detecting the presence of blood within, the hood 12 may include detecting transmitted light through the imaging fluid within imaging hood 12. If a source of white light, e.g., utilizing LEDs or optical fibers, is illuminated inside imaging hood 12, the presence of blood may cause the color red to be filtered, through this fluid. The degree or intensity of the red color detected may correspond to the amount of blood present within imaging hood 12. A red color sensor can simply comprise, in one variation, a phototransistor with a red transmitting filter over it which can establish how much red light is detected, which in turn can indicate the presence of blood, within imaging hood 12. Once blood is detected, the system may pump more clearing fluid through and enable closed loop feedback control of the clearing fluid pressure and flow level.
  • Any number of sensors may be positioned along the exterior 302 of imaging hood 12 or within the interior 304 of imaging hood 12 to detect parameters not only exteriorly to imaging hood 12 but also within imaging hood 12. Such a configuration, as shown in FIG. 24B, may be particularly useful for automatically maintaining a clear imaging field based upon physical, parameters such as blood pressure, as described above for FIGS. 10A and 10B.
  • Aside from sensors, one or more light emitting diodes (LEDs) may be utilized to provide lighting within the imaging hood 12. Although illumination may be provided by optical fibers routed through deployment catheter 16, the use of LEDs over the imaging hood 12 may eliminate the need for additional optical fibers for providing illumination. The electrical wires connected to the one or more LEDs may be routed through or over the hood 12 and along an exterior surface or extruded within deployment catheter 16. One or more LEDs may be positioned in a circumferential pattern 306 around imaging hood 12, as shown in FIG. 25A, or in a linear longitudinal pattern 308 along imaging hood 12, as shown in FIG. 25B. Other patterns, such as a helical or spiral pattern, may also be utilized. Alternatively, LEDs may be positioned along a support member forming part of imaging hood 12.
  • In another alternative for illumination within imaging hood 12, a separate illumination tool 310 may be utilized, as shown in FIG. 26A. An example of such a tool may comprise a flexible intravascular delivery member 312 having a carrier member 314 pivotably connected 316 to a distal end of delivery member 312. One or more LEDs 318 may be mounted along carrier member 314. In use, delivery member 312 may be advanced through deployment catheter 16 until carrier member 314 is positioned within imaging hood 12. Once within imaging hood 12, carrier member 314 may be pivoted in any number of directions to facilitate or optimize the illumination within the imaging hood 12, as shown, in FIG. 26B.
  • In utilizing LEDs for illumination, whether positioned along imaging hood 12 or along a separate instrument, the LEDs may comprise a single LED color, e.g., white light. Alternatively, LEDs of other colors, e.g., red, blue, yellow, etc., may be utilized exclusively or in combination with white LEDs to provide for varied illumination of the tissue or fluids, being imaged. Alternatively, sources of infrared or ultraviolet light may be employed to enable imaging beneath the tissue, surface or cause fluorescence of tissue for use in system guidance, diagnosis, or therapy.
  • Aside from providing a visualization platform, the imaging assembly may also be utilized to provide a therapeutic platform for treating tissue being visualized. As shown in FIG. 27, deployment catheter 320 may have imaging hood 322, as described above, and fluid delivery lumen 324 and imaging lumen 326. In this variation, a therapeutic tool such as needle 328 may be delivered, through fluid delivery lumen 324 or in another working lumen and advanced through open area 332 for treating the tissue which is visualized. In this instance, needle 328 may define one or several ports 330 for delivering drugs therethrough. Thus, once the appropriate region of tissue has been imaged and located, needle 328 may be advanced and pierced into the underlying tissue where a therapeutic agent may be delivered through ports 330. Alternatively, needle 328 may be in electrical communication with a power source 334, e.g., radio-frequency, microwave, etc., for ablating the underlying tissue area of interest.
  • FIG. 28 shows another alternative in which deployment catheter 340 may have imaging hood 342 attached thereto, as above, but with a therapeutic tool 344 in the configuration of a helical tissue piercing device 344. Also shown and described above in FIGS. 7A and 7B for use in stabilizing the imaging hood relative to the underlying tissue, the helical tissue piercing device 344 may also be utilized to manipulate the tissue for a variety of therapeutic procedures. The helical portion 346 may also define one or several ports for delivery of therapeutic agents therethrough.
  • In yet another alternative, FIG. 29 shows a deployment catheter 350 having an expandable imaging balloon 352 filled with, e.g., saline 356. A therapeutic tool 344, as above, may be translatable relative to balloon 352. To prevent the piercing portion 346 of the tool from tearing balloon 352, a stop 354 may be formed on balloon 352 to prevent the proximal passage of portion 346 past stop 354.
  • Alternative configurations for tools which may be delivered through deployment catheter 16 for use in tissue manipulation within imaging hood 12 are shown in FIGS. 30A and 30B. FIG. 30A shows one variation of an angled instrument 360, such as a tissue grasper, which may be configured to have an elongate shaft for intravascular delivery through deployment catheter 16 with a distal end which may be angled relative to its elongate shaft upon deployment into imaging hood 12. The elongate shaft may be configured to angle itself automatically, e.g., by the elongate shaft being made at least partially from a shape memory alloy, or upon actuation, e.g., by tensioning a pull wire. FIG. 30B shows another configuration for an instrument 362 being configured to reconfigure its distal portion into an off-axis configuration within imaging hood 12. In either case, the instruments 360, 362 may be reconfigured into a low-profile shape upon withdrawing them proximally back into deployment catheter 16.
  • Other instruments or tools which may be utilized with the imaging system is shown in the side and end views of FIGS. 31A to 31C. FIG. 31A shows a probe 370 having a distal end effector 372, which may be reconfigured from, a low-profile shape to a curved profile. The end effector 372 may be configured as an ablation probe utilizing radio-frequency energy, microwave energy, ultrasound energy, laser energy or even cryo-ablation. Alternatively, the end effector 372 may have several electrodes upon it for detecting or mapping electrical signals transmitted through the underlying tissue.
  • In the case of an end effector 372 utilized for ablation of the underlying tissue, an additional temperature sensor such as a thermocouple or thermistor 374 positioned upon an elongate member 376 may be advanced into the imaging hood 12 adjacent to the distal, end effector 372 for contacting and monitoring a temperature of the ablated tissue. FIG. 31B shows an example in the end view of one configuration for the distal end effector 372 which may be simply angled into a perpendicular configuration for contacting the tissue. FIG. 31C shows another example where the end effector may be reconfigured into a curved end effector 378 for increased tissue contact.
  • FIGS. 32A and 32B show another variation of an ablation tool utilized with an imaging hood 12 having an enclosed bottom portion. In this variation, an ablation probe, such as a cryo-ablation probe 380 having a distal end effector 382, may be positioned through the imaging hood 12 such that the end effector 382 is placed distally of a transparent membrane or enclosure 384, as shown in the end view of FIG. 32B. The shaft of probe 380 may pass through an opening 386 defined through the membrane 384. In use, the clear fluid may be pumped into imaging hood 12, as described above, and the distal end effector 382 may be placed against a tissue region, to be ablated with the imaging hood 12 and the membrane 384 positioned atop or adjacent to the ablated tissue. In the case of cryo-ablation, the imaging fluid may be warmed prior to dispensing into the imaging hood 12 such that the tissue contacted by the membrane 384 may be warmed during the cryo-ablation: procedure. In the case of thermal ablation, e.g., utilizing radio-frequency energy, the fluid dispensed into the imaging hood 12 may be cooled such that the tissue contacted by tire membrane 384 and adjacent to the ablation probe during the ablation procedure is likewise cooled.
  • In either example described above, the imaging fluid may be varied in its temperature to facilitate various procedures to be performed upon the tissue, brother cases, the imaging fluid itself may be altered to facilitate various procedures. For instance as shown in FIG. 33A, a deployment catheter 16 and imaging hood 12 may be advanced within a hollow body organ, such as a bladder filled with urine 394, towards a lesion or tumor 392 on the bladder wall. The imaging hood 12 may be placed entirely over the lesion 392, or over a portion of the lesion. Once secured against the tissue wall 390, a cryo-fluid, i.e., a fluid which has been cooled to below freezing temperatures of, e.g., water or blood, may be pumped into the imaging hood 12 to cryo-ablate the lesion 390, as shown in FIG. 33B while avoiding the creation of ice on the instrument or surface of tissue.
  • As the cryo-fluid leaks out of the imaging hood 12 and into the organ, the fluid may be warmed naturally by the patient body and ultimately removed. The cryo-fluid may be a colorless and translucent fluid which enables visualization therethrough of the underlying tissue. An example of such a fluid is Fluorinert™ (3M, St. Paul, Minn.), which is a colorless and odorless perfluorinated liquid. The use of a liquid such as Fluorinert™ enables the cryo-ablation procedure without the formation of ice within or outside of the imaging hood 12. Alternatively, rather than utilizing cryo-ablation, hyperthermic treatments may also be effected by heating the Fluorinert™ liquid to elevated temperatures for ablating the lesion 392 within the imaging hood 12. Moreover, Fluorinert™ may be utilized in various other parts of the body, such as within the heart.
  • FIG. 34A shows another variation of an instrument which may be utilized with the imaging system. In this variation, a laser ring generator 400 may be passed through the deployment catheter 16 and partially into imaging hood 12. A laser ring generator 400 is typically used to create a circular ring of laser energy 402 for generating a conduction block around the pulmonary veins typically in the treatment of atrial fibrillation. The circular ring of laser energy 402 may be generated such that a diameter of the ring 402 is contained within a diameter of the imaging hood 12 to allow for tissue ablation directly upon tissue being imaged. Signals which cause atrial fibrillation typically come from the entry area of the pulmonary veins into the left atrium and treatments may sometimes include delivering ablation energy to the ostia of the pulmonary veins within the atrium. The ablated areas of the tissue may produce a circular scar which blocks the impulses for atrial fibrillation.
  • When using the laser energy to ablate the tissue of the heart, it may be generally desirable to maintain the integrity and health of the tissue overlying the surface while ablating the underlying tissue. This may be accomplished, for example, by cooling the imaging fluid to a temperature below the body temperature of the patient but which is above the freezing point of blood (e.g., 2° C. to 35° C.). The cooled imaging fluid may thus maintain the surface tissue at the cooled fluid temperature while the deeper underlying tissue remains at the patient body temperature. When the laser energy (or other types of energy such as radio frequency energy, microwave energy, ultrasound energy, etc.) irradiates the tissue, both the cooled tissue surface as well as the deeper underlying tissue will rise in temperature uniformly. The deeper underlying tissue, which was maintained at the body temperature, will increase to temperatures which are sufficiently high to destroy the underlying tissue. Meanwhile, the temperature of the cooled surface tissue will also rise but only to temperatures that are near body temperature or slightly above.
  • Accordingly, as shown in FIG. 34B, one example for treatment may include passing deployment catheter 16 across the atrial septum AS and into the left atrium LA of the patient's heart H. Other methods of accessing the left atrium LA may also be utilized. The imaging hood 12 and laser ring generator 400 may be positioned adjacent to or over one or more of the ostium OT of the pulmonary veins PV and the laser generator 400 may ablate the tissue around the ostium OT with the circular ring of laser energy 402 to create a conduction block. Once one or more of the tissue, around the ostium OT have been ablated, the imaging hood 12 may be reconfigured into a low profile for removal from the patient heart H.
  • One of the difficulties in treating tissue in or around the ostium OT is the dynamic fluid flow of blood through the ostium OT. The dynamic forces make cannulation or entry of the ostium OT difficult. Thus, another variation on instruments or tools utilizable with the imaging system is an extendible cannula 410 having a cannula lumen 412 defined therethrough, as shown in FIG. 35A. The extendible cannula 410 may generally comprise an elongate tubular member which may be positioned within the deployment catheter 16 during delivery and then projected distally through the imaging hood 12 and optionally beyond, as shown in FIG. 35B.
  • In use, once the imaging hood 12 has been desirably positioned relative to the tissue, e.g., as shown in FIG. 35C outside the ostium OT of a pulmonary vein PV, the extendible cannula 410 may be projected distally from, the deployment catheter 16 while optionally imaging tire tissue through the imaging hood 12, as described above. The extendible cannula 410 may be projected distally until its distal end is extended at least partially into the ostium OT. Once in the ostium OT, an instrument or energy ablation device may be extended through and out of the cannula lumen 412 for treatment within the ostium OT. Upon completion of the procedure, the cannula 410 may be withdrawn proximally and removed from the patient body. The extendible cannula 410 may also include an inflatable occlusion balloon at or near its distal end to block the blood flow out of the PV to maintain a clear view of the tissue region. Alternatively, the extendible cannula 410 may define a lumen therethrough beyond the occlusion balloon to bypass at least a portion of the blood that normally exits the pulmonary vein PV by directing the blood through the cannula 410 to exit proximal of the imaging hood.
  • Yet another variation for tool, or instrument use may be seen in the side and end views of FIGS. 36A and 36B. In this variation, imaging hood 12 may have one or more tubular support members 420 integrated with the hood 12. Each of the tubular support members 420 may define an access lumen 422 through which one or more instruments or tools may be delivered for treatment upon the underlying tissue. One particular example is shown and described above for FIG. 7C.
  • Various methods and instruments may be utilized for using or facilitating the use of the system. For instance, one method may include facilitating the initial delivery and placement of a device into the patient's heart, in initially guiding the imaging assembly within the heart chamber to, e.g., the mitral valve MV, a separate guiding probe 430 may be utilized, as shown, in FIGS. 37A and 37B. Guiding probe 430 may, for example, comprise an optical fiber through which, a light source 434 may be used to illuminate a distal tip portion 432. The tip portion 432 may be advanced into the heart: through, e.g., the coronary sinus CS, until the tip is positioned adjacent to the mitral valve MV. The tip 432 may be illuminated, as shown in FIG. 37A, and imaging assembly 10 may then be guided towards the illuminated tip 432, which, is visible from within the atrial chamber, towards mitral valve MV.
  • Aside from the devices and methods described above, the imaging system may be utilized to facilitate various other procedures. Turning now to FIGS. 38A and 38B, the imaging hood of the device in particular may be utilized. In this example, a collapsible membrane or disk-shaped member 440 may be temporarily secured around the contact edge or lip of imaging hood 12. During intravascular delivery, the imaging hood 12 and the attached member 440 may both be in a collapsed configuration to maintain a low profile for delivery. Upon deployment, both the imaging hood 12 and the member 440 may extend into their expanded configurations.
  • The disk-shaped member 440 may be comprised of a variety of materials depending upon the application. For instance, member 440 may be fabricated from a porous polymeric material infused with a drug eluting medicament 442 for implantation against a tissue surface for slow infusion of the medicament into tire underlying tissue. Alternatively, the member 440 may be fabricated from a non-porous material, e.g., metal or polymer, for implantation and closure of a wound or over a cavity to prevent fluid leakage. In yet another alternative, the member 440 may be made from a distensible material which is secured to imaging hood 12 in an expanded condition. Once implanted or secured on a tissue surface or wound, the expanded member 440 may be released from imaging hood 12. Upon release, the expanded member 440 may shrink to a smaller size while approximating the attached underlying tissue, e.g., to close a wound or opening.
  • One method for securing the disk-shaped member 440 to a tissue surface may include a plurality of tissue anchors 444, e.g., barbs, hooks, projections, etc., which are attached to a surface of the member 440. Other methods of attachments may include adhesives, suturing, etc. In use, as shown in FIGS. 39A to 39C, the imaging hood 12 may be deployed in its expanded configuration with member 440 attached thereto with the plurality of tissue anchors 444 projecting distally. The tissue anchors 444 may be urged into a tissue region to be treated 446, as seen in FIG. 39A, until the anchors 444 are secured in the tissue and member 440 is positioned directly against the tissue, as shown in FIG. 39B. A pullwire may be actuated to release the member 440 from the imaging hood 12 and deployment catheter 16 may be withdrawn proximally to leave member 440 secured against the tissue 446.
  • Another variation for tissue manipulation, and treatment may be seen in the variation of FIG. 40A, which illustrates an imaging hood 12 having a deployable anchor assembly 450 attached to the tissue contact edge 22. FIG. 40B illustrates the anchor assembly 450 detached from the imaging hood 12 for clarity. The anchor assembly 450 may be seen as having a plurality of discrete tissue anchors 456, e.g., barbs, hooks, projections, etc., each having a suture retaining end, e.g., an eyelet or opening 458 in a proximal end of the anchors 456. A suture member or wire 452 may be slidingly connected to each anchor 456 through the openings 458 and through a cinching element 454, which may be configured to slide uni-directionally over the suture or wire 452 to approximate each of the anchors 456 towards one another. Each of the anchors 456 may be temporarily attached to the imaging hood 12 through a variety of methods. For instance, a pullwire or retaining wire may hold each of the anchors within a receiving ring around the circumference of the imaging hood 12. When the anchors 456 are released, the pullwire or retaining wire may be tensioned from its proximal end outside the patient body to thereby free the anchors 456 from the imaging hood 12.
  • One example for use of the anchor assembly 450 is shown in FIGS. 41A to 41D for closure of an opening or wound 460, e.g., patent foramen ovale (PFO). The deployment catheter 16 and imaging hood 12 may be delivered intravascularly into, e.g., a patient heart. As the imaging hood 12 is deployed into its expanded configuration, the imaging hood 12 may be positioned adjacent to the opening or wound 460, as shown in FIG. 41A. With the anchor assembly 450 positioned upon the expanded imaging hood 12, deployment catheter 16 may be directed to urge the contact edge of imaging hood 12 and anchor assembly 450 into the region surrounding the tissue opening 460, as shown in FIG. 41B. Once the anchor assembly 450 has been secured within the surrounding, tissue, the anchors may be released from imaging hood 12 leaving the anchor assembly 450 and suture member 452 trailing from the anchors, as shown in FIG. 41C. The suture or wire member 452 may be tightened by pulling it proximally from outside the patient body to approximate the anchors of anchor assembly 450 towards one another in a purse-string manner to close the tissue opening 462, as shown in FIG. 41D. The cinching element 454 may also be pushed distally over the suture or wire member 452 to prevent the approximated-anchor assembly 450 from loosening or widening.
  • Another example for an alternative use is shown in FIG. 42, where the deployment catheter 16 and deployed imaging hood 12 may be positioned within a patient body for drawing blood 472 into deployment catheter 16. The drawn blood 472 may be pumped through a dialysis unit 470 located externally of the patient body for filtering the drawn blood 472 and the filtered blood may be reintroduced back into the patient.
  • Yet another variation is shown, in FIGS. 43A and 43B, which show a variation of the deployment catheter 480 having a first deployable hood 482 and a second deployable hood 484 positioned distal to the first hood 482. The deployment catheter 480 may also have a side-viewing imaging element 486 positioned between the first and second hoods 482, 484 along the length of the deployment catheter 480. In use, such a device may be introduced through a lumen 488 of a vessel VS, where one or both hoods 482, 484 may be expanded to gently contact the surrounding walls of vessel VS. Once hoods 482, 484 have been expanded, the clear imaging fluid may be pumped in the space defined between the hoods 482, 484 to displace any blood and to create an imaging space 490, as shown in FIG. 43B. With the clear fluid in-between hoods 482, 484, the imaging element 486 may be used to view the surrounding tissue surface contained between hoods 482, 484. Other instruments or tools may be passed through deployment catheter 480 and through one or more openings defined along the catheter 480 for additionally performing therapeutic procedures upon the vessel wall.
  • Another variation of a deployment catheter 500 which may be used for imaging tissue to the side of the instrument may be seen in FIGS. 44A to 45B. FIGS. 44A and 44B show side and end views of deployment catheter 500 having a side-imaging balloon 502 in an un-inflated low-profile configuration. A side-imaging element 504 may be positioned within a distal portion of the catheter 500 where the balloon 502 is disposed. When balloon 502 is inflated, it may expand radially to contact the surrounding tissue, but where the imaging element 504 is located, a visualization field 506 may be created by the balloon 502, as shown in the side, top, and end views of FIGS. 45A to 45B, respectively. The visualization field 506 may simply be a cavity or channel which is defined within the inflated balloon 502 such that the visualization element 504 is provided an image of the area within field 506 which is clear and unobstructed by balloon 502.
  • In use, deployment catheter 500 may be advanced intravascularly through vessel lumen 488 towards a lesion or tumor 508 to be visualized and/or treated. Upon reaching the lesion 508, deployment catheter 500 may be positioned adjacently to the lesion 508 and balloon 502 may be inflated such that the lesion 508 is contained within the visualization field 506. Once balloon 502 is fully inflated and in contact against the vessel wall, clear fluid may be pumped into visualization field 506 through deployment catheter 500 to displace any blood or opaque fluids from the field 506, as shown in the side and end views of FIGS. 46A and 46B, respectively. The lesion 508 may then be visually inspected and treated by passing any number of instruments through deployment catheter 500 and into field 506.
  • In controlling the advancement and articulation of any of the delivery catheters described herein, the catheter may be manually controlled or robotically-controlled, as mentioned above. Examples of robotically-controlled catheter systems which utilize precision motion control mechanisms are shown and described in U.S. Pat. App. 2006/0084945 A1 and U.S. Pat. No. 7,090,683, each of which is incorporated herein by reference in its entirety. Generally, a visualization hood may be attached or coupled to the distal end of a catheter articulated or controlled by precision motion control mechanisms. The articulatable neck portion of the shaft, located proximally of the visualization hood, may be comprised of an assembly of links fabricated, e.g., from stainless steel, plastics, etc., that allow the neck portion to be articulated in multiple planes. One or more, e.g., four, pullwires may be routed through the neck and/or shaft such that they terminate at the hood attachment, while the proximal end or ends of the pullwires may be routed through the links to a proximal end of the catheter. Combinations of retraction and/or extension motions of these pullwires may be utilized to steer the neck portion to articulate the hood in multiple directions as desired by the operator.
  • The proximal ends of the pullwires are threaded through a pulley assembly and terminated in rotatable spools. Rotating these spools will either retract the pullwires or release more slack into the catheter to enable steering as appropriate. The pullwire spools are further driven by control elements such, as low speed motors, which, in turn, may be driven by a central processing unit. Precise and consistent, low speed rotation of the spools controlled by the central processing unit and the motors will enable the pullwires to be retracted or released with high precision. This will translate into precision articulation and motion control of the tissue visualization hood.
  • Referring now to FIG. 47A, an example of a robotic guide instrument 600 is illustrated having two control element interface assemblies configured to drive, e.g., four control elements 606, e.g., pullwires. Rotation of the pulleys in a first direction may spool and proximally displace one control element 606, while unspooling in a second opposite direction may distally displace a complementary control element 606 to deflect the distal end of the deployment catheter 14 in the opposite direction. Tension may be maintained in the control elements 606 via pre-tensioning or pre-stressing the elements to prevent excess slack. Tension may also be maintained, on the control elements 606 using a slotted guide instrument base 602 which forms one or more slots 604 through which the control elements 606 may remain taut.
  • FIG. 47B illustrates the robotic guide instrument 600 having hood 12 positioned upon deployment catheter 16 with an inflatable balloon or membrane 608 optionally disposable within or upon hood 12 and an instrument advanced through catheter 16 and into hood 12. As schematically illustrated, the robotic guide instrument 600, and optionally the instruments advanced through hood 12, may be controlled via a computer or processor 612 to control the articulation of the hood 12 as well as other functions. The treatment instrument may include any number of instruments, e.g., ablation tools, a piercing needle 610, etc., which may be advanced through the hood for treating the underlying tissue. Examples of instruments as well as alternative configurations for hood 12 are shown and described in further detail in the following U.S. patent application Ser. Nos. 11/775,771 and 11/775,837 both filed Jul. 10, 2007, and Ser. No. 11/828,267 filed Jul. 25, 2007, each of which is incorporated herein by reference in its entirety.
  • FIG. 47C illustrates an example of how a robotic guide instrument may be utilized with a visualization system. Generally, a user may interface with input device 651, which may utilize any number of different interfaces, e.g., handle, joystick, etc., by which the user may transmit desired, commands to processor 631. Processor 631 may receive the commands and transmit the appropriate drive signals to the catheter and computer-controlled guidance assembly 639 which may then control the hood, imaging systems, fluid purging systems, etc. in accordance with the received commands from the user. When the catheter and/or hood interfaces with the surrounding tissue, the resulting force or tracking feedback, may be optionally sensed by guidance assembly 639 and transmitted back to processor 631, which in turn may signal or indicate to the user via force feedback through input device 651 or some other force or visual feedback. Moreover, the image data captured by the imaging element within or along hood 12 may also be received by guidance assembly 639 and transmitted to processor 631, which may receive foe image data for processing, and display upon a tissue surface image display 649 to the user.
  • Catheter and computer-controlled guidance assembly 639 may comprise several sub-systems for controlling each of a number of different functions, for instance (amongst other sub-systems), an articulation drive 641 for controlling a movement of the catheter 16 and/or hood 12, a movement tracking system 643 for tracking a position and/or orientation of the catheter 16 and/or hood 12 within the patient body, an imaging element system 645 for controlling the visualization features, as well as a blood displacement system 647 for controlling and/or tracking an infusion of transparent, fluid into the hood 12.
  • Processor 631 may also be configured to handle several different processing functions to process various data. For instance, processor 631 may be configured to input commands registered with tissue surface images 633 as received from input device 651, as well as process catheter position data 635 based, upon catheter tracking feedback, signals as received from the movement tracking system 643 from guidance assembly 639. Moreover, processor 631 may be configured to process desired catheter articulations 637 in accordance with the commands received from the input device 651 such that drive signals are generated by processor 631 and transmitted to the articulation drive 641 in guidance assembly 639 to control the movements of the catheter and/or hood in a desired manner.
  • FIG. 48A illustrates a perspective view of a variation of a robotic control assembly showing base 602 having four proximal drive assemblies 630 attached thereupon where each assembly 630 may control a corresponding control element, e.g., pullwire, for controlling an articulation of hood 12 positioned upon deployment catheter 16. Delivery catheter or sheath 14 may be attached or otherwise coupled to base 602 or to sheath instrument 632 having an instrument base 636, which may also have a drive assembly 630 rotatably positioned thereon. The control elements attached to their respective drive assembly 630 may each extend through delivery catheter 14 and couple to the hood 12, as described below, to bend, the distal end of the deployment catheter 16 and/or hood 12 itself in any number of directions by displacing one of the control elements in the proximal direction to deflect the distal end of the catheter member in the predetermined direction.
  • Catheter 14 may be coupled to instrument base 636 such that, the drive assembly 630 may be used to control a retraction or advancement of the catheter 14 relative to hood 12 to control the expansion or collapse of hood 12, FIG. 48B shows a detail perspective view of the distal end of catheter 16 extending from delivery catheter 14 and articulation of the hood 12 relative to the catheter 16. In one variation, hood 12 may utilize imaging element 620, e.g., CMOS, CCD imager, etc., positioned off axis relative to a longitudinal axis of catheter 16 and attached along one or more support struts 622 within hood 12. Hood 12 may be connected to hood base 640 which is pivotable in a first plane via hinge or pivot 642. Flood base 640 may itself be pivotable in a second plane via hinge or pivot 644 and the distal end of deployment catheter 16 may further define an articulatable section 638, which may allow its distal, end to articulate within a plane when urged by the one or more control elements.
  • FIG. 48C illustrates a perspective view of another variation of a robotic control, assembly having an inflatable imaging balloon 653 assembly. As shown, imaging balloon 653 may be positioned upon articulatable deployment catheter 16 and may further include a separate anchoring balloon 655 positioned, upon support catheter 657 distally of imaging balloon 653. Support catheter 657 may extend through both anchoring balloon 655 and imaging balloon 653 and define a lumen 659 therethrough for accessing the tissue regions with, any number of instruments 667. In use, support catheter 657 and anchoring balloon 655 (in its deflated state) may be advanced into a vessel lumen, e.g., through the ostium of a pulmonary vein, where anchoring balloon 655 may be inflated into contact against the surrounding vessel walls. With anchoring balloon 655 inflated, support catheter 657 may be independently translatable with, respect to imaging balloon 653 (which may be inflated prior to, during, or after anchoring of the anchoring balloon 655) to allow for positional adjustment between imaging balloon 653 and the tissue surrounding the ostium.
  • Imaging balloon 653 may be inflated with a transparent fluid or gas, as described above, and may be further supported structurally by one or more support struts 665 extending distally from catheter 16 within or along a proximal portion of imaging balloon 653. During introduction and/or advancement through the patient body, support struts 665 may be collapsed along with imaging balloon 653 into a low-profile configuration and when deployed, balloon 653 may be inflated and support struts 665 may extend radially relative to catheter 16 to support imaging balloon 653. Additionally, support struts 665 may also support, one or more light sources 661, e.g., light emitting diodes, optical fibers, etc. to provide illumination through imaging balloon 653 for viewing the underlying contacted tissue. Imaging element 663, as above, may also be supported along or upon a support strut 665 for viewing the tissue region through balloon 653 as well.
  • A partially disassembled view of the control element 606 spooled around a respective drive assembly 630 is illustrated in the perspective view of FIG. 49. As shown, each assembly 630 may comprise an axle 650 about which assembly 630 may rotate in a first direction to spool, and thus proximally displace an attached control element 606 to deflect the distal end of catheter 16 is a first direction, or rotate in a second opposite direction to unspool, and thus distally displace the attached control element 606 to deflect the distal end of catheter 16 in a second opposite direction.
  • The guide instrument 662 and sheath instrument 632 having deployment catheter 16 extending distally therefrom with hood 12 articulately disposed upon the distal end of catheter 16 is illustrated, in the perspective assembly view of FIG. 50. Both guide instrument 662 and instrument guide 632 are illustrated mounted upon instrument driver 660, which functions as a platform. Instrument driver 660 may also provide additional degrees of precision control movements for the visualization catheter system. FIG. 51 shows a partial disassembled perspective view of the instrument driver 660 assembly illustrating the main housing structure 670 underlying the assembly. As illustrated, cams and motors may be controlled by one or more electronics boards 672 which may be coupled to the main housing structure 670.
  • In yet another variation of a mechanism which provides precision steering and articulation of the hood 12 is shown in the perspective assembly view of FIG. 52A. A precision control drive unit 680 may be attached to delivery catheter 14 and/or deployment catheter 16 for providing articulation control. FIG. 52B illustrates a detailed perspective view of the distal end of one variation of deployment catheter 16 having the articulatable section 638. Hinge or pivot 642 and 644 may provide for articulation in at least two planes transverse to one another for viewing tissue structures via imaging element 620 positioned within hood 12, as described above. FIG. 53 illustrates an example of a simplified assembly view of the mechanisms within control drive unit 680 for controlling the articulation of hood 12. As shown, one or more pullwires 682 may be routed through catheter 14 to hood 12 with their proximal ends coupled to one or more cams 684 or gears. These cams 684 may be rotatably coupled to one or more drive wheels 686, which are in turn in communication through control cables 688 to (optional) gearing 692 of motor driver 690.
  • The examples illustrating precision control assemblies for articulating the hood 12 and/or catheter 16 are further described in detail in U.S. Pat. App. 2006/0084945 A1 and U.S. Pat. No. 7,090,683, each of which has been incorporated above in their entirety.
  • In enabling the precision control assemblies to steer hood 12 and/or catheter 16 in multiple degrees of freedom, various couplings between hood 12 and catheter 16 may be provided. One variation is illustrated in the detail perspective view of FIGS. 54A and 54B, which show an assembled view and exploded assembly view, respectively. In this variation, hood 12, having imaging element 620 positioned therewithin in an off-axis location, may be coupled or otherwise attached to hood base 640, which itself is pivotably coupled via hood mating portion 706 connected to receiving portion 708 via pin 710 to allow hood 12 to articulate within a first plane. Receiving portion 708 may also be pivotably coupled to receiving portion 702 via pin 704 to allow hood 12 to articulate within a second plane transverse to the first plane. The receiving portion 708 may also have one or more pullwire termination points 700 to which one or more pullwires 682 may be terminated.
  • FIGS. 55A and 55C shows another variation where a pair of pullwires 682 may steer a first planarly articulatable spine section 720 located near or at the distal end of deployment catheter 16. A second pair of pullwires 682 may steer hood base 640 and hood 12 in a second plane transverse to the first plane. The steerable spine section 720 may comprise a spine segment 722 having multiple cut-outs or reduced sections 724 along either side of the spine segment 722 such that the spine section 720 may bend in a plane by flexing to either side of the reduced sections 724 while maintaining structural integrity by the spine segment 722, as illustrated in the detail view of FIG. 55B. Spine section 720 may be comprised of various materials, e.g., stainless steel, PEEK or hard plastics, through machining, molding or metal injection molding. Moreover, stainless steel cables, Nitinol, elgiloy, or tungsten wires can be used for pullwires. The section 720 can be alternatively constructed as bump links, pinned links, ring links, laser cut tubes, fish bone spine links, silt tubes or double durometer tubes, etc., may also be steered using various mechanisms such as single bend steering, double bend steering with two or more pullwires, multi-way bend steering, and/or steering through multiple variations of catheter-sheath interactions.
  • FIGS. 56A and 56C illustrate yet another variation of steering mechanisms in the perspective assembly and exploded assembly views. In this variation, a fully articulatable spine section 730 may be included near or at the distal end of deployment, catheter 16, as above, where the section 730 includes a central spine 734 having multiple cut-outs or reduced sections 732 circumferentially defined about central spine 734, as illustrated in FIG. 56B. Having the reduced sections 732 defined, entirely around spine 734 enables full articulation of hood 12 about spine 734 rather than being limited for movement within a plane.
  • While utilizing a computer-controller for articulating the assembly, the computer may also track the movement of hood 12 within a patient body, e.g., within the left atrial chamber of the heart, such that the location, and position relative to an anatomical landmark, e.g., the pulmonary veins, are known, at any given time. Other alternative mechanisms may also be utilized to track and/or record the position of hood 12 within the body at any given time.
  • For instance, FIG. 57A shows a perspective view of one such variation where a ferromagnetic ring 740 may be attached circumferentially around the lip of hood 12. Such a configuration may be utilized in conjunction with conventional magnetic navigation, systems, such as the NIOBE® system developed by Stereotaxis. Inc. (Saint Louis, Mo.), as illustrated in the perspective view of FIG. 57B. An example of such a magnetic navigation system is shown and described in U.S. Pat. No. 7,019,610 (Creighton et al.) which is incorporated herein by reference in its entirety. Generally, an arrangement of two magnets 746, 748 may be positioned externally to the patient. With external control by an operator, the two magnets 746, 748 may swing into position on each side of the patient creating a magnetic field that directs and digitally controls either the distal tip of the tissue visualization catheter or, in this case, the ferromagnetic ring 740 positioned about the lip of hood 12. By rotating and moving the external magnets 746, 748 to change the direction of the magnetic field, the system automatically controls the catheter advancement and retraction of the visualization catheter, eliminating any pulling or pushing on the device. This may be particularly advantageous when the tissue visualization catheter is threaded through tortuous pathways where force transmission is greatly reduced, consequently affecting accuracy in navigational control that requires the pushing or pulling of the sheath or navigation that requires steering internal pullwires.
  • FIG. 58 shows a perspective view of yet another variation of the tissue visualization catheter which is configured to detect the position and/or orientation of the hood 12 through the use of existing ultrasound technologies as described in, e.g., U.S. Pat. No. 5,515,853, which is incorporated herein by reference in its entirety. As shown, a first 750 and second 752 ultrasound signal transducer may be symmetrically attached, to the hood 12 around the circumference of the lip of hood 12, while a third ultrasound transducer 754 may be placed between, the tip of the deployment catheter 16 and the proximal end of the hood 12.
  • A ferromagnetic ring or an electromagnetic coil 740 that is able to interact with a magnetic field to pull the hood towards a tissue surface may also be attached to the circumference of the hood 12. Alternatively, the struts 758 supporting hood 12 may be made of a ferromagnetic material where one or more of the struts 758 may have electromagnetic coils 756 wound around the struts 758, as shown in the perspective view of FIG. 59. In yet another alternative, a ferromagnetic disc 760 positioned upon a support member 762 extending through hood 12 may also be utilized, as shown in the perspective view of FIG. 60. In these or other variations of hood 12, a circumferential balloon 742 which is inflatably positioned within hood 12 and which defines a lumen or channel 744 through the inflated balloon 742 may be optionally utilized. Such a balloon 742 is described in further detail in U.S. Pat. App. 11/775,771 filed Jul. 10, 2007, which is incorporated herein by reference in its entirety.
  • In either case, the ferromagnetic or electromagnetic feature and the ultrasound signal transducers 750, 752, 754 along hood 12 may be used with a position sensor assembly 770, as shown in the perspective view of FIG. 61. Position sensor assembly 770 may generally comprise a plate 772 made of radio-transparent material which may be positioned externally of a patient along a skin surface proximate or adjacent to where the hood 12 is to be controlled or tracked within the patient body. Plate 772 may have three or more ultrasound transducers 778, 780, 782 positioned along the plate surface separated by a known distance from one another. An electromagnet 776 attached to handle 774 may be slidably positioned within plate 772 for controlling a position of hood 12 within the patient body, as described below.
  • Generally, each of the ultrasound transducers 750, 752, 754 positioned along hood 12 may communicate with the ultrasound transducers 778, 780, 782 on the plate 772 to determine their relative distances from one other by measuring the time between transmission and detection of the ultrasound signals, as illustrated in FIG. 62. By triangulation methods, the position of each transducer along hood 12 relative to each transducer along plate 772, the three-dimensional orientation and position of the hood 12 within the patient body may be computationally determined by a processor and displayed graphically or otherwise to the user. The user may determine an orientation of the hood 12, for instance if the hood 12 is facing the external plate 772 within the patient body, when 750 and 752 are of equal distance to the plate 772. Similarly using the same triangulation method, the position of the hood 12 can be determined. Moreover, knowing which quadrant 790, 792, 794, 796 of the plate the hood 12 is relatively positioned may be utilized in differentiating between particular anatomical features, e.g., determining which of the four pulmonary veins the user may be viewing in a patient's heart utilizing the imaging element within hood 12, as described above.
  • Detailed examples are further shown and described in U.S. Pat. No. 5,515,853, which is incorporated herein above. Additionally, although three transducers are illustrated in the example on hood 12 as well as plate 772, additional transducers may be optionally utilized.
  • Moreover, in activating the electromagnet 776, e.g., by a foot pedal, the ferromagnetic element located on the hood 12 may be drawn via magnetic attraction towards the externally located plate 772 such that hood 12 is consequently drawn against the internal tissue surface. By drawing the hood 12 against the internal tissue surface, hood 12 may be positioned or articulated against the tissue surface by the externally located handle 774 and electromagnet 776 to facilitate movement of the hood 12 along tissue walls.
  • An example is illustrated, in FIGS. 63A to 63C which shows hood 12 having circumferential ferromagnetic ring 740 positioned thereon located within the left atrium LA of heart H. In placing plate 772 of assembly 770 against the external skin surface S of the patient body (e.g., behind the back of the patient, in a position directly below the heart H, or any other position on the patient body where a visualization catheter is to be advanced along, into, or through an underlying organ or body lumen), a layer of ultrasound coupling gel may be applied between tire skin S and the external plate 772, to ensure that ultrasound signals are conducted efficiently. After entry of hood 12 within left atrium LA, the orientation and position of the hood 12 may be determined via triangulation relative to plate assembly 770, as shown in FIG. 63A. Upon orienting the hood 12 in a desired orientation and/or position, the movable electromagnet 776 in the external plate 772 can be magnetized, e.g., by stepping on a foot pedal, to draw the electromagnetic ring 740 mid hood 12 towards the tissue wall, as shown in FIG. 63B. With the hood 12 positioned upon the tissue wall, handle 774 and electromagnet 776 may be moved in a direction 800 within plate 772 to “walk” or move hood 12 along the tissue wall in a corresponding direction 800′. While hood 12 is drawn against the tissue wall, the open area may be purged of blood and the underlying tissue may be viewed through imaging element 620, as described above.
  • Another variation is illustrated in the partial cross-sectional, view of FIG. 64, which illustrates an example where rather than utilizing ultrasound transducers along an externally located plate, a catheter 810 having at least three transducers 812, 814, 816 at known distances from one another may be intravascularly advanced, e.g., into the coronary sinus CS of a patient heart and positioned such that the transducers are located about the mitral valve. Temporarily positioning the transducers 812, 814, 816 within the coronary sinus CS, where they are in closer proximity with the transducers on the hood 12, may reduce the loss of ultrasound signals to the environment as compared to having-transducers placed outside the body. Moreover, having the transducers communicating within the body also removes the need for ultrasound coupling gel to be applied, on the patient's skin.
  • The applications of the disclosed invention discussed above are not limited to certain treatments or regions of the body, but may include any number of other treatments and areas of the body. Modification of the above-described methods and devices for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of this disclosure. Moreover, various combinations of aspects between examples are also contemplated and are considered to be within the scope of this disclosure as well.

Claims (30)

1. A computer-assisted heart treatment system for treating a tissue of a heart, wherein blood is disposed within a chamber of the heart, the heart, treatment system comprising:
an articulatable catheter;
an imaging assembly carried by the catheter, the imaging assembly configured to obtain, while blood is disposed in the chamber, an image of a tissue surface within the chamber;
a display coupleable to the imaging assembly so as to display tire tissue surface image;
a computer-controlled guidance assembly coupled to the catheter so as to move the imaging assembly; and
a processor coupled to the computer-controlled guidance assembly so that the articulation of the catheter effects repositioning of the imaging assemble registered to the displayed tissue surface.
2. The system, of claim 1 further comprising a tracking system transmitting position feedback signals to the processor, wherein the processor transmits drive signals for the computer-controlled guidance assembly using the position feedback signals.
3. The system, of claim 2 wherein the imaging assembly comprises an imaging element and a barrier or membrane, and wherein the imaging assembly is pivotably coupled to the articulatable catheter.
4. The system of claim 3 wherein the barrier or membrane is pivotably coupled to the articulatable catheter such that the membrane is movable within a first plane in response to signals from the computer-controlled guidance assembly, and wherein the barrier or membrane is further pivotably coupled to the articulatable catheter such that the barrier or membrane is movable within a second plane transverse to the first plane in response to signals from the computer-controlled guidance assembly.
5. The system of claim 3 wherein the articulatable catheter comprises a steerable segment proximal to the barrier or membrane and having a spine and a plurality of reduced sections along the segment to facilitate steering of the segment.
6. The system of claim 5 wherein the plurality of reduced sections are located circumferentially such that the segment is steerable in more than one plane.
7. The system of claim 1 wherein the computer-controlled guidance assembly comprises one or more drive assemblies coupled to the distal end of the catheter via a respective pullwire.
8. The system of claim 7 wherein the drive assemblies comprise a member rotatably positioned upon an axle such that rotation of the member in a first rotational direction urges the catheter to deflect in a first direction and rotation of the member in a second rotational direction opposite to the first rotational direction urges the catheter to deflect in a second direction opposite to the first direction.
9. The system of claim 1 further comprising an instrument guidance assembly configured to retract an outer sheath relative to the articulatable catheter.
10. The system of claim 1 further comprising an instrument driver upon which the catheter is mounted and extends from.
11. A computer-assisted heart treatment system for treating a tissue of a heart, wherein blood is disposed within a chamber of the heart, the heart treatment system comprising:
an articulatable catheter;
an imaging assembly carried by the catheter, the imaging assembly configured to obtain, while blood is disposed in the chamber, an image of a tissue surface within the chamber;
a computer-control led guidance assembly coupled to the catheter so as to move the imaging assembly in response to drive signals;
a tracking system transmitting position feedback signals in response to movement of the imaging assembly; and
a processor coupled to the computer-controlled guidance assembly and the tracking system, the processor configured to transmits the drive signals using the position feedback signals.
12. A tissue treatment system, comprising:
a barrier or membrane having a first low-profile configuration and a second expanded, configuration defining an open area therein;
an articulatable catheter upon which the membrane projects distally; and
at least one magnetic element positioned within or along the barrier or membrane.
13. The system of claim 12 wherein the barrier or membrane is configured in a conical shape.
14. The system of claim 12 further comprising an imaging element positioned within or along the barrier or membrane such that tissue adjacent to the open area is able to be visualized via the imaging element.
15. The system of claim 12 wherein the open area is in communication with a fluid lumen defined through the catheter, and further comprising a fluid, reservoir fluidly coupled to the barrier or membrane via the fluid lumen.
16. The system of claim 12 wherein the at least one magnetic element comprises a magnetic ring positioned circumferentially about a lip of the barrier or membrane.
17. The system of claim 12 wherein the at least, one magnetic element comprises one or more coils positioned about one or more respective support struts extending along the barrier or membrane.
18. The system of claim 12 wherein the at least one magnetic element comprises a magnetic disc positioned upon, a support member extending through the barrier or membrane.
19. The system of claim 12 further comprising at least two external magnets positioned in proximity to a patient body and independently moveable, wherein movement by the at least two external magnets relative to the patient body results in a corresponding movement by the at least one magnetic element within the patient body.
20. The system of claim 12 further comprising at least two ultrasonic transducers positioned along the barrier or membrane and a third ultrasonic transducer positioned proximal to the barrier or membrane.
21. The system of claim 20 further comprising an external plate assembly having at least three ultrasonic transducers positioned over the plate assembly at known distances relative to one another.
22. The system of claim 21 further comprising an electromagnetic element moveable over the plate assembly, whereby movement by the electromagnetic element relative to the patient body results in a corresponding movement by the at least one magnetic element within the patient body.
23. A computer assisted method of treating a tissue surface region within a chamber of a heart, comprising:
positioning a distal portion of a catheter within the chamber, the catheter coupled to a computer-controlled guidance assembly;
locally displacing blood with a transparent fluid from an open area disposed within a portion of the chamber, the open area disposed adjacent the tissue region;
visualizing, on a display, the tissue region within the open area as imaged through the transparent fluid, and
articulating the catheter with the computer-controlled guidance assembly so that movement of the catheter within the chamber is registered, with the tissue surface region shown on the display.
24. The method of claim 23 wherein positioning comprises advancing the barrier or membrane into a left atrial chamber of a heart.
25. The method of claim 23 wherein positioning comprises deploying the barrier or membrane from a low-profile delivery configuration into an expanded deployed configuration.
26. The method of claim 23 wherein positioning comprises stabilizing a position of the barrier or membrane relative to the tissue region.
27. The method of claim 23 wherein displacing an opaque fluid comprises infusing the transparent fluid into the open area through a fluid delivery lumen defined through the catheter.
28. The method of claim 27 wherein infusing the transparent fluid comprises pumping saline, plasma, water, or perfluorinated liquid into the open area such that blood is displaced from therefrom.
29. The method of claim 23 wherein positioning comprises rotating one or more drive assemblies coupled to a distal end of the catheter via a respective pullwire.
30. The method of claim 29 wherein rotation of the drive assemblies in a first rotational direction urges the catheter to deflect in a first direction and rotation of the member in a second rotational direction opposite to the first rotational direction urges the catheter to deflect in a second direction opposite to the first direction.
US11/848,429 2006-09-01 2007-08-31 Precision control systems for tissue visualization and manipulation assemblies Abandoned US20080097476A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US11/848,429 US20080097476A1 (en) 2006-09-01 2007-08-31 Precision control systems for tissue visualization and manipulation assemblies
US12/464,800 US10070772B2 (en) 2006-09-01 2009-05-12 Precision control systems for tissue visualization and manipulation assemblies
US16/117,993 US11779195B2 (en) 2006-09-01 2018-08-30 Precision control systems for tissue visualization and manipulation assemblies
US18/462,175 US20240032776A1 (en) 2006-09-01 2023-09-06 Precision control systems for tissue visualization and manipulation assemblies

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82442106P 2006-09-01 2006-09-01
US91664007P 2007-05-08 2007-05-08
US11/848,429 US20080097476A1 (en) 2006-09-01 2007-08-31 Precision control systems for tissue visualization and manipulation assemblies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/464,800 Continuation US10070772B2 (en) 2006-09-01 2009-05-12 Precision control systems for tissue visualization and manipulation assemblies

Publications (1)

Publication Number Publication Date
US20080097476A1 true US20080097476A1 (en) 2008-04-24

Family

ID=39318997

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/848,429 Abandoned US20080097476A1 (en) 2006-09-01 2007-08-31 Precision control systems for tissue visualization and manipulation assemblies
US12/464,800 Active US10070772B2 (en) 2006-09-01 2009-05-12 Precision control systems for tissue visualization and manipulation assemblies
US16/117,993 Active 2028-06-02 US11779195B2 (en) 2006-09-01 2018-08-30 Precision control systems for tissue visualization and manipulation assemblies
US18/462,175 Pending US20240032776A1 (en) 2006-09-01 2023-09-06 Precision control systems for tissue visualization and manipulation assemblies

Family Applications After (3)

Application Number Title Priority Date Filing Date
US12/464,800 Active US10070772B2 (en) 2006-09-01 2009-05-12 Precision control systems for tissue visualization and manipulation assemblies
US16/117,993 Active 2028-06-02 US11779195B2 (en) 2006-09-01 2018-08-30 Precision control systems for tissue visualization and manipulation assemblies
US18/462,175 Pending US20240032776A1 (en) 2006-09-01 2023-09-06 Precision control systems for tissue visualization and manipulation assemblies

Country Status (1)

Country Link
US (4) US20080097476A1 (en)

Cited By (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060184048A1 (en) * 2005-02-02 2006-08-17 Vahid Saadat Tissue visualization and manipulation system
US20070288078A1 (en) * 2006-03-17 2007-12-13 Steve Livneh Apparatus and method for skin tightening and corrective forming
US20080009747A1 (en) * 2005-02-02 2008-01-10 Voyage Medical, Inc. Transmural subsurface interrogation and ablation
US20080033290A1 (en) * 2005-10-25 2008-02-07 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US20080058590A1 (en) * 2006-09-01 2008-03-06 Nidus Medical, Llc. Tissue visualization device having multi-segmented frame
US20080108876A1 (en) * 2001-09-06 2008-05-08 Houser Russell A Superelastic/Shape Memory Tissue Stabilizers and Surgical Instruments
US20080214889A1 (en) * 2006-10-23 2008-09-04 Voyage Medical, Inc. Methods and apparatus for preventing tissue migration
US20090227999A1 (en) * 2007-05-11 2009-09-10 Voyage Medical, Inc. Visual electrode ablation systems
US20100049099A1 (en) * 2008-07-18 2010-02-25 Vytronus, Inc. Method and system for positioning an energy source
US20100094081A1 (en) * 2008-10-10 2010-04-15 Voyage Medical, Inc. Electrode placement and connection systems
US20100204561A1 (en) * 2009-02-11 2010-08-12 Voyage Medical, Inc. Imaging catheters having irrigation
US20100211057A1 (en) * 1995-01-23 2010-08-19 Cardio Vascular Technologies, Inc. a California Corporation Tissue heating device and rf heating method with tissue attachment feature
US20100262140A1 (en) * 2008-10-10 2010-10-14 Voyage Medical, Inc. Integral electrode placement and connection systems
US20100292558A1 (en) * 2006-06-14 2010-11-18 Voyage Medical, Inc. In-vivo visualization systems
US20100305451A1 (en) * 2009-05-29 2010-12-02 Boston Scientific Scimed, Inc. Systems and methods for making and using image-guided intravascular and endocardial therapy systems
US7860556B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue imaging and extraction systems
US7918787B2 (en) 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US20110160596A1 (en) * 2009-12-24 2011-06-30 Renzo Cecere Instrument including a movement sensor and method of using same
US8050746B2 (en) 2005-02-02 2011-11-01 Voyage Medical, Inc. Tissue visualization device and method variations
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US8131350B2 (en) 2006-12-21 2012-03-06 Voyage Medical, Inc. Stabilization of visualization catheters
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US20130012929A1 (en) * 2011-07-08 2013-01-10 Tyco Healthcare Group Lp Swinging Bars with Axial Wheels to Drive Articulating Cables
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US8694071B2 (en) 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
US8758229B2 (en) 2006-12-21 2014-06-24 Intuitive Surgical Operations, Inc. Axial visualization systems
US20140276725A1 (en) * 2013-03-13 2014-09-18 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US8858609B2 (en) 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US20140330133A1 (en) * 2013-05-02 2014-11-06 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US8934962B2 (en) 2005-02-02 2015-01-13 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US9014789B2 (en) 2011-09-22 2015-04-21 The George Washington University Systems and methods for visualizing ablated tissue
US9084611B2 (en) 2011-09-22 2015-07-21 The George Washington University Systems and methods for visualizing ablated tissue
US9101735B2 (en) 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US9155452B2 (en) 2007-04-27 2015-10-13 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US9468364B2 (en) 2008-11-14 2016-10-18 Intuitive Surgical Operations, Inc. Intravascular catheter with hood and image processing systems
US9510732B2 (en) 2005-10-25 2016-12-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
US20180021089A1 (en) * 2015-02-09 2018-01-25 Vimecon Gmbh Laser Applicator Having Electrodes
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US10058380B2 (en) 2007-10-05 2018-08-28 Maquet Cordiovascular Llc Devices and methods for minimally-invasive surgical procedures
US10064540B2 (en) 2005-02-02 2018-09-04 Intuitive Surgical Operations, Inc. Visualization apparatus for transseptal access
US10070772B2 (en) 2006-09-01 2018-09-11 Intuitive Surgical Operations, Inc. Precision control systems for tissue visualization and manipulation assemblies
US10143517B2 (en) 2014-11-03 2018-12-04 LuxCath, LLC Systems and methods for assessment of contact quality
CN109310283A (en) * 2016-04-19 2019-02-05 波士顿科学国际有限公司 Foley's tube visualization device including reinforcing element
US10441136B2 (en) 2006-12-18 2019-10-15 Intuitive Surgical Operations, Inc. Systems and methods for unobstructed visualization and ablation
CN111278343A (en) * 2017-10-25 2020-06-12 波士顿科学国际有限公司 Direct visualization catheter and system
US10722301B2 (en) 2014-11-03 2020-07-28 The George Washington University Systems and methods for lesion assessment
CN111655115A (en) * 2017-09-14 2020-09-11 维卡瑞斯外科手术股份有限公司 Virtual reality surgical camera system
US10779904B2 (en) 2015-07-19 2020-09-22 460Medical, Inc. Systems and methods for lesion formation and assessment
US20200311930A1 (en) * 2019-03-28 2020-10-01 Purdue Research Foundation System and methods for clear optimally matched panoramic channel technique for deep brain photonic interface
US10828081B2 (en) 2013-03-07 2020-11-10 Arthrocare Corporation Methods and systems related to electrosurgical wands
WO2021022205A1 (en) * 2019-07-31 2021-02-04 Orsus, Llc Devices and methods for guide wire placement
CN112584774A (en) * 2018-06-28 2021-03-30 皇家飞利浦有限公司 Internally ultrasound assisted local therapy delivery
US11096584B2 (en) 2013-11-14 2021-08-24 The George Washington University Systems and methods for determining lesion depth using fluorescence imaging
US11344365B2 (en) 2016-01-05 2022-05-31 Cardiofocus, Inc. Ablation system with automated sweeping ablation energy element
US11389236B2 (en) 2018-01-15 2022-07-19 Cardiofocus, Inc. Ablation system with automated ablation energy element
US11406250B2 (en) 2005-02-02 2022-08-09 Intuitive Surgical Operations, Inc. Methods and apparatus for treatment of atrial fibrillation
US11439464B2 (en) * 2016-06-28 2022-09-13 Karl PIEPER Appliance for conveying a catheter, light guide or cable in a controlled manner
CN115040063A (en) * 2022-06-10 2022-09-13 兰州大学第二医院 Biliary tract photography catheter system and use method
US11457817B2 (en) 2013-11-20 2022-10-04 The George Washington University Systems and methods for hyperspectral analysis of cardiac tissue
US20220322926A1 (en) * 2017-11-09 2022-10-13 Corinth MedTech, Inc. Surgical devices and methods
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110015484A1 (en) * 2009-07-16 2011-01-20 Alvarez Jeffrey B Endoscopic robotic catheter system
US9254090B2 (en) * 2010-10-22 2016-02-09 Intuitive Surgical Operations, Inc. Tissue contrast imaging systems
US9629595B2 (en) * 2013-03-15 2017-04-25 Hansen Medical, Inc. Systems and methods for localizing, tracking and/or controlling medical instruments
US10772655B2 (en) * 2016-02-23 2020-09-15 Koninklijke Philips N.V. Ultrasound ablation device
EP3372356B1 (en) * 2017-03-06 2020-05-06 Siemens Healthcare GmbH System and method for motion capture and controlling a robotic tool
JP2021104072A (en) * 2018-03-14 2021-07-26 オリンパス株式会社 Endoscope apparatus and fluid feeding method using endoscope apparatus
CA3157362A1 (en) 2019-10-15 2021-04-22 Imperative Care, Inc. Systems and methods for multivariate stroke detection
US11786106B2 (en) 2020-05-26 2023-10-17 Canon U.S.A., Inc. Robotic endoscope probe having orientation reference markers
EP4213697A1 (en) * 2020-09-17 2023-07-26 Shifamed Holdings, LLC Tissue piercing assemblies and methods of use

Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4681093A (en) * 1982-12-13 1987-07-21 Sumitomo Electric Industries, Ltd. Endoscope
US5515853A (en) * 1995-03-28 1996-05-14 Sonometrics Corporation Three-dimensional digital ultrasound tracking system
US5575756A (en) * 1993-08-16 1996-11-19 Olympus Optical Co., Ltd. Endoscope apparatus
US5695448A (en) * 1994-08-29 1997-12-09 Olympus Optical Co., Ltd. Endoscopic sheath
US5895417A (en) * 1996-03-06 1999-04-20 Cardiac Pathways Corporation Deflectable loop design for a linear lesion ablation apparatus
US5941845A (en) * 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US5944690A (en) * 1997-03-17 1999-08-31 C.R. Bard, Inc. Slidable control mechanism for steerable catheter
US6129724A (en) * 1993-10-14 2000-10-10 Ep Technologies, Inc. Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements
US6258083B1 (en) * 1996-03-29 2001-07-10 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US20020087166A1 (en) * 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US20020087169A1 (en) * 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US6428536B2 (en) * 1996-01-19 2002-08-06 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US6475223B1 (en) * 1997-08-29 2002-11-05 Stereotaxis, Inc. Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter
US6482162B1 (en) * 1998-12-08 2002-11-19 Scimed Life Systems, Inc. Loop imaging catheter
US6587709B2 (en) * 2001-03-28 2003-07-01 Koninklijke Philips Electronics N.V. Method of and imaging ultrasound system for determining the position of a catheter
US20030171741A1 (en) * 2001-11-14 2003-09-11 Latis, Inc. Catheters for clot removal
US20040117032A1 (en) * 1993-02-22 2004-06-17 Roth Alex T. Devices for less-invasive intracardiac interventions
US20050182465A1 (en) * 2004-02-12 2005-08-18 Ness Gregory O. Instruments and methods for accessing an anatomic space
US20060030844A1 (en) * 2004-08-04 2006-02-09 Knight Bradley P Transparent electrode for the radiofrequency ablation of tissue
US7019610B2 (en) * 2002-01-23 2006-03-28 Stereotaxis, Inc. Magnetic navigation system
US20060084945A1 (en) * 2004-03-05 2006-04-20 Hansen Medical, Inc. Instrument driver for robotic catheter system
US20060184048A1 (en) * 2005-02-02 2006-08-17 Vahid Saadat Tissue visualization and manipulation system
US20060271032A1 (en) * 2005-05-26 2006-11-30 Chin Albert K Ablation instruments and methods for performing abalation
US20070270686A1 (en) * 2006-05-03 2007-11-22 Ritter Rogers C Apparatus and methods for using inertial sensing to navigate a medical device
US20070293724A1 (en) * 2005-02-02 2007-12-20 Voyage Medical, Inc. Visualization apparatus for transseptal access
US20080009747A1 (en) * 2005-02-02 2008-01-10 Voyage Medical, Inc. Transmural subsurface interrogation and ablation
US20080015569A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Methods and apparatus for treatment of atrial fibrillation
US20080015445A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Tissue visualization device and method variations
US20080033290A1 (en) * 2005-10-25 2008-02-07 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US20080275300A1 (en) * 2007-04-27 2008-11-06 Voyage Medical, Inc. Complex shape steerable tissue visualization and manipulation catheter

Family Cites Families (545)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US623002A (en) 1899-04-11 Gerald
US623022A (en) 1899-04-11 johnson
US2305462A (en) 1940-06-20 1942-12-15 Wolf Richard Cystoscopic instrument
US2453862A (en) 1947-06-02 1948-11-16 Salisbury Peter Frederic Gastroscope
US3559651A (en) * 1968-10-14 1971-02-02 David H Moss Body-worn all disposable urinal
US3831587A (en) 1973-02-08 1974-08-27 Mc Anally R Multipurpose vaginal and cervical device
US3903877A (en) 1973-06-13 1975-09-09 Olympus Optical Co Endoscope
US4175545A (en) 1977-03-10 1979-11-27 Zafmedico Corp. Method and apparatus for fiber-optic cardiovascular endoscopy
DE2853466C2 (en) 1977-12-11 1983-03-24 Kabushiki Kaisha Medos Kenkyusho, Tokyo endoscope
US4198981A (en) * 1978-03-27 1980-04-22 Manfred Sinnreich Intrauterine surgical device
US4326529A (en) 1978-05-26 1982-04-27 The United States Of America As Represented By The United States Department Of Energy Corneal-shaping electrode
US4403612A (en) 1980-10-20 1983-09-13 Fogarty Thomas J Dilatation method
JPS5869527A (en) 1981-10-20 1983-04-25 富士写真フイルム株式会社 High frequency knife and endoscope using same
US4470407A (en) 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
US4445892A (en) 1982-05-06 1984-05-01 Laserscope, Inc. Dual balloon catheter device
US5435805A (en) 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
JPS5993413A (en) 1982-11-18 1984-05-29 Olympus Optical Co Ltd Endoscope
CA1244889A (en) 1983-01-24 1988-11-15 Kureha Chemical Ind Co Ltd Device for hyperthermia
JPS59172621A (en) * 1983-03-22 1984-09-29 Sumitomo Electric Ind Ltd Fiberscope
JPS59181315A (en) 1983-03-31 1984-10-15 Kiyoshi Inoue Fiber scope
US4619247A (en) 1983-03-31 1986-10-28 Sumitomo Electric Industries, Ltd. Catheter
US4569335A (en) * 1983-04-12 1986-02-11 Sumitomo Electric Industries, Ltd. Fiberscope
JPS60125610U (en) 1984-02-03 1985-08-24 オリンパス光学工業株式会社 Strabismus-type rigid endoscope
US4960411A (en) 1984-09-18 1990-10-02 Medtronic Versaflex, Inc. Low profile sterrable soft-tip catheter
JPS626212A (en) * 1985-07-02 1987-01-13 Olympus Optical Co Ltd Image signal processing circuit
US4696668A (en) * 1985-07-17 1987-09-29 Wilcox Gilbert M Double balloon nasobiliary occlusion catheter for treating gallstones and method of using the same
EP0214712B1 (en) 1985-07-31 1992-09-02 C.R. Bard, Inc. Infrared laser catheter apparatus
US4917084A (en) 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US4772260A (en) 1986-05-02 1988-09-20 Heyden Eugene L Rectal catheter
US4709698A (en) 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US4838246A (en) 1986-08-13 1989-06-13 Messerschmitt-Bolkow-Blohm Gmbh Application part for an endoscope
US4784133A (en) 1987-01-28 1988-11-15 Mackin Robert A Working well balloon angioscope and method
US4976710A (en) 1987-01-28 1990-12-11 Mackin Robert A Working well balloon method
US4961738A (en) 1987-01-28 1990-10-09 Mackin Robert A Angioplasty catheter with illumination and visualization within angioplasty balloon
NL8700329A (en) 1987-02-11 1988-09-01 Hoed Daniel Stichting DEVICE AND METHOD FOR EXAMINING AND / OR EXPOSING A CAVE IN A BODY.
US5090959A (en) * 1987-04-30 1992-02-25 Advanced Cardiovascular Systems, Inc. Imaging balloon dilatation catheter
US4943290A (en) 1987-06-23 1990-07-24 Concept Inc. Electrolyte purging electrode tip
IT1235460B (en) 1987-07-31 1992-07-30 Confida Spa FLEXIBLE ENDOSCOPE.
US5372138A (en) 1988-03-21 1994-12-13 Boston Scientific Corporation Acousting imaging catheters and the like
US4998972A (en) * 1988-04-28 1991-03-12 Thomas J. Fogarty Real time angioscopy imaging system
AU3696989A (en) 1988-05-18 1989-12-12 Kasevich Associates, Inc. Microwave balloon angioplasty
US4880015A (en) * 1988-06-03 1989-11-14 Nierman David M Biopsy forceps
US6120437A (en) 1988-07-22 2000-09-19 Inbae Yoon Methods for creating spaces at obstructed sites endoscopically and methods therefor
US4957484A (en) 1988-07-26 1990-09-18 Automedix Sciences, Inc. Lymph access catheters and methods of administration
US5123428A (en) 1988-10-11 1992-06-23 Schwarz Gerald R Laparoscopically implanting bladder control apparatus
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US4998916A (en) * 1989-01-09 1991-03-12 Hammerslag Julius G Steerable medical device
US4914521A (en) 1989-02-03 1990-04-03 Adair Edwin Lloyd Sterilizable video camera cover
USRE34002E (en) 1989-02-03 1992-07-21 Sterilizable video camera cover
US4911148A (en) * 1989-03-14 1990-03-27 Intramed Laboratories, Inc. Deflectable-end endoscope with detachable flexible shaft assembly
US4991578A (en) * 1989-04-04 1991-02-12 Siemens-Pacesetter, Inc. Method and system for implanting self-anchoring epicardial defibrillation electrodes
DE3915636C1 (en) 1989-05-12 1990-04-26 Sass, Wolfgang, Dr.
NL8901350A (en) * 1989-05-29 1990-12-17 Wouter Matthijs Muijs Van De M CLOSURE ASSEMBLY.
US4950285A (en) 1989-11-27 1990-08-21 Wilk Peter J Suture device
US5514153A (en) 1990-03-02 1996-05-07 General Surgical Innovations, Inc. Method of dissecting tissue layers
US5345927A (en) 1990-03-02 1994-09-13 Bonutti Peter M Arthroscopic retractors
US5025778A (en) 1990-03-26 1991-06-25 Opielab, Inc. Endoscope with potential channels and method of using the same
JP2893833B2 (en) 1990-03-30 1999-05-24 東レ株式会社 Endoscopic balloon catheter
WO1991015155A1 (en) 1990-04-02 1991-10-17 Kanji Inoue Device for closing shunt opening by nonoperative method
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5197457A (en) 1990-09-12 1993-03-30 Adair Edwin Lloyd Deformable and removable sheath for optical catheter
US5370647A (en) 1991-01-23 1994-12-06 Surgical Innovations, Inc. Tissue and organ extractor
JP2953079B2 (en) 1991-02-14 1999-09-27 富士写真光機株式会社 Electronic endoscope device
US5156141A (en) 1991-03-11 1992-10-20 Helmut Krebs Connector for coupling an endoscope to a video camera
JP3065702B2 (en) 1991-04-23 2000-07-17 オリンパス光学工業株式会社 Endoscope system
US5330496A (en) 1991-05-06 1994-07-19 Alferness Clifton A Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof
US5865728A (en) 1991-05-29 1999-02-02 Origin Medsystems, Inc. Method of using an endoscopic inflatable lifting apparatus to create an anatomic working space
DK0637223T3 (en) 1991-05-29 1999-04-26 Origin Medsystems Inc Endoscopic Surgery Retention Device
US5697281A (en) 1991-10-09 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
JPH05103746A (en) 1991-10-18 1993-04-27 Olympus Optical Co Ltd Metabolism information measuring device
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5281238A (en) * 1991-11-22 1994-01-25 Chin Albert K Endoscopic ligation instrument
US5697882A (en) 1992-01-07 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US6190381B1 (en) * 1995-06-07 2001-02-20 Arthrocare Corporation Methods for tissue resection, ablation and aspiration
CA2089999A1 (en) 1992-02-24 1993-08-25 H. Jonathan Tovey Resilient arm mesh deployer
US5334159A (en) 1992-03-30 1994-08-02 Symbiosis Corporation Thoracentesis needle assembly utilizing check valve
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
DE4214283A1 (en) 1992-04-30 1993-11-04 Schneider Co Optische Werke Contactless length measuring camera - contains semiconducting transducer moved axially within camera body during focussing
US5305121A (en) 1992-06-08 1994-04-19 Origin Medsystems, Inc. Stereoscopic endoscope system
US5336252A (en) 1992-06-22 1994-08-09 Cohen Donald M System and method for implanting cardiac electrical leads
US5672153A (en) 1992-08-12 1997-09-30 Vidamed, Inc. Medical probe device and method
US5527338A (en) 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5313934A (en) 1992-09-10 1994-05-24 Deumed Group Inc. Lens cleaning means for invasive viewing medical instruments
US5339800A (en) 1992-09-10 1994-08-23 Devmed Group Inc. Lens cleaning means for invasive viewing medical instruments with anti-contamination means
AT397458B (en) 1992-09-25 1994-04-25 Avl Verbrennungskraft Messtech SENSOR ARRANGEMENT
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5373840A (en) 1992-10-02 1994-12-20 Knighton; David R. Endoscope and method for vein removal
NL9201965A (en) 1992-11-10 1994-06-01 Draeger Med Electronics Bv Invasive MRI transducer.
US6923805B1 (en) 1992-11-13 2005-08-02 Scimed Life Systems, Inc. Electrophysiology energy treatment devices and methods of use
DE4338758C2 (en) 1992-11-13 2001-08-09 Scimed Life Systems Inc Catheter assembly
US5676693A (en) 1992-11-13 1997-10-14 Scimed Life Systems, Inc. Electrophysiology device
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US6068653A (en) 1992-11-13 2000-05-30 Scimed Life Systems, Inc. Electrophysiology catheter device
US5348554A (en) 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5417699A (en) * 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5385146A (en) 1993-01-08 1995-01-31 Goldreyer; Bruce N. Orthogonal sensing for use in clinical electrophysiology
US5409483A (en) 1993-01-22 1995-04-25 Jeffrey H. Reese Direct visualization surgical probe
US5403326A (en) 1993-02-01 1995-04-04 The Regents Of The University Of California Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US5797960A (en) 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5306234A (en) 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5403311A (en) 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5549553A (en) 1993-04-29 1996-08-27 Scimed Life Systems, Inc. Dilation ballon for a single operator exchange intravascular catheter or similar device
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
DE69432148T2 (en) 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5391199A (en) 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US6285898B1 (en) 1993-07-20 2001-09-04 Biosense, Inc. Cardiac electromechanics
AU7404994A (en) 1993-07-30 1995-02-28 Regents Of The University Of California, The Endocardial infusion catheter
US5385148A (en) * 1993-07-30 1995-01-31 The Regents Of The University Of California Cardiac imaging and ablation catheter
US5391182A (en) * 1993-08-03 1995-02-21 Origin Medsystems, Inc. Apparatus and method for closing puncture wounds
US5431649A (en) 1993-08-27 1995-07-11 Medtronic, Inc. Method and apparatus for R-F ablation
US5405376A (en) 1993-08-27 1995-04-11 Medtronic, Inc. Method and apparatus for ablation
US5575810A (en) 1993-10-15 1996-11-19 Ep Technologies, Inc. Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like
US5797903A (en) 1996-04-12 1998-08-25 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces
US5462521A (en) 1993-12-21 1995-10-31 Angeion Corporation Fluid cooled and perfused tip for a catheter
US5458612A (en) 1994-01-06 1995-10-17 Origin Medsystems, Inc. Prostatic ablation method and apparatus for perineal approach
US5471515A (en) 1994-01-28 1995-11-28 California Institute Of Technology Active pixel sensor with intra-pixel charge transfer
GB9401913D0 (en) 1994-02-01 1994-03-30 Watkins David L Bag sealing apparatus
US5411016A (en) 1994-02-22 1995-05-02 Scimed Life Systems, Inc. Intravascular balloon catheter for use in combination with an angioscope
US5547455A (en) 1994-03-30 1996-08-20 Medical Media Systems Electronically steerable endoscope
US5653677A (en) 1994-04-12 1997-08-05 Fuji Photo Optical Co. Ltd Electronic endoscope apparatus with imaging unit separable therefrom
US5484412A (en) * 1994-04-19 1996-01-16 Pierpont; Brien E. Angioplasty method and means for performing angioplasty
US5746747A (en) 1994-05-13 1998-05-05 Mckeating; John A. Polypectomy instrument
US5842973A (en) 1994-05-17 1998-12-01 Bullard; James Roger Nasal intubation apparatus
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US6056744A (en) 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US5575788A (en) 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5593405A (en) * 1994-07-16 1997-01-14 Osypka; Peter Fiber optic endoscope
US5593424A (en) * 1994-08-10 1997-01-14 Segmed, Inc. Apparatus and method for reducing and stabilizing the circumference of a vascular structure
US5643282A (en) 1994-08-22 1997-07-01 Kieturakis; Maciej J. Surgical instrument and method for removing tissue from an endoscopic workspace
US6423055B1 (en) 1999-07-14 2002-07-23 Cardiofocus, Inc. Phototherapeutic wave guide apparatus
US6558375B1 (en) 2000-07-14 2003-05-06 Cardiofocus, Inc. Cardiac ablation instrument
US6579285B2 (en) 1994-09-09 2003-06-17 Cardiofocus, Inc. Photoablation with infrared radiation
US6168591B1 (en) * 1994-09-09 2001-01-02 Cardiofocus, Inc. Guide for penetrating phototherapy
US6676656B2 (en) * 1994-09-09 2004-01-13 Cardiofocus, Inc. Surgical ablation with radiant energy
US6102905A (en) 1994-09-09 2000-08-15 Cardiofocus, Inc. Phototherapy device including housing for an optical element and method of making
US8025661B2 (en) 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US6572609B1 (en) 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US6270492B1 (en) 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US5792045A (en) 1994-10-03 1998-08-11 Adair; Edwin L. Sterile surgical coupler and drape
US5498230A (en) * 1994-10-03 1996-03-12 Adair; Edwin L. Sterile connector and video camera cover for sterile endoscope
US5591119A (en) * 1994-12-07 1997-01-07 Adair; Edwin L. Sterile surgical coupler and drape
US5879366A (en) * 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
AU1426995A (en) 1995-01-19 1996-08-07 Ten Cate, F.J. Local delivery and monitoring of drugs
US5665062A (en) 1995-01-23 1997-09-09 Houser; Russell A. Atherectomy catheter and RF cutting method
US6690963B2 (en) 1995-01-24 2004-02-10 Biosense, Inc. System for determining the location and orientation of an invasive medical instrument
US6409722B1 (en) * 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6063081A (en) 1995-02-22 2000-05-16 Medtronic, Inc. Fluid-assisted electrocautery device
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6132438A (en) * 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
ES2154824T5 (en) * 1995-06-23 2005-04-01 Gyrus Medical Limited ELECTROCHIRURGICAL INSTRUMENT.
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
JP3134726B2 (en) 1995-08-14 2001-02-13 富士写真光機株式会社 Ultrasound diagnostic equipment
JP3151153B2 (en) 1995-09-20 2001-04-03 定夫 尾股 Frequency deviation detection circuit and measuring instrument using the same
US5716321A (en) * 1995-10-10 1998-02-10 Conceptus, Inc. Method for maintaining separation between a falloposcope and a tubal wall
US6726677B1 (en) 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US5860953A (en) 1995-11-21 1999-01-19 Catheter Imaging Systems, Inc. Steerable catheter having disposable module and sterilizable handle and method of connecting same
AU690862B2 (en) 1995-12-04 1998-04-30 Target Therapeutics, Inc. Fibered micro vaso-occlusive devices
US5846239A (en) 1996-04-12 1998-12-08 Ep Technologies, Inc. Tissue heating and ablation systems and methods using segmented porous electrode structures
US5749889A (en) 1996-02-13 1998-05-12 Imagyn Medical, Inc. Method and apparatus for performing biopsy
DE69732362T2 (en) 1996-02-15 2006-03-23 Biosense Webster, Inc., Diamond Bar Method for calibrating a probe
US5725523A (en) * 1996-03-29 1998-03-10 Mueller; Richard L. Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications
US6063077A (en) 1996-04-08 2000-05-16 Cardima, Inc. Linear ablation device and assembly
US6549800B1 (en) 1996-04-25 2003-04-15 Johns Hopkins Unversity School Of Medicine Methods for in vivo magnetic resonance imaging
US5713867A (en) 1996-04-29 1998-02-03 Medtronic, Inc. Introducer system having kink resistant splittable sheath
US6270477B1 (en) 1996-05-20 2001-08-07 Percusurge, Inc. Catheter for emboli containment
US5754313A (en) 1996-07-17 1998-05-19 Welch Allyn, Inc. Imager assembly
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US6905505B2 (en) 1996-07-26 2005-06-14 Kensey Nash Corporation System and method of use for agent delivery and revascularizing of grafts and vessels
US6830577B2 (en) 1996-07-26 2004-12-14 Kensey Nash Corporation System and method of use for treating occluded vessels and diseased tissue
US5826576A (en) 1996-08-08 1998-10-27 Medtronic, Inc. Electrophysiology catheter with multifunction wire and method for making
US6126682A (en) 1996-08-13 2000-10-03 Oratec Interventions, Inc. Method for treating annular fissures in intervertebral discs
US5827175A (en) 1996-09-30 1998-10-27 Fuji Photo Optical Co., Ltd. Endoscopically inserting ultrasound probe
WO1998015226A1 (en) 1996-10-08 1998-04-16 Hitachi Medical Corporation Method and apparatus for forming and displaying image from a plurality of sectional images
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US6237605B1 (en) 1996-10-22 2001-05-29 Epicor, Inc. Methods of epicardial ablation
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6840936B2 (en) 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
US6719755B2 (en) * 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US5904651A (en) 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5722403A (en) * 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5752518A (en) 1996-10-28 1998-05-19 Ep Technologies, Inc. Systems and methods for visualizing interior regions of the body
US5848969A (en) 1996-10-28 1998-12-15 Ep Technologies, Inc. Systems and methods for visualizing interior tissue regions using expandable imaging structures
US5908445A (en) 1996-10-28 1999-06-01 Ep Technologies, Inc. Systems for visualizing interior tissue regions including an actuator to move imaging element
US5827268A (en) 1996-10-30 1998-10-27 Hearten Medical, Inc. Device for the treatment of patent ductus arteriosus and method of using the device
US6002955A (en) 1996-11-08 1999-12-14 Medtronic, Inc. Stabilized electrophysiology catheter and method for use
US5749890A (en) 1996-12-03 1998-05-12 Shaknovich; Alexander Method and system for stent placement in ostial lesions
US6071279A (en) 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6007521A (en) 1997-01-07 1999-12-28 Bidwell; Robert E. Drainage catheter system
US6013024A (en) 1997-01-20 2000-01-11 Suzuki Motor Corporation Hybrid operation system
JP3134287B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Catheter assembly for endocardial suture surgery
US5968053A (en) 1997-01-31 1999-10-19 Cardiac Assist Technologies, Inc. Method and apparatus for implanting a graft in a vessel of a patient
US6295989B1 (en) 1997-02-06 2001-10-02 Arteria Medical Science, Inc. ICA angioplasty with cerebral protection
US20020026145A1 (en) * 1997-03-06 2002-02-28 Bagaoisan Celso J. Method and apparatus for emboli containment
US6086534A (en) 1997-03-07 2000-07-11 Cardiogenesis Corporation Apparatus and method of myocardial revascularization using ultrasonic pulse-echo distance ranging
WO1998040014A1 (en) 1997-03-10 1998-09-17 Robin Medical Inc. Method and apparatus for the assessment and display of variability in mechanical activity of the heart, and enhancement of ultrasound contrast imaging by variability analysis
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US5897487A (en) 1997-04-15 1999-04-27 Asahi Kogaku Kogyo Kabushiki Kaisha Front end hood for endoscope
US6081740A (en) 1997-04-23 2000-06-27 Accumed International, Inc. Method and apparatus for imaging and sampling diseased tissue
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6251109B1 (en) 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6514249B1 (en) * 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6997925B2 (en) 1997-07-08 2006-02-14 Atrionx, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
DE69822713T2 (en) 1997-07-22 2005-02-10 Terumo K.K. Indwelling catheter set and manufacturing method
EP1003428B1 (en) 1997-07-24 2005-04-27 Rex Medical, LP Breast surgery apparatus
US5902299A (en) * 1997-07-29 1999-05-11 Jayaraman; Swaminathan Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
US6459919B1 (en) 1997-08-26 2002-10-01 Color Kinetics, Incorporated Precision illumination methods and systems
US6086528A (en) 1997-09-11 2000-07-11 Adair; Edwin L. Surgical devices with removable imaging capability and methods of employing same
US6211904B1 (en) 1997-09-11 2001-04-03 Edwin L. Adair Surgical devices incorporating reduced area imaging devices
US6401719B1 (en) 1997-09-11 2002-06-11 Vnus Medical Technologies, Inc. Method of ligating hollow anatomical structures
US6043839A (en) 1997-10-06 2000-03-28 Adair; Edwin L. Reduced area imaging devices
US5929901A (en) 1997-10-06 1999-07-27 Adair; Edwin L. Reduced area imaging devices incorporated within surgical instruments
US6179832B1 (en) * 1997-09-11 2001-01-30 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes
US5916147A (en) 1997-09-22 1999-06-29 Boury; Harb N. Selectively manipulable catheter
US5986693A (en) 1997-10-06 1999-11-16 Adair; Edwin L. Reduced area imaging devices incorporated within surgical instruments
US6310642B1 (en) 1997-11-24 2001-10-30 Micro-Medical Devices, Inc. Reduced area imaging devices incorporated within surgical instruments
US7030904B2 (en) 1997-10-06 2006-04-18 Micro-Medical Devices, Inc. Reduced area imaging device incorporated within wireless endoscopic devices
US6240312B1 (en) 1997-10-23 2001-05-29 Robert R. Alfano Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6234995B1 (en) 1998-11-12 2001-05-22 Advanced Interventional Technologies, Inc. Apparatus and method for selectively isolating a proximal anastomosis site from blood in an aorta
US6982740B2 (en) * 1997-11-24 2006-01-03 Micro-Medical Devices, Inc. Reduced area imaging devices utilizing selected charge integration periods
US5997571A (en) 1997-12-17 1999-12-07 Cardiofocus, Inc. Non-occluding phototherapy probe stabilizers
US6632171B2 (en) 1997-12-22 2003-10-14 Given Imaging Ltd. Method for in vivo delivery of autonomous capsule
US6071302A (en) 1997-12-31 2000-06-06 Cardiofocus, Inc. Phototherapeutic apparatus for wide-angle diffusion
US6423058B1 (en) 1998-02-19 2002-07-23 Curon Medical, Inc. Assemblies to visualize and treat sphincters and adjoining tissue regions
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
US5997509A (en) 1998-03-06 1999-12-07 Cornell Research Foundation, Inc. Minimally invasive gene therapy delivery device and method
US6115626A (en) 1998-03-26 2000-09-05 Scimed Life Systems, Inc. Systems and methods using annotated images for controlling the use of diagnostic or therapeutic instruments in instruments in interior body regions
US6383195B1 (en) 1998-04-13 2002-05-07 Endoline, Inc. Laparoscopic specimen removal apparatus
JPH11299725A (en) 1998-04-21 1999-11-02 Olympus Optical Co Ltd Hood for endoscope
US6522930B1 (en) 1998-05-06 2003-02-18 Atrionix, Inc. Irrigated ablation device assembly
AU3893299A (en) 1998-05-13 1999-11-29 Inbae Yoon Penetrating endoscope and endoscopic surgical instrument with cmos image sensor and display
US6908474B2 (en) * 1998-05-13 2005-06-21 Gore Enterprise Holdings, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US7263397B2 (en) 1998-06-30 2007-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for catheter navigation and location and mapping in the heart
US6537272B2 (en) 1998-07-07 2003-03-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6706039B2 (en) 1998-07-07 2004-03-16 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6238393B1 (en) 1998-07-07 2001-05-29 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6315777B1 (en) 1998-07-07 2001-11-13 Medtronic, Inc. Method and apparatus for creating a virtual electrode used for the ablation of tissue
US6494902B2 (en) 1998-07-07 2002-12-17 Medtronic, Inc. Method for creating a virtual electrode for the ablation of tissue and for selected protection of tissue during an ablation
US6394096B1 (en) 1998-07-15 2002-05-28 Corazon Technologies, Inc. Method and apparatus for treatment of cardiovascular tissue mineralization
US6527979B2 (en) 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
AU5101699A (en) 1998-07-15 2000-02-07 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of vascular calcified lesions
US6290689B1 (en) 1999-10-22 2001-09-18 Corazón Technologies, Inc. Catheter devices and methods for their use in the treatment of calcified vascular occlusions
US6562020B1 (en) 1998-07-15 2003-05-13 Corazon Technologies, Inc. Kits for use in the treatment of vascular calcified lesions
US6352503B1 (en) 1998-07-17 2002-03-05 Olympus Optical Co., Ltd. Endoscopic surgery apparatus
US6112123A (en) 1998-07-28 2000-08-29 Endonetics, Inc. Device and method for ablation of tissue
JP2003524443A (en) 1998-08-02 2003-08-19 スーパー ディメンション リミテッド Medical guidance device
US6139508A (en) 1998-08-04 2000-10-31 Endonetics, Inc. Articulated medical device
US6461327B1 (en) 1998-08-07 2002-10-08 Embol-X, Inc. Atrial isolator and method of use
US6099498A (en) 1998-09-02 2000-08-08 Embol-X, Inc Cardioplegia access view probe and methods of use
US6123703A (en) 1998-09-19 2000-09-26 Tu; Lily Chen Ablation catheter and methods for treating tissues
US6178346B1 (en) * 1998-10-23 2001-01-23 David C. Amundson Infrared endoscopic imaging in a liquid with suspended particles: method and apparatus
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6152144A (en) 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US6396873B1 (en) 1999-02-25 2002-05-28 Envision Advanced Medical Systems Optical device
JP3596340B2 (en) 1999-03-18 2004-12-02 株式会社日立製作所 Surgical insertion device
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US20040044350A1 (en) 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US6167297A (en) 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
JP3490933B2 (en) 1999-06-07 2004-01-26 ペンタックス株式会社 Swallowable endoscope device
US6890329B2 (en) 1999-06-15 2005-05-10 Cryocath Technologies Inc. Defined deflection structure
US6306132B1 (en) 1999-06-17 2001-10-23 Vivant Medical Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use
AUPQ115499A0 (en) * 1999-06-24 1999-07-15 Colocare Holdings Pty Limited Colostomy pump device
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US7637905B2 (en) 2003-01-15 2009-12-29 Usgi Medical, Inc. Endoluminal tool deployment system
US20050234436A1 (en) 1999-07-14 2005-10-20 Cardiofocus, Inc. Methods of cardiac ablation in the vicinity of the right inferior pulmonary vein
US20050222558A1 (en) 1999-07-14 2005-10-06 Cardiofocus, Inc. Methods of cardiac ablation employing a deflectable sheath catheter
US8540704B2 (en) 1999-07-14 2013-09-24 Cardiofocus, Inc. Guided cardiac ablation catheters
US7935108B2 (en) 1999-07-14 2011-05-03 Cardiofocus, Inc. Deflectable sheath catheters
US20050234437A1 (en) 1999-07-14 2005-10-20 Cardiofocus, Inc. Deflectable sheath catheters with out-of-plane bent tip
CA2377583A1 (en) 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US6235044B1 (en) 1999-08-04 2001-05-22 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue
US20040167503A1 (en) 1999-08-25 2004-08-26 Cardiofocus, Inc. Malleable surgical ablation instruments
US6755811B1 (en) 1999-08-25 2004-06-29 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
US20040147913A1 (en) 1999-08-25 2004-07-29 Cardiofocus, Inc. Surgical ablation instruments with irrigation features
US6702780B1 (en) 1999-09-08 2004-03-09 Super Dimension Ltd. Steering configuration for catheter with rigid distal device
US6458151B1 (en) 1999-09-10 2002-10-01 Frank S. Saltiel Ostial stent positioning device and method
US6315778B1 (en) 1999-09-10 2001-11-13 C. R. Bard, Inc. Apparatus for creating a continuous annular lesion
US6423051B1 (en) 1999-09-16 2002-07-23 Aaron V. Kaplan Methods and apparatus for pericardial access
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6385476B1 (en) 1999-09-21 2002-05-07 Biosense, Inc. Method and apparatus for intracardially surveying a condition of a chamber of a heart
US6915154B1 (en) 1999-09-24 2005-07-05 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US6485489B2 (en) 1999-10-02 2002-11-26 Quantum Cor, Inc. Catheter system for repairing a mitral valve annulus
US6533767B2 (en) 2000-03-20 2003-03-18 Corazon Technologies, Inc. Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
US6488671B1 (en) 1999-10-22 2002-12-03 Corazon Technologies, Inc. Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
US6780151B2 (en) 1999-10-26 2004-08-24 Acmi Corporation Flexible ureteropyeloscope
US7758521B2 (en) 1999-10-29 2010-07-20 Medtronic, Inc. Methods and systems for accessing the pericardial space
US6613062B1 (en) 1999-10-29 2003-09-02 Medtronic, Inc. Method and apparatus for providing intra-pericardial access
US6711444B2 (en) * 1999-11-22 2004-03-23 Scimed Life Systems, Inc. Methods of deploying helical diagnostic and therapeutic element supporting structures within the body
US6529756B1 (en) 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
US6156350A (en) 1999-12-02 2000-12-05 Corazon Technologies, Inc. Methods and kits for use in preventing restenosis
CA2395924C (en) 2000-01-06 2008-11-18 Raymond L. Bedell Steerable fiberoptic epidural balloon catheter and scope
AU2001232906A1 (en) 2000-01-21 2001-07-31 Molecular Diagnostics, Inc. In-vivo tissue inspection and sampling
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US6478769B1 (en) 2000-02-22 2002-11-12 The Board Of Trustees Of The University Of Arkansas Anatomical fluid evacuation apparatus and method
US6436118B1 (en) 2000-02-25 2002-08-20 General Surgical Innovations, Inc. IMA dissection device
US6544195B2 (en) 2000-03-04 2003-04-08 Joseph F. Wilson Tissue of foreign body extractor
US6565526B2 (en) 2000-03-09 2003-05-20 The Regents Of The University Of California Bistable microvalve and microcatheter system
JP2001258822A (en) 2000-03-14 2001-09-25 Olympus Optical Co Ltd Endoscope
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US6440061B1 (en) 2000-03-24 2002-08-27 Donald E. Wenner Laparoscopic instrument system for real-time biliary exploration and stone removal
EP1267986B1 (en) 2000-03-31 2006-05-10 Medtronic, Inc. Deflection Mechanism
US6858005B2 (en) * 2000-04-03 2005-02-22 Neo Guide Systems, Inc. Tendon-driven endoscope and methods of insertion
US6692430B2 (en) 2000-04-10 2004-02-17 C2Cure Inc. Intra vascular imaging apparatus
IL135571A0 (en) 2000-04-10 2001-05-20 Doron Adler Minimal invasive surgery imaging system
US7056294B2 (en) 2000-04-13 2006-06-06 Ev3 Sunnyvale, Inc Method and apparatus for accessing the left atrial appendage
US6650923B1 (en) 2000-04-13 2003-11-18 Ev3 Sunnyvale, Inc. Method for accessing the left atrium of the heart by locating the fossa ovalis
US6558382B2 (en) 2000-04-27 2003-05-06 Medtronic, Inc. Suction stabilized epicardial ablation devices
US6375654B1 (en) 2000-05-19 2002-04-23 Cardiofocus, Inc. Catheter system with working portion radially expandable upon rotation
JP4674975B2 (en) 2000-05-26 2011-04-20 オリンパス株式会社 Endoscope hood
US6532380B1 (en) 2000-06-30 2003-03-11 Cedars Sinai Medical Center Image guidance for coronary stent deployment
US6811562B1 (en) 2000-07-31 2004-11-02 Epicor, Inc. Procedures for photodynamic cardiac ablation therapy and devices for those procedures
US7399271B2 (en) 2004-01-09 2008-07-15 Cardiokinetix, Inc. Ventricular partitioning device
US6538375B1 (en) 2000-08-17 2003-03-25 General Electric Company Oled fiber light source
JP2002058642A (en) 2000-08-21 2002-02-26 Asahi Optical Co Ltd Imaging element for electronic endoscope
US6605055B1 (en) 2000-09-13 2003-08-12 Cardiofocus, Inc. Balloon catheter with irrigation sheath
JP3533163B2 (en) 2000-09-18 2004-05-31 ペンタックス株式会社 Endoscope tip
JP2002177198A (en) 2000-10-02 2002-06-25 Olympus Optical Co Ltd Endoscope
US6926669B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US6659981B2 (en) 2000-12-08 2003-12-09 Medtronic, Inc. Medical device delivery catheter with distal locator
US6623452B2 (en) 2000-12-19 2003-09-23 Scimed Life Systems, Inc. Drug delivery catheter having a highly compliant balloon with infusion holes
AU2002231074A1 (en) * 2000-12-20 2002-07-01 Fox Hollow Technologies, Inc. Debulking catheter
US6540733B2 (en) 2000-12-29 2003-04-01 Corazon Technologies, Inc. Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion
US6958069B2 (en) 2001-01-17 2005-10-25 Mark LoGuidice Instruments and methods for use in laparoscopic surgery
US6676692B2 (en) 2001-04-27 2004-01-13 Intek Technology L.L.C. Apparatus for delivering, repositioning and/or retrieving self-expanding stents
US7422579B2 (en) 2001-05-01 2008-09-09 St. Jude Medical Cardiology Divison, Inc. Emboli protection devices and related methods of use
CA2445392C (en) 2001-05-10 2011-04-26 Rita Medical Systems, Inc. Rf tissue ablation apparatus and method
US6635070B2 (en) 2001-05-21 2003-10-21 Bacchus Vascular, Inc. Apparatus and methods for capturing particulate material within blood vessels
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
JP3722729B2 (en) * 2001-06-04 2005-11-30 オリンパス株式会社 Endoscope treatment device
US6693821B2 (en) 2001-06-28 2004-02-17 Sharp Laboratories Of America, Inc. Low cross-talk electrically programmable resistance cross point memory
US6796963B2 (en) 2001-07-10 2004-09-28 Myocardial Therapeutics, Inc. Flexible tissue injection catheters with controlled depth penetration
US6773402B2 (en) 2001-07-10 2004-08-10 Biosense, Inc. Location sensing with real-time ultrasound imaging
US6916286B2 (en) 2001-08-09 2005-07-12 Smith & Nephew, Inc. Endoscope with imaging probe
US7218344B2 (en) * 2001-08-15 2007-05-15 Sony Corporation System and method for efficiently performing a white balance operation
US20030036698A1 (en) * 2001-08-16 2003-02-20 Robert Kohler Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US7125421B2 (en) 2001-08-31 2006-10-24 Mitral Interventions, Inc. Method and apparatus for valve repair
US6862468B2 (en) 2001-09-28 2005-03-01 Scimed Life Systems, Inc. Systems and methods for magnetic resonance imaging elastography
CA2460501A1 (en) 2001-09-28 2003-04-10 Institut De Cardiologie De Montreal Method for identification and visualization of atrial tissue
CA2463021A1 (en) 2001-10-12 2003-04-24 Applied Medical Resources Corporation High-flow low-pressure irrigation system
WO2003039350A2 (en) 2001-11-09 2003-05-15 Cardio-Optics, Inc. Direct, real-time imaging guidance of cardiac catheterization
WO2003053226A2 (en) 2001-12-11 2003-07-03 C2Cure Inc. Apparatus, method and system for intravascular photographic imaging
CN101612435B (en) 2001-12-26 2012-03-21 耶鲁大学 Vascular access device
US7717899B2 (en) 2002-01-28 2010-05-18 Cardiac Pacemakers, Inc. Inner and outer telescoping catheter delivery system
JP3826045B2 (en) 2002-02-07 2006-09-27 オリンパス株式会社 Endoscope hood
JP2005518861A (en) 2002-02-28 2005-06-30 メドトロニック・インコーポレーテッド Improved system and method for deploying an implantable medical device
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US20060146172A1 (en) 2002-03-18 2006-07-06 Jacobsen Stephen C Miniaturized utility device having integrated optical capabilities
US7787939B2 (en) 2002-03-18 2010-08-31 Sterling Lc Miniaturized imaging device including utility aperture and SSID
US6712798B2 (en) 2002-03-18 2004-03-30 Corazon Technologies, Inc. Multilumen catheters and methods for their use
US7591780B2 (en) 2002-03-18 2009-09-22 Sterling Lc Miniaturized imaging device with integrated circuit connector system
US6866651B2 (en) 2002-03-20 2005-03-15 Corazon Technologies, Inc. Methods and devices for the in situ dissolution of renal calculi
US6932809B2 (en) 2002-05-14 2005-08-23 Cardiofocus, Inc. Safety shut-off device for laser surgical instruments employing blackbody emitters
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US8194121B2 (en) 2002-05-16 2012-06-05 C2Cure, Inc. Miniature camera head
EP1513440A2 (en) 2002-05-30 2005-03-16 The Board of Trustees of The Leland Stanford Junior University Apparatus and method for coronary sinus access
US8956280B2 (en) 2002-05-30 2015-02-17 Intuitive Surgical Operations, Inc. Apparatus and methods for placing leads using direct visualization
US7101395B2 (en) 2002-06-12 2006-09-05 Mitral Interventions, Inc. Method and apparatus for tissue connection
EP1530441B1 (en) * 2002-06-13 2017-08-02 Ancora Heart, Inc. Devices and methods for heart valve repair
US6783491B2 (en) 2002-06-13 2004-08-31 Vahid Saadat Shape lockable apparatus and method for advancing an instrument through unsupported anatomy
US6679836B2 (en) * 2002-06-21 2004-01-20 Scimed Life Systems, Inc. Universal programmable guide catheter
US20030236493A1 (en) 2002-06-25 2003-12-25 Medamicus, Inc. Articulating handle for a deflectable catheter and method therefor
US7421295B2 (en) 2002-07-19 2008-09-02 Oscor Inc. Implantable cardiac lead having removable fluid delivery port
US6887237B2 (en) 2002-07-22 2005-05-03 Medtronic, Inc. Method for treating tissue with a wet electrode and apparatus for using same
US7314446B2 (en) 2002-07-22 2008-01-01 Ep Medsystems, Inc. Method and apparatus for time gating of medical images
US7001329B2 (en) 2002-07-23 2006-02-21 Pentax Corporation Capsule endoscope guidance system, capsule endoscope holder, and capsule endoscope
US6701581B2 (en) 2002-08-10 2004-03-09 Epicor Industries, Inc. Clamp retention device
US6863668B2 (en) 2002-08-16 2005-03-08 Edwards Lifesciences Corporation Articulation mechanism for medical devices
EP1542587B1 (en) 2002-08-24 2011-04-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for locating the fossa ovalis and performing transseptal puncture
US6755790B2 (en) 2002-10-14 2004-06-29 Medtronic, Inc. Transseptal access tissue thickness sensing dilator devices and methods for fabricating and using same
US20040248837A1 (en) 2002-11-01 2004-12-09 Eyal Raz Methods of treating pulmonary fibrotic disorders
US6899672B2 (en) 2002-11-08 2005-05-31 Scimed Life Systems, Inc. Endoscopic imaging system including removable deflection device
US20050020914A1 (en) * 2002-11-12 2005-01-27 David Amundson Coronary sinus access catheter with forward-imaging
AU2002952663A0 (en) 2002-11-14 2002-11-28 Western Sydney Area Health Service An intramural needle-tipped surgical device
US7697972B2 (en) 2002-11-19 2010-04-13 Medtronic Navigation, Inc. Navigation system for cardiac therapies
US20040158289A1 (en) 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
JP4391765B2 (en) 2002-12-02 2009-12-24 オリンパス株式会社 Endoscopic mucosal resection tool
US20040138707A1 (en) 2003-01-14 2004-07-15 Greenhalgh E. Skott Anchor removable from a substrate
US20040249367A1 (en) 2003-01-15 2004-12-09 Usgi Medical Corp. Endoluminal tool deployment system
US6984232B2 (en) * 2003-01-17 2006-01-10 St. Jude Medical, Daig Division, Inc. Ablation catheter assembly having a virtual electrode comprising portholes
US7323001B2 (en) * 2003-01-30 2008-01-29 Ev3 Inc. Embolic filters with controlled pore size
US8021359B2 (en) * 2003-02-13 2011-09-20 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
CA2516559C (en) 2003-02-21 2016-09-27 Electro-Cat, Llc System and method for measuring cross-sectional areas and pressure gradients in luminal organs
US7473237B2 (en) 2003-02-25 2009-01-06 The Cleveland Clinic Foundation Apparatus for auto-retroperfusion of a coronary vein
US7004925B2 (en) 2003-02-25 2006-02-28 Cleveland Clinic Foundation Apparatus and method for auto-retroperfusion of a coronary vein
US20050015048A1 (en) 2003-03-12 2005-01-20 Chiu Jessica G. Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof
US7658747B2 (en) 2003-03-12 2010-02-09 Nmt Medical, Inc. Medical device for manipulation of a medical implant
US20070055142A1 (en) 2003-03-14 2007-03-08 Webler William E Method and apparatus for image guided position tracking during percutaneous procedures
US7211073B2 (en) 2003-03-18 2007-05-01 Catharos Medical Systems Inc. Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site
US7300429B2 (en) 2003-03-18 2007-11-27 Catharos Medical Systems, Inc. Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site
US7293562B2 (en) * 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US6939348B2 (en) 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US20040199052A1 (en) 2003-04-01 2004-10-07 Scimed Life Systems, Inc. Endoscopic imaging system
US7569952B1 (en) 2003-04-18 2009-08-04 Ferro Solutions, Inc. High efficiency, inductive vibration energy harvester
US7112195B2 (en) 2003-04-21 2006-09-26 Cynosure, Inc. Esophageal lesion treatment method
US20040215180A1 (en) 2003-04-25 2004-10-28 Medtronic, Inc. Ablation of stomach lining to treat obesity
US20040220471A1 (en) 2003-04-29 2004-11-04 Yitzhack Schwartz Method and device for transseptal facilitation using location system
US6994094B2 (en) * 2003-04-29 2006-02-07 Biosense, Inc. Method and device for transseptal facilitation based on injury patterns
US7604649B2 (en) 2003-04-29 2009-10-20 Rex Medical, L.P. Distal protection device
JP4414682B2 (en) 2003-06-06 2010-02-10 オリンパス株式会社 Ultrasound endoscope device
US20040260182A1 (en) 2003-06-23 2004-12-23 Zuluaga Andres F. Intraluminal spectroscope with wall contacting probe
JP4398184B2 (en) 2003-06-24 2010-01-13 オリンパス株式会社 Endoscope
DE602004025954D1 (en) 2003-07-17 2010-04-22 Cordis Corp DEVICES FOR THE PERCUTANEOUS TREATMENT OF AORTIC VALVE STENOSES
US20050027163A1 (en) * 2003-07-29 2005-02-03 Scimed Life Systems, Inc. Vision catheter
US7534204B2 (en) 2003-09-03 2009-05-19 Guided Delivery Systems, Inc. Cardiac visualization devices and methods
US7691112B2 (en) 2003-09-11 2010-04-06 Nmt Medical, Inc. Devices, systems, and methods for suturing tissue
US20050059862A1 (en) 2003-09-12 2005-03-17 Scimed Life Systems, Inc. Cannula with integrated imaging and optical capability
US7569052B2 (en) 2003-09-12 2009-08-04 Boston Scientific Scimed, Inc. Ablation catheter with tissue protecting assembly
US7736362B2 (en) 2003-09-15 2010-06-15 Boston Scientific Scimed, Inc. Catheter balloons
US8172747B2 (en) 2003-09-25 2012-05-08 Hansen Medical, Inc. Balloon visualization for traversing a tissue wall
US7435248B2 (en) 2003-09-26 2008-10-14 Boston Scientific Scimed, Inc. Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel
US7207989B2 (en) 2003-10-27 2007-04-24 Biosense Webster, Inc. Method for ablating with needle electrode
US20050096502A1 (en) 2003-10-29 2005-05-05 Khalili Theodore M. Robotic surgical device
EP1680039A1 (en) * 2003-10-30 2006-07-19 Medical Cv, Inc. Apparatus and method for laser treatment
WO2005046487A1 (en) 2003-11-06 2005-05-26 Nmt Medical, Inc. Transseptal puncture apparatus
US20050215895A1 (en) 2003-11-12 2005-09-29 Popp Richard L Devices and methods for obtaining three-dimensional images of an internal body site
WO2005053517A1 (en) 2003-12-01 2005-06-16 Olympus Corporation Endoscope system
US20050177182A1 (en) 2003-12-04 2005-08-11 Van Der Burg Erik J. System and method for delivering a left atrial appendage containment device
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US20050165456A1 (en) 2003-12-19 2005-07-28 Brian Mann Digital electrode for cardiac rhythm management
JP3823321B2 (en) 2003-12-25 2006-09-20 有限会社エスアールジェイ Balloon control device
US7179224B2 (en) 2003-12-30 2007-02-20 Cardiothoracic Systems, Inc. Organ manipulator and positioner and methods of using the same
WO2005077435A1 (en) 2004-01-19 2005-08-25 Atul Kumar A system for distending body tissue cavities by continuous flow irrigation
US20050228452A1 (en) 2004-02-11 2005-10-13 Mourlas Nicholas J Steerable catheters and methods for using them
US20050197623A1 (en) 2004-02-17 2005-09-08 Leeflang Stephen A. Variable steerable catheters and methods for using them
US8052636B2 (en) * 2004-03-05 2011-11-08 Hansen Medical, Inc. Robotic catheter system and methods
JP4755638B2 (en) 2004-03-05 2011-08-24 ハンセン メディカル,インク. Robotic guide catheter system
US7632265B2 (en) * 2004-05-28 2009-12-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Radio frequency ablation servo catheter and method
US7537580B2 (en) 2004-06-23 2009-05-26 Boston Scientific Scimed, Inc. Intravascular dilatation infusion catheter
US7678081B2 (en) * 2004-07-12 2010-03-16 Pacesetter, Inc. Methods and devices for transseptal access
US8005537B2 (en) * 2004-07-19 2011-08-23 Hansen Medical, Inc. Robotically controlled intravascular tissue injection system
US7242832B2 (en) 2004-07-27 2007-07-10 Medeikon Corporation Device for tissue characterization
US7300397B2 (en) * 2004-07-29 2007-11-27 C2C Cure, Inc. Endoscope electronics assembly
EP2272420B1 (en) 2004-08-24 2013-06-19 The General Hospital Corporation Apparatus for imaging of vessel segments
ES2381384T3 (en) 2004-08-31 2012-05-25 Fox Chase Cancer Center Yeast / bacteria bihybrid system and procedures for its use
US7753906B2 (en) * 2004-09-14 2010-07-13 Richard Esposito Catheter having anchoring and stabilizing devices
US8029470B2 (en) 2004-09-30 2011-10-04 Pacesetter, Inc. Transmembrane access systems and methods
US20060069313A1 (en) 2004-09-30 2006-03-30 Couvillon Lucien A Jr Medical devices with light emitting regions
US20060069303A1 (en) 2004-09-30 2006-03-30 Couvillon Lucien A Jr Endoscopic apparatus with integrated hemostasis device
US7875049B2 (en) 2004-10-04 2011-01-25 Medtronic, Inc. Expandable guide sheath with steerable backbone and methods for making and using them
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
US20060122587A1 (en) 2004-11-17 2006-06-08 Shiva Sharareh Apparatus for real time evaluation of tissue ablation
US20060149129A1 (en) 2005-01-05 2006-07-06 Watts H D Catheter with multiple visual elements
US7883503B2 (en) 2005-01-26 2011-02-08 Kalser Gary Illuminating balloon catheter and method for using the catheter
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US7860556B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue imaging and extraction systems
US7918787B2 (en) * 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US9510732B2 (en) 2005-10-25 2016-12-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
WO2006091597A1 (en) 2005-02-22 2006-08-31 Cardiofocus, Inc. Deflectable sheath catheters
US7789890B2 (en) 2005-03-30 2010-09-07 Ethicon Endo-Surgery, Inc. Harness and balloon catheter assembly and method for use in anastomosis procedures
US20060258909A1 (en) 2005-04-08 2006-11-16 Usgi Medical, Inc. Methods and apparatus for maintaining sterility during transluminal procedures
US20070016130A1 (en) * 2005-05-06 2007-01-18 Leeflang Stephen A Complex Shaped Steerable Catheters and Methods for Making and Using Them
JP2007000463A (en) * 2005-06-24 2007-01-11 Terumo Corp Catheter assembly
WO2007011689A2 (en) 2005-07-15 2007-01-25 The Brigham And Women's Hospital, Inc. Sterile access conduit
WO2007014313A2 (en) 2005-07-26 2007-02-01 Precision Thoracic Corporation Minimally invasive methods and apparatus
US7575569B2 (en) 2005-08-16 2009-08-18 Medtronic, Inc. Apparatus and methods for delivering stem cells and other agents into cardiac tissue
US7765014B2 (en) * 2005-08-16 2010-07-27 Medtronic, Inc. Apparatus and methods for delivering transvenous leads
US7416552B2 (en) 2005-08-22 2008-08-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
US8355801B2 (en) 2005-09-26 2013-01-15 Biosense Webster, Inc. System and method for measuring esophagus proximity
US20070083099A1 (en) 2005-09-29 2007-04-12 Henderson Stephen W Path related three dimensional medical imaging
US20070100324A1 (en) 2005-10-17 2007-05-03 Coaptus Medical Corporation Systems and methods for applying vacuum to a patient, including via a disposable liquid collection unit
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US7918793B2 (en) 2005-10-28 2011-04-05 Biosense Webster, Inc. Synchronization of ultrasound imaging data with electrical mapping
US20070106113A1 (en) 2005-11-07 2007-05-10 Biagio Ravo Combination endoscopic operative delivery system
EP1955643B1 (en) 2005-12-01 2019-01-09 Olympus Corporation Guiding long medical member and long medical device
US20070135826A1 (en) 2005-12-01 2007-06-14 Steve Zaver Method and apparatus for delivering an implant without bias to a left atrial appendage
US8303505B2 (en) 2005-12-02 2012-11-06 Abbott Cardiovascular Systems Inc. Methods and apparatuses for image guided medical procedures
US20090240248A1 (en) 2005-12-30 2009-09-24 C.R. Bard , Inc Methods and Apparatus for Ablation of Cardiac Tissue
EP1980194B1 (en) 2006-01-06 2013-05-08 Olympus Medical Systems Corp. Trans-natural opening based or transcutaneous medical system
WO2007106081A2 (en) 2006-03-10 2007-09-20 The Board Of Trustees Of The Leland Stanford Junior University Percutaneous access and visualization of the spine
US7621894B2 (en) 2006-03-20 2009-11-24 Medtronic, Inc. Slittable or removable valves and apparatus and methods for making and using them
US20070239010A1 (en) 2006-04-11 2007-10-11 Medtronic Vascular, Inc. Catheters with Laterally Deployable Elements and Linear Ultrasound Arrays
US7942871B2 (en) 2006-05-12 2011-05-17 Vytronus, Inc. Device for ablating body tissue
US20070270639A1 (en) 2006-05-17 2007-11-22 Long Gary L Medical instrument having a catheter and having a catheter accessory device and method for using
US7615067B2 (en) 2006-06-05 2009-11-10 Cambridge Endoscopic Devices, Inc. Surgical instrument
US20070299456A1 (en) 2006-06-06 2007-12-27 Teague James A Light responsive medical retrieval devices
US9220402B2 (en) 2006-06-07 2015-12-29 Intuitive Surgical Operations, Inc. Visualization and treatment via percutaneous methods and devices
US9055906B2 (en) 2006-06-14 2015-06-16 Intuitive Surgical Operations, Inc. In-vivo visualization systems
EP2037828A2 (en) * 2006-07-12 2009-03-25 Les Hôpitaux Universitaires De Geneve Medical device for tissue ablation
WO2008014425A2 (en) * 2006-07-26 2008-01-31 Hansen Medical, Inc. Systems for performing minimally invasive surgical operations
US20080033241A1 (en) * 2006-08-01 2008-02-07 Ruey-Feng Peh Left atrial appendage closure
CN101542525B (en) 2006-08-02 2012-12-05 皇家飞利浦电子股份有限公司 3D segmentation by voxel classification based on intensity histogram thresholding initialized by K-means clustering
EP2046227A2 (en) 2006-08-03 2009-04-15 Hansen Medical, Inc. Systems for performing minimally invasive procedures
WO2008024261A2 (en) 2006-08-23 2008-02-28 Cardio-Optics, Inc Image-guided therapy of the fossa ovalis and septal defects
US20080057106A1 (en) 2006-08-29 2008-03-06 Erickson Signe R Low profile bioactive agent delivery device
US20080097476A1 (en) 2006-09-01 2008-04-24 Voyage Medical, Inc. Precision control systems for tissue visualization and manipulation assemblies
US20080058590A1 (en) 2006-09-01 2008-03-06 Nidus Medical, Llc. Tissue visualization device having multi-segmented frame
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
JP2010502313A (en) * 2006-09-01 2010-01-28 ボエッジ メディカル, インコーポレイテッド Method and apparatus for the treatment of atrial fibrillation
US10335131B2 (en) 2006-10-23 2019-07-02 Intuitive Surgical Operations, Inc. Methods for preventing tissue migration
US8337518B2 (en) 2006-12-20 2012-12-25 Onset Medical Corporation Expandable trans-septal sheath
US8131350B2 (en) 2006-12-21 2012-03-06 Voyage Medical, Inc. Stabilization of visualization catheters
US8758229B2 (en) 2006-12-21 2014-06-24 Intuitive Surgical Operations, Inc. Axial visualization systems
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
JP2010526598A (en) 2007-05-11 2010-08-05 ボエッジ メディカル, インコーポレイテッド Visual electrode ablation system
US8527032B2 (en) 2007-05-16 2013-09-03 General Electric Company Imaging system and method of delivery of an instrument to an imaged subject
US20080287805A1 (en) 2007-05-16 2008-11-20 General Electric Company System and method to guide an instrument through an imaged subject
KR20100029235A (en) 2007-06-08 2010-03-16 싸이노슈어, 인코포레이티드 Surgical waveguide
US20090030276A1 (en) * 2007-07-27 2009-01-29 Voyage Medical, Inc. Tissue visualization catheter with imaging systems integration
US20090048480A1 (en) 2007-08-13 2009-02-19 Paracor Medical, Inc. Cardiac harness delivery device
US20090076476A1 (en) 2007-08-15 2009-03-19 Hansen Medical, Inc. Systems and methods employing force sensing for mapping intra-body tissue
US20090062871A1 (en) 2007-08-27 2009-03-05 Singfatt Chin Balloon cannula system for accessing and visualizing spine and related methods
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US20090062790A1 (en) 2007-08-31 2009-03-05 Voyage Medical, Inc. Direct visualization bipolar ablation systems
US20090125022A1 (en) 2007-11-12 2009-05-14 Voyage Medical, Inc. Tissue visualization and ablation systems
US20090143640A1 (en) 2007-11-26 2009-06-04 Voyage Medical, Inc. Combination imaging and treatment assemblies
WO2009092021A1 (en) 2008-01-17 2009-07-23 Nidus Medical, Llc Epicardial access and treatment systems
US8858609B2 (en) 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
WO2009112262A2 (en) 2008-03-12 2009-09-17 Afreeze Gmbh Handle for an ablation device
US7534294B1 (en) 2008-04-14 2009-05-19 Xerox Corporation Quinacridone nanoscale pigment particles and methods of making same
US8532734B2 (en) 2008-04-18 2013-09-10 Regents Of The University Of Minnesota Method and apparatus for mapping a structure
US8494608B2 (en) 2008-04-18 2013-07-23 Medtronic, Inc. Method and apparatus for mapping a structure
US9125562B2 (en) 2009-07-01 2015-09-08 Avinger, Inc. Catheter-based off-axis optical coherence tomography imaging system
US20090326572A1 (en) 2008-06-27 2009-12-31 Ruey-Feng Peh Apparatus and methods for rapid tissue crossing
US9101735B2 (en) * 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US8333012B2 (en) 2008-10-10 2012-12-18 Voyage Medical, Inc. Method of forming electrode placement and connection systems
US9468364B2 (en) 2008-11-14 2016-10-18 Intuitive Surgical Operations, Inc. Intravascular catheter with hood and image processing systems
US8468637B2 (en) 2009-02-06 2013-06-25 Endoclear Llc Mechanically-actuated endotracheal tube cleaning device
WO2010143271A1 (en) 2009-06-09 2010-12-16 独立行政法人産業技術総合研究所 Device for examining vascular function
US8906007B2 (en) 2009-09-28 2014-12-09 Covidien Lp Electrosurgical devices, directional reflector assemblies coupleable thereto, and electrosurgical systems including same
US20110144576A1 (en) 2009-12-14 2011-06-16 Voyage Medical, Inc. Catheter orientation control system mechanisms
US9204858B2 (en) 2010-02-05 2015-12-08 Ultrasonix Medical Corporation Ultrasound pulse-wave doppler measurement of blood flow velocity and/or turbulence
US8694071B2 (en) * 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
US9254090B2 (en) 2010-10-22 2016-02-09 Intuitive Surgical Operations, Inc. Tissue contrast imaging systems
KR101323330B1 (en) 2011-12-28 2013-10-29 삼성메디슨 주식회사 Ultrasound system and method for providing vector doppler image based on decision data
US10537310B2 (en) 2012-04-18 2020-01-21 Hitachi, Ltd. Ultrasound image capture device and ultrasound image capture method
CN106028948B (en) 2014-02-28 2019-04-16 株式会社日立制作所 Ultrasonic imaging apparatus and method
CN110897590B (en) 2014-03-28 2021-11-16 直观外科手术操作公司 Surgical system with haptic feedback based on quantitative three-dimensional imaging

Patent Citations (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4681093A (en) * 1982-12-13 1987-07-21 Sumitomo Electric Industries, Ltd. Endoscope
US20040117032A1 (en) * 1993-02-22 2004-06-17 Roth Alex T. Devices for less-invasive intracardiac interventions
US5575756A (en) * 1993-08-16 1996-11-19 Olympus Optical Co., Ltd. Endoscope apparatus
US6129724A (en) * 1993-10-14 2000-10-10 Ep Technologies, Inc. Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements
US5695448A (en) * 1994-08-29 1997-12-09 Olympus Optical Co., Ltd. Endoscopic sheath
US5515853A (en) * 1995-03-28 1996-05-14 Sonometrics Corporation Three-dimensional digital ultrasound tracking system
US6428536B2 (en) * 1996-01-19 2002-08-06 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US5895417A (en) * 1996-03-06 1999-04-20 Cardiac Pathways Corporation Deflectable loop design for a linear lesion ablation apparatus
US6258083B1 (en) * 1996-03-29 2001-07-10 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US5944690A (en) * 1997-03-17 1999-08-31 C.R. Bard, Inc. Slidable control mechanism for steerable catheter
US5941845A (en) * 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US6475223B1 (en) * 1997-08-29 2002-11-05 Stereotaxis, Inc. Method and apparatus for magnetically controlling motion direction of a mechanically pushed catheter
US20020087166A1 (en) * 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US20020087169A1 (en) * 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US7090683B2 (en) * 1998-02-24 2006-08-15 Hansen Medical, Inc. Flexible instrument
US6482162B1 (en) * 1998-12-08 2002-11-19 Scimed Life Systems, Inc. Loop imaging catheter
US6587709B2 (en) * 2001-03-28 2003-07-01 Koninklijke Philips Electronics N.V. Method of and imaging ultrasound system for determining the position of a catheter
US20030171741A1 (en) * 2001-11-14 2003-09-11 Latis, Inc. Catheters for clot removal
US7019610B2 (en) * 2002-01-23 2006-03-28 Stereotaxis, Inc. Magnetic navigation system
US20050182465A1 (en) * 2004-02-12 2005-08-18 Ness Gregory O. Instruments and methods for accessing an anatomic space
US20060084945A1 (en) * 2004-03-05 2006-04-20 Hansen Medical, Inc. Instrument driver for robotic catheter system
US20060030844A1 (en) * 2004-08-04 2006-02-09 Knight Bradley P Transparent electrode for the radiofrequency ablation of tissue
US20080015569A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Methods and apparatus for treatment of atrial fibrillation
US20070293724A1 (en) * 2005-02-02 2007-12-20 Voyage Medical, Inc. Visualization apparatus for transseptal access
US20080009747A1 (en) * 2005-02-02 2008-01-10 Voyage Medical, Inc. Transmural subsurface interrogation and ablation
US20060184048A1 (en) * 2005-02-02 2006-08-17 Vahid Saadat Tissue visualization and manipulation system
US20080015445A1 (en) * 2005-02-02 2008-01-17 Voyage Medical, Inc. Tissue visualization device and method variations
US20060271032A1 (en) * 2005-05-26 2006-11-30 Chin Albert K Ablation instruments and methods for performing abalation
US20080033290A1 (en) * 2005-10-25 2008-02-07 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US20070270686A1 (en) * 2006-05-03 2007-11-22 Ritter Rogers C Apparatus and methods for using inertial sensing to navigate a medical device
US20080275300A1 (en) * 2007-04-27 2008-11-06 Voyage Medical, Inc. Complex shape steerable tissue visualization and manipulation catheter

Cited By (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100211057A1 (en) * 1995-01-23 2010-08-19 Cardio Vascular Technologies, Inc. a California Corporation Tissue heating device and rf heating method with tissue attachment feature
US20080108876A1 (en) * 2001-09-06 2008-05-08 Houser Russell A Superelastic/Shape Memory Tissue Stabilizers and Surgical Instruments
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US10772492B2 (en) * 2005-02-02 2020-09-15 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US10278588B2 (en) 2005-02-02 2019-05-07 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US20080009747A1 (en) * 2005-02-02 2008-01-10 Voyage Medical, Inc. Transmural subsurface interrogation and ablation
US8814845B2 (en) 2005-02-02 2014-08-26 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US10064540B2 (en) 2005-02-02 2018-09-04 Intuitive Surgical Operations, Inc. Visualization apparatus for transseptal access
US8934962B2 (en) 2005-02-02 2015-01-13 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US9526401B2 (en) 2005-02-02 2016-12-27 Intuitive Surgical Operations, Inc. Flow reduction hood systems
US8050746B2 (en) 2005-02-02 2011-11-01 Voyage Medical, Inc. Tissue visualization device and method variations
US11406250B2 (en) 2005-02-02 2022-08-09 Intuitive Surgical Operations, Inc. Methods and apparatus for treatment of atrial fibrillation
US20060184048A1 (en) * 2005-02-02 2006-08-17 Vahid Saadat Tissue visualization and manipulation system
US11889982B2 (en) 2005-02-02 2024-02-06 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US7860555B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue visualization and manipulation system
US7860556B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue imaging and extraction systems
US7918787B2 (en) 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US10463237B2 (en) 2005-02-02 2019-11-05 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US8419613B2 (en) 2005-02-02 2013-04-16 Voyage Medical, Inc. Tissue visualization device
US8417321B2 (en) 2005-02-02 2013-04-09 Voyage Medical, Inc Flow reduction hood systems
US11819190B2 (en) 2005-02-02 2023-11-21 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US10368729B2 (en) 2005-02-02 2019-08-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US9332893B2 (en) 2005-02-02 2016-05-10 Intuitive Surgical Operations, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US8137333B2 (en) 2005-10-25 2012-03-20 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US9192287B2 (en) 2005-10-25 2015-11-24 Intuitive Surgical Operations, Inc. Tissue visualization device and method variations
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US20080033290A1 (en) * 2005-10-25 2008-02-07 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US9510732B2 (en) 2005-10-25 2016-12-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US20070288078A1 (en) * 2006-03-17 2007-12-13 Steve Livneh Apparatus and method for skin tightening and corrective forming
US20100292558A1 (en) * 2006-06-14 2010-11-18 Voyage Medical, Inc. In-vivo visualization systems
US20150250382A1 (en) * 2006-06-14 2015-09-10 Intuitive Surgical Operations, Inc. In-Vivo Visualization Systems
US9055906B2 (en) * 2006-06-14 2015-06-16 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US11882996B2 (en) 2006-06-14 2024-01-30 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US10470643B2 (en) * 2006-06-14 2019-11-12 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US11337594B2 (en) 2006-09-01 2022-05-24 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US11779195B2 (en) 2006-09-01 2023-10-10 Intuitive Surgical Operations, Inc. Precision control systems for tissue visualization and manipulation assemblies
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US10070772B2 (en) 2006-09-01 2018-09-11 Intuitive Surgical Operations, Inc. Precision control systems for tissue visualization and manipulation assemblies
US20080058590A1 (en) * 2006-09-01 2008-03-06 Nidus Medical, Llc. Tissue visualization device having multi-segmented frame
US11369356B2 (en) 2006-10-23 2022-06-28 Intuitive Surgical Operations, Inc. Methods and apparatus for preventing tissue migration
US20080214889A1 (en) * 2006-10-23 2008-09-04 Voyage Medical, Inc. Methods and apparatus for preventing tissue migration
US10335131B2 (en) 2006-10-23 2019-07-02 Intuitive Surgical Operations, Inc. Methods for preventing tissue migration
US10441136B2 (en) 2006-12-18 2019-10-15 Intuitive Surgical Operations, Inc. Systems and methods for unobstructed visualization and ablation
US10390685B2 (en) 2006-12-21 2019-08-27 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US8131350B2 (en) 2006-12-21 2012-03-06 Voyage Medical, Inc. Stabilization of visualization catheters
US11559188B2 (en) 2006-12-21 2023-01-24 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US8758229B2 (en) 2006-12-21 2014-06-24 Intuitive Surgical Operations, Inc. Axial visualization systems
US9226648B2 (en) 2006-12-21 2016-01-05 Intuitive Surgical Operations, Inc. Off-axis visualization systems
US9155452B2 (en) 2007-04-27 2015-10-13 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US10092172B2 (en) 2007-05-08 2018-10-09 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US10624695B2 (en) 2007-05-11 2020-04-21 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US8709008B2 (en) 2007-05-11 2014-04-29 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US20090227999A1 (en) * 2007-05-11 2009-09-10 Voyage Medical, Inc. Visual electrode ablation systems
US9155587B2 (en) 2007-05-11 2015-10-13 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US10993766B2 (en) 2007-10-05 2021-05-04 Maquet Cardiovascular Llc Devices and methods for minimally-invasive surgical procedures
US10058380B2 (en) 2007-10-05 2018-08-28 Maquet Cordiovascular Llc Devices and methods for minimally-invasive surgical procedures
US11241325B2 (en) 2008-02-07 2022-02-08 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US8858609B2 (en) 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US10278849B2 (en) 2008-02-07 2019-05-07 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
US9101735B2 (en) 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US11350815B2 (en) 2008-07-07 2022-06-07 Intuitive Surgical Operations, Inc. Catheter control systems
US20100049099A1 (en) * 2008-07-18 2010-02-25 Vytronus, Inc. Method and system for positioning an energy source
US10111705B2 (en) 2008-10-10 2018-10-30 Intuitive Surgical Operations, Inc. Integral electrode placement and connection systems
US8333012B2 (en) 2008-10-10 2012-12-18 Voyage Medical, Inc. Method of forming electrode placement and connection systems
US20100262140A1 (en) * 2008-10-10 2010-10-14 Voyage Medical, Inc. Integral electrode placement and connection systems
US8894643B2 (en) 2008-10-10 2014-11-25 Intuitive Surgical Operations, Inc. Integral electrode placement and connection systems
US20100094081A1 (en) * 2008-10-10 2010-04-15 Voyage Medical, Inc. Electrode placement and connection systems
US9468364B2 (en) 2008-11-14 2016-10-18 Intuitive Surgical Operations, Inc. Intravascular catheter with hood and image processing systems
US11622689B2 (en) 2008-11-14 2023-04-11 Intuitive Surgical Operations, Inc. Mapping and real-time imaging a plurality of ablation lesions with registered ablation parameters received from treatment device
US20100204561A1 (en) * 2009-02-11 2010-08-12 Voyage Medical, Inc. Imaging catheters having irrigation
US8545412B2 (en) * 2009-05-29 2013-10-01 Boston Scientific Scimed, Inc. Systems and methods for making and using image-guided intravascular and endocardial therapy systems
US20100305451A1 (en) * 2009-05-29 2010-12-02 Boston Scientific Scimed, Inc. Systems and methods for making and using image-guided intravascular and endocardial therapy systems
US20110160596A1 (en) * 2009-12-24 2011-06-30 Renzo Cecere Instrument including a movement sensor and method of using same
US8758257B2 (en) 2009-12-24 2014-06-24 Renzo Cecere Instrument including a movement sensor for positioning an effective portion and method of using same
US9474471B2 (en) 2009-12-24 2016-10-25 Renzo Cecere Instrument including a movement sensor for determining the position of an anchoring mechanism
US8694071B2 (en) 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
US9351751B2 (en) * 2011-07-08 2016-05-31 Covidien Lp Swinging bars with axial wheels to drive articulating cables
US20130012929A1 (en) * 2011-07-08 2013-01-10 Tyco Healthcare Group Lp Swinging Bars with Axial Wheels to Drive Articulating Cables
US10076238B2 (en) 2011-09-22 2018-09-18 The George Washington University Systems and methods for visualizing ablated tissue
US9014789B2 (en) 2011-09-22 2015-04-21 The George Washington University Systems and methods for visualizing ablated tissue
US10736512B2 (en) 2011-09-22 2020-08-11 The George Washington University Systems and methods for visualizing ablated tissue
US9084611B2 (en) 2011-09-22 2015-07-21 The George Washington University Systems and methods for visualizing ablated tissue
US10716462B2 (en) 2011-09-22 2020-07-21 The George Washington University Systems and methods for visualizing ablated tissue
US11559192B2 (en) 2011-09-22 2023-01-24 The George Washington University Systems and methods for visualizing ablated tissue
US10828081B2 (en) 2013-03-07 2020-11-10 Arthrocare Corporation Methods and systems related to electrosurgical wands
US20140276725A1 (en) * 2013-03-13 2014-09-18 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US10695121B2 (en) * 2013-03-13 2020-06-30 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US9801678B2 (en) * 2013-03-13 2017-10-31 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US20180014873A1 (en) * 2013-03-13 2018-01-18 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US11363965B2 (en) 2013-05-02 2022-06-21 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US11701033B2 (en) * 2013-05-02 2023-07-18 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US10219724B2 (en) * 2013-05-02 2019-03-05 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US20220338758A1 (en) * 2013-05-02 2022-10-27 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US20140330133A1 (en) * 2013-05-02 2014-11-06 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
US11096584B2 (en) 2013-11-14 2021-08-24 The George Washington University Systems and methods for determining lesion depth using fluorescence imaging
US11457817B2 (en) 2013-11-20 2022-10-04 The George Washington University Systems and methods for hyperspectral analysis of cardiac tissue
US11596472B2 (en) 2014-11-03 2023-03-07 460Medical, Inc. Systems and methods for assessment of contact quality
US10143517B2 (en) 2014-11-03 2018-12-04 LuxCath, LLC Systems and methods for assessment of contact quality
US10722301B2 (en) 2014-11-03 2020-07-28 The George Washington University Systems and methods for lesion assessment
US10682179B2 (en) 2014-11-03 2020-06-16 460Medical, Inc. Systems and methods for determining tissue type
US11559352B2 (en) 2014-11-03 2023-01-24 The George Washington University Systems and methods for lesion assessment
US20180021089A1 (en) * 2015-02-09 2018-01-25 Vimecon Gmbh Laser Applicator Having Electrodes
US10779904B2 (en) 2015-07-19 2020-09-22 460Medical, Inc. Systems and methods for lesion formation and assessment
US11344365B2 (en) 2016-01-05 2022-05-31 Cardiofocus, Inc. Ablation system with automated sweeping ablation energy element
US11832878B2 (en) 2016-01-05 2023-12-05 Cardiofocus, Inc. Ablation system with automated ablation energy element
CN109310283A (en) * 2016-04-19 2019-02-05 波士顿科学国际有限公司 Foley's tube visualization device including reinforcing element
US11439464B2 (en) * 2016-06-28 2022-09-13 Karl PIEPER Appliance for conveying a catheter, light guide or cable in a controlled manner
US11911116B2 (en) 2017-09-14 2024-02-27 Vicarious Surgical Inc. Virtual reality surgical camera system
CN111655115A (en) * 2017-09-14 2020-09-11 维卡瑞斯外科手术股份有限公司 Virtual reality surgical camera system
CN111278343A (en) * 2017-10-25 2020-06-12 波士顿科学国际有限公司 Direct visualization catheter and system
US20220322926A1 (en) * 2017-11-09 2022-10-13 Corinth MedTech, Inc. Surgical devices and methods
US11389236B2 (en) 2018-01-15 2022-07-19 Cardiofocus, Inc. Ablation system with automated ablation energy element
CN112584774A (en) * 2018-06-28 2021-03-30 皇家飞利浦有限公司 Internally ultrasound assisted local therapy delivery
US11599994B2 (en) * 2019-03-28 2023-03-07 Purdue Research Foundation System and methods for clear optimally matched panoramic channel technique for deep brain photonic interface
US20200311930A1 (en) * 2019-03-28 2020-10-01 Purdue Research Foundation System and methods for clear optimally matched panoramic channel technique for deep brain photonic interface
WO2021022205A1 (en) * 2019-07-31 2021-02-04 Orsus, Llc Devices and methods for guide wire placement
CN114375213A (en) * 2019-07-31 2022-04-19 奥盛有限责任公司 Device and method for guidewire placement
US20220151711A1 (en) * 2019-07-31 2022-05-19 Orsus, Llc Devices And Methods For Guide Wire Placement
CN115040063A (en) * 2022-06-10 2022-09-13 兰州大学第二医院 Biliary tract photography catheter system and use method

Also Published As

Publication number Publication date
US11779195B2 (en) 2023-10-10
US20190008360A1 (en) 2019-01-10
US10070772B2 (en) 2018-09-11
US20090221871A1 (en) 2009-09-03
US20240032776A1 (en) 2024-02-01

Similar Documents

Publication Publication Date Title
US20240032776A1 (en) Precision control systems for tissue visualization and manipulation assemblies
US11337594B2 (en) Coronary sinus cannulation
US11478152B2 (en) Electrophysiology mapping and visualization system
US20220338712A1 (en) Methods and apparatus for treatment of atrial fibrillation
US10278588B2 (en) Electrophysiology mapping and visualization system
US20190014975A1 (en) Tissue visualization and manipulation system
US8221310B2 (en) Tissue visualization device and method variations
US8419613B2 (en) Tissue visualization device
US7918787B2 (en) Tissue visualization and manipulation systems
WO2007109554A2 (en) Tissue visualization and manipulation systems

Legal Events

Date Code Title Description
AS Assignment

Owner name: VOYAGE MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PEH, RUEY-FENG;SAADAT, VAHID;TAM, EDMUND A.;REEL/FRAME:020104/0329

Effective date: 20070906

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: INTUITIVE SURGICAL OPERATIONS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VOYAGE MEDICAL, INC.;REEL/FRAME:031030/0061

Effective date: 20130816